| GO Terms | Score | Description |
|---|---|---|
| GO:0008150 | 19.50% | biological_process |
| GO:0065007 | 16.95% | biological regulation |
| GO:0050789 | 16.31% | regulation of biological process |
| GO:0050794 | 15.49% | regulation of cellular process |
| GO:0009987 | 14.28% | cellular process |
| GO:0007165 | 11.60% | signal transduction |
| GO:0032501 | 11.35% | multicellular organismal process |
| GO:0032502 | 11.11% | developmental process |
| GO:0019222 | 10.45% | regulation of metabolic process |
| GO:0050896 | 10.24% | response to stimulus |
| GO:0065008 | 9.99% | regulation of biological quality |
| GO:0010646 | 9.50% | regulation of cell communication |
| GO:0051239 | 9.45% | regulation of multicellular organismal process |
| GO:0023051 | 9.45% | regulation of signaling |
| GO:0031323 | 9.36% | regulation of cellular metabolic process |
| GO:0080090 | 9.32% | regulation of primary metabolic process |
| GO:0048519 | 9.28% | negative regulation of biological process |
| GO:0048856 | 9.28% | anatomical structure development |
| GO:0060255 | 9.18% | regulation of macromolecule metabolic process |
| GO:0048583 | 9.15% | regulation of response to stimulus |
| GO:0051179 | 8.97% | localization |
| GO:0071704 | 8.77% | organic substance metabolic process |
| GO:0051234 | 8.70% | establishment of localization |
| GO:0008152 | 8.67% | metabolic process |
| GO:0048523 | 8.62% | negative regulation of cellular process |
| GO:0044238 | 8.56% | primary metabolic process |
| GO:0006810 | 8.51% | transport |
| GO:0051171 | 8.51% | regulation of nitrogen compound metabolic process |
| GO:0009966 | 8.44% | regulation of signal transduction |
| GO:0048518 | 8.44% | positive regulation of biological process |
| GO:0048869 | 8.43% | cellular developmental process |
| GO:0050793 | 8.29% | regulation of developmental process |
| GO:0009628 | 8.04% | response to abiotic stimulus |
| GO:0042221 | 8.02% | response to chemical |
| GO:0003008 | 7.97% | system process |
| GO:0051704 | 7.94% | multi-organism process |
| GO:0035556 | 7.85% | intracellular signal transduction |
| GO:0044237 | 7.81% | cellular metabolic process |
| GO:0006950 | 7.78% | response to stress |
| GO:0009653 | 7.59% | anatomical structure morphogenesis |
| GO:0007186 | 7.53% | G protein-coupled receptor signaling pathway |
| GO:0048522 | 7.51% | positive regulation of cellular process |
| GO:0050790 | 7.42% | regulation of catalytic activity |
| GO:0010468 | 7.41% | regulation of gene expression |
| GO:0009889 | 7.38% | regulation of biosynthetic process |
| GO:0006793 | 7.38% | phosphorus metabolic process |
| GO:0009605 | 7.34% | response to external stimulus |
| GO:0030154 | 7.31% | cell differentiation |
| GO:0065009 | 7.28% | regulation of molecular function |
| GO:0006796 | 7.24% | phosphate-containing compound metabolic process |
| GO:2000026 | 7.16% | regulation of multicellular organismal development |
| GO:0044281 | 7.16% | small molecule metabolic process |
| GO:0050877 | 7.14% | nervous system process |
| GO:0022414 | 7.10% | reproductive process |
| GO:0007610 | 7.09% | behavior |
| GO:0031326 | 7.03% | regulation of cellular biosynthetic process |
| GO:0006807 | 6.88% | nitrogen compound metabolic process |
| GO:0042592 | 6.87% | homeostatic process |
| GO:0051716 | 6.84% | cellular response to stimulus |
| GO:0051246 | 6.80% | regulation of protein metabolic process |
| GO:0009416 | 6.79% | response to light stimulus |
| GO:0032268 | 6.66% | regulation of cellular protein metabolic process |
| GO:0009314 | 6.59% | response to radiation |
| GO:0009892 | 6.58% | negative regulation of metabolic process |
| GO:0009607 | 6.57% | response to biotic stimulus |
| GO:0043207 | 6.52% | response to external biotic stimulus |
| GO:1901700 | 6.50% | response to oxygen-containing compound |
| GO:0009719 | 6.49% | response to endogenous stimulus |
| GO:0007275 | 6.47% | multicellular organism development |
| GO:0006629 | 6.45% | lipid metabolic process |
| GO:0032879 | 6.44% | regulation of localization |
| GO:0005975 | 6.43% | carbohydrate metabolic process |
| GO:0006952 | 6.42% | defense response |
| GO:2000112 | 6.40% | regulation of cellular macromolecule biosynthetic process |
| GO:0003006 | 6.39% | developmental process involved in reproduction |
| GO:0048584 | 6.37% | positive regulation of response to stimulus |
| GO:0010556 | 6.37% | regulation of macromolecule biosynthetic process |
| GO:0023057 | 6.30% | negative regulation of signaling |
| GO:0010648 | 6.29% | negative regulation of cell communication |
| GO:0010033 | 6.29% | response to organic substance |
| GO:0002376 | 6.28% | immune system process |
| GO:0045595 | 6.28% | regulation of cell differentiation |
| GO:0019219 | 6.27% | regulation of nucleobase-containing compound metabolic process |
| GO:0043170 | 6.27% | macromolecule metabolic process |
| GO:0071702 | 6.26% | organic substance transport |
| GO:0048731 | 6.20% | system development |
| GO:0071840 | 6.20% | cellular component organization or biogenesis |
| GO:0016043 | 6.17% | cellular component organization |
| GO:0051128 | 6.13% | regulation of cellular component organization |
| GO:0006955 | 6.12% | immune response |
| GO:0051707 | 6.11% | response to other organism |
| GO:0048585 | 6.10% | negative regulation of response to stimulus |
| GO:0009893 | 6.10% | positive regulation of metabolic process |
| GO:0007600 | 6.10% | sensory perception |
| GO:1901564 | 6.10% | organonitrogen compound metabolic process |
| GO:0043900 | 6.09% | regulation of multi-organism process |
| GO:0010035 | 6.08% | response to inorganic substance |
| GO:1902531 | 6.06% | regulation of intracellular signal transduction |
| GO:0007267 | 6.03% | cell-cell signaling |
| GO:0070887 | 5.98% | cellular response to chemical stimulus |
| GO:0009790 | 5.98% | embryo development |
| GO:0048513 | 5.97% | animal organ development |
| GO:0031324 | 5.95% | negative regulation of cellular metabolic process |
| GO:0009725 | 5.94% | response to hormone |
| GO:0023056 | 5.91% | positive regulation of signaling |
| GO:0051174 | 5.91% | regulation of phosphorus metabolic process |
| GO:0019220 | 5.90% | regulation of phosphate metabolic process |
| GO:0010647 | 5.89% | positive regulation of cell communication |
| GO:2001141 | 5.87% | regulation of RNA biosynthetic process |
| GO:0051240 | 5.86% | positive regulation of multicellular organismal process |
| GO:1903506 | 5.85% | regulation of nucleic acid-templated transcription |
| GO:0006355 | 5.82% | regulation of transcription, DNA-templated |
| GO:0007154 | 5.79% | cell communication |
| GO:0010941 | 5.78% | regulation of cell death |
| GO:0042127 | 5.78% | regulation of cell population proliferation |
| GO:0009968 | 5.77% | negative regulation of signal transduction |
| GO:0010817 | 5.77% | regulation of hormone levels |
| GO:2000241 | 5.76% | regulation of reproductive process |
| GO:0051252 | 5.74% | regulation of RNA metabolic process |
| GO:0007166 | 5.73% | cell surface receptor signaling pathway |
| GO:0023052 | 5.72% | signaling |
| GO:0048878 | 5.72% | chemical homeostasis |
| GO:0006928 | 5.70% | movement of cell or subcellular component |
| GO:0048609 | 5.70% | multicellular organismal reproductive process |
| GO:0040008 | 5.67% | regulation of growth |
| GO:0019932 | 5.65% | second-messenger-mediated signaling |
| GO:0048646 | 5.65% | anatomical structure formation involved in morphogenesis |
| GO:0080134 | 5.58% | regulation of response to stress |
| GO:0062012 | 5.54% | regulation of small molecule metabolic process |
| GO:0010605 | 5.53% | negative regulation of macromolecule metabolic process |
| GO:0022610 | 5.48% | biological adhesion |
| GO:0043067 | 5.47% | regulation of programmed cell death |
| GO:0043085 | 5.46% | positive regulation of catalytic activity |
| GO:0033554 | 5.45% | cellular response to stress |
| GO:0031399 | 5.43% | regulation of protein modification process |
| GO:0032989 | 5.42% | cellular component morphogenesis |
| GO:0033993 | 5.42% | response to lipid |
| GO:0007155 | 5.42% | cell adhesion |
| GO:0043086 | 5.41% | negative regulation of catalytic activity |
| GO:0051172 | 5.38% | negative regulation of nitrogen compound metabolic process |
| GO:0040011 | 5.38% | locomotion |
| GO:0044057 | 5.36% | regulation of system process |
| GO:0014070 | 5.33% | response to organic cyclic compound |
| GO:0009967 | 5.32% | positive regulation of signal transduction |
| GO:0009755 | 5.31% | hormone-mediated signaling pathway |
| GO:0016310 | 5.29% | phosphorylation |
| GO:0051336 | 5.29% | regulation of hydrolase activity |
| GO:0051049 | 5.27% | regulation of transport |
| GO:0006970 | 5.25% | response to osmotic stress |
| GO:0019538 | 5.24% | protein metabolic process |
| GO:1901360 | 5.20% | organic cyclic compound metabolic process |
| GO:0051094 | 5.17% | positive regulation of developmental process |
| GO:0042981 | 5.16% | regulation of apoptotic process |
| GO:0040012 | 5.16% | regulation of locomotion |
| GO:0046890 | 5.15% | regulation of lipid biosynthetic process |
| GO:0032269 | 5.14% | negative regulation of cellular protein metabolic process |
| GO:0042325 | 5.13% | regulation of phosphorylation |
| GO:0007167 | 5.12% | enzyme linked receptor protein signaling pathway |
| GO:0051241 | 5.12% | negative regulation of multicellular organismal process |
| GO:0044093 | 5.12% | positive regulation of molecular function |
| GO:0051248 | 5.10% | negative regulation of protein metabolic process |
| GO:0009791 | 5.09% | post-embryonic development |
| GO:0044260 | 5.05% | cellular macromolecule metabolic process |
| GO:0104004 | 5.04% | cellular response to environmental stimulus |
| GO:0009792 | 5.04% | embryo development ending in birth or egg hatching |
| GO:0071214 | 5.03% | cellular response to abiotic stimulus |
| GO:0040007 | 5.01% | growth |
| GO:2000145 | 5.01% | regulation of cell motility |
| GO:0048589 | 5.00% | developmental growth |
| GO:0098542 | 4.96% | defense response to other organism |
| GO:0044092 | 4.96% | negative regulation of molecular function |
| GO:0019725 | 4.94% | cellular homeostasis |
| GO:0032101 | 4.94% | regulation of response to external stimulus |
| GO:0044255 | 4.93% | cellular lipid metabolic process |
| GO:0006811 | 4.93% | ion transport |
| GO:0098771 | 4.93% | inorganic ion homeostasis |
| GO:0006109 | 4.92% | regulation of carbohydrate metabolic process |
| GO:0001539 | 4.91% | cilium or flagellum-dependent cell motility |
| GO:0008284 | 4.90% | positive regulation of cell population proliferation |
| GO:0051270 | 4.89% | regulation of cellular component movement |
| GO:0048608 | 4.89% | reproductive structure development |
| GO:0043902 | 4.88% | positive regulation of multi-organism process |
| GO:0097305 | 4.88% | response to alcohol |
| GO:0009617 | 4.87% | response to bacterium |
| GO:0044087 | 4.86% | regulation of cellular component biogenesis |
| GO:0042493 | 4.84% | response to drug |
| GO:0097722 | 4.84% | sperm motility |
| GO:0051338 | 4.83% | regulation of transferase activity |
| GO:0010038 | 4.82% | response to metal ion |
| GO:0009888 | 4.82% | tissue development |
| GO:0030317 | 4.81% | flagellated sperm motility |
| GO:0010604 | 4.80% | positive regulation of macromolecule metabolic process |
| GO:0007606 | 4.80% | sensory perception of chemical stimulus |
| GO:1902533 | 4.77% | positive regulation of intracellular signal transduction |
| GO:0007187 | 4.76% | G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger |
| GO:0099177 | 4.76% | regulation of trans-synaptic signaling |
| GO:0050801 | 4.75% | ion homeostasis |
| GO:1901575 | 4.74% | organic substance catabolic process |
| GO:0009056 | 4.73% | catabolic process |
| GO:0007188 | 4.72% | adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
| GO:0048870 | 4.71% | cell motility |
| GO:0022603 | 4.71% | regulation of anatomical structure morphogenesis |
| GO:0043436 | 4.71% | oxoacid metabolic process |
| GO:0051093 | 4.71% | negative regulation of developmental process |
| GO:0009890 | 4.67% | negative regulation of biosynthetic process |
| GO:0006066 | 4.66% | alcohol metabolic process |
| GO:0055080 | 4.66% | cation homeostasis |
| GO:0034641 | 4.63% | cellular nitrogen compound metabolic process |
| GO:0009058 | 4.63% | biosynthetic process |
| GO:0031325 | 4.62% | positive regulation of cellular metabolic process |
| GO:0060285 | 4.61% | cilium-dependent cell motility |
| GO:0032103 | 4.61% | positive regulation of response to external stimulus |
| GO:0001501 | 4.59% | skeletal system development |
| GO:0009266 | 4.59% | response to temperature stimulus |
| GO:0050804 | 4.57% | modulation of chemical synaptic transmission |
| GO:0051050 | 4.56% | positive regulation of transport |
| GO:0019216 | 4.55% | regulation of lipid metabolic process |
| GO:0051703 | 4.54% | intraspecies interaction between organisms |
| GO:0008104 | 4.53% | protein localization |
| GO:0009887 | 4.53% | animal organ morphogenesis |
| GO:0051960 | 4.53% | regulation of nervous system development |
| GO:0006082 | 4.52% | organic acid metabolic process |
| GO:0033036 | 4.52% | macromolecule localization |
| GO:0044267 | 4.52% | cellular protein metabolic process |
| GO:0060548 | 4.52% | negative regulation of cell death |
| GO:0006725 | 4.51% | cellular aromatic compound metabolic process |
| GO:0019752 | 4.51% | carboxylic acid metabolic process |
| GO:0001101 | 4.51% | response to acid chemical |
| GO:0055065 | 4.50% | metal ion homeostasis |
| GO:0019935 | 4.50% | cyclic-nucleotide-mediated signaling |
| GO:0048511 | 4.49% | rhythmic process |
| GO:0001932 | 4.48% | regulation of protein phosphorylation |
| GO:0007283 | 4.48% | spermatogenesis |
| GO:0051301 | 4.47% | cell division |
| GO:0043412 | 4.46% | macromolecule modification |
| GO:1901615 | 4.46% | organic hydroxy compound metabolic process |
| GO:0048232 | 4.46% | male gamete generation |
| GO:0045087 | 4.44% | innate immune response |
| GO:0050890 | 4.43% | cognition |
| GO:1901576 | 4.42% | organic substance biosynthetic process |
| GO:0022607 | 4.41% | cellular component assembly |
| GO:0045926 | 4.41% | negative regulation of growth |
| GO:0007049 | 4.41% | cell cycle |
| GO:1901701 | 4.41% | cellular response to oxygen-containing compound |
| GO:2000243 | 4.40% | positive regulation of reproductive process |
| GO:0000003 | 4.37% | reproduction |
| GO:0006357 | 4.36% | regulation of transcription by RNA polymerase II |
| GO:0031327 | 4.36% | negative regulation of cellular biosynthetic process |
| GO:0007276 | 4.36% | gamete generation |
| GO:0071705 | 4.35% | nitrogen compound transport |
| GO:0010675 | 4.34% | regulation of cellular carbohydrate metabolic process |
| GO:0007189 | 4.33% | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:0019933 | 4.31% | cAMP-mediated signaling |
| GO:0007626 | 4.30% | locomotory behavior |
| GO:0019637 | 4.30% | organophosphate metabolic process |
| GO:0051129 | 4.29% | negative regulation of cellular component organization |
| GO:0031400 | 4.28% | negative regulation of protein modification process |
| GO:0030334 | 4.28% | regulation of cell migration |
| GO:0040013 | 4.27% | negative regulation of locomotion |
| GO:0006464 | 4.27% | cellular protein modification process |
| GO:0036211 | 4.26% | protein modification process |
| GO:0009991 | 4.26% | response to extracellular stimulus |
| GO:0016311 | 4.25% | dephosphorylation |
| GO:0043269 | 4.24% | regulation of ion transport |
| GO:0001701 | 4.24% | in utero embryonic development |
| GO:0010629 | 4.24% | negative regulation of gene expression |
| GO:0051341 | 4.23% | regulation of oxidoreductase activity |
| GO:0006091 | 4.22% | generation of precursor metabolites and energy |
| GO:0098609 | 4.20% | cell-cell adhesion |
| GO:0031347 | 4.19% | regulation of defense response |
| GO:0030030 | 4.19% | cell projection organization |
| GO:0046677 | 4.17% | response to antibiotic |
| GO:0051173 | 4.17% | positive regulation of nitrogen compound metabolic process |
| GO:0043069 | 4.16% | negative regulation of programmed cell death |
| GO:0006873 | 4.13% | cellular ion homeostasis |
| GO:0031667 | 4.13% | response to nutrient levels |
| GO:0044249 | 4.11% | cellular biosynthetic process |
| GO:0045934 | 4.11% | negative regulation of nucleobase-containing compound metabolic process |
| GO:0007586 | 4.10% | digestion |
| GO:0043549 | 4.09% | regulation of kinase activity |
| GO:0060284 | 4.09% | regulation of cell development |
| GO:0002682 | 4.08% | regulation of immune system process |
| GO:0051271 | 4.08% | negative regulation of cellular component movement |
| GO:0008217 | 4.08% | regulation of blood pressure |
| GO:0001817 | 4.08% | regulation of cytokine production |
| GO:0051641 | 4.06% | cellular localization |
| GO:0043009 | 4.06% | chordate embryonic development |
| GO:0046483 | 4.04% | heterocycle metabolic process |
| GO:0021700 | 4.03% | developmental maturation |
| GO:0007601 | 4.02% | visual perception |
| GO:0048509 | 4.01% | regulation of meristem development |
| GO:0043066 | 4.00% | negative regulation of apoptotic process |
| GO:0010565 | 4.00% | regulation of cellular ketone metabolic process |
| GO:0044282 | 4.00% | small molecule catabolic process |
| GO:0007611 | 4.00% | learning or memory |
| GO:0010906 | 4.00% | regulation of glucose metabolic process |
| GO:2000146 | 3.99% | negative regulation of cell motility |
| GO:0030534 | 3.99% | adult behavior |
| GO:0000902 | 3.97% | cell morphogenesis |
| GO:0006996 | 3.97% | organelle organization |
| GO:0008283 | 3.96% | cell population proliferation |
| GO:0006974 | 3.96% | cellular response to DNA damage stimulus |
| GO:0071496 | 3.96% | cellular response to external stimulus |
| GO:0050953 | 3.96% | sensory perception of light stimulus |
| GO:0042391 | 3.95% | regulation of membrane potential |
| GO:0042742 | 3.95% | defense response to bacterium |
| GO:0007399 | 3.95% | nervous system development |
| GO:0043933 | 3.95% | protein-containing complex subunit organization |
| GO:0031644 | 3.94% | regulation of nervous system process |
| GO:0045597 | 3.93% | positive regulation of cell differentiation |
| GO:0048638 | 3.93% | regulation of developmental growth |
| GO:0007200 | 3.93% | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO:0031589 | 3.93% | cell-substrate adhesion |
| GO:0008219 | 3.90% | cell death |
| GO:0031647 | 3.90% | regulation of protein stability |
| GO:0048640 | 3.90% | negative regulation of developmental growth |
| GO:0033043 | 3.90% | regulation of organelle organization |
| GO:0007169 | 3.87% | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0042445 | 3.87% | hormone metabolic process |
| GO:1901135 | 3.87% | carbohydrate derivative metabolic process |
| GO:0080135 | 3.87% | regulation of cellular response to stress |
| GO:0009651 | 3.86% | response to salt stress |
| GO:0070482 | 3.86% | response to oxygen levels |
| GO:0032787 | 3.85% | monocarboxylic acid metabolic process |
| GO:0099536 | 3.85% | synaptic signaling |
| GO:0071310 | 3.85% | cellular response to organic substance |
| GO:0006869 | 3.84% | lipid transport |
| GO:0050920 | 3.84% | regulation of chemotaxis |
| GO:0000904 | 3.84% | cell morphogenesis involved in differentiation |
| GO:0030162 | 3.83% | regulation of proteolysis |
| GO:0055082 | 3.82% | cellular chemical homeostasis |
| GO:0045596 | 3.82% | negative regulation of cell differentiation |
| GO:0007168 | 3.82% | receptor guanylyl cyclase signaling pathway |
| GO:0044764 | 3.81% | multi-organism cellular process |
| GO:1901698 | 3.81% | response to nitrogen compound |
| GO:0098916 | 3.81% | anterograde trans-synaptic signaling |
| GO:0097306 | 3.81% | cellular response to alcohol |
| GO:0030435 | 3.80% | sporulation resulting in formation of a cellular spore |
| GO:0022402 | 3.80% | cell cycle process |
| GO:0007010 | 3.79% | cytoskeleton organization |
| GO:0030003 | 3.79% | cellular cation homeostasis |
| GO:0045936 | 3.79% | negative regulation of phosphate metabolic process |
| GO:0043408 | 3.78% | regulation of MAPK cascade |
| GO:0007015 | 3.78% | actin filament organization |
| GO:0007268 | 3.78% | chemical synaptic transmission |
| GO:0051130 | 3.77% | positive regulation of cellular component organization |
| GO:0008610 | 3.77% | lipid biosynthetic process |
| GO:0007608 | 3.76% | sensory perception of smell |
| GO:0071478 | 3.76% | cellular response to radiation |
| GO:0044262 | 3.76% | cellular carbohydrate metabolic process |
| GO:0007605 | 3.76% | sensory perception of sound |
| GO:0090257 | 3.76% | regulation of muscle system process |
| GO:0001558 | 3.75% | regulation of cell growth |
| GO:0044089 | 3.75% | positive regulation of cellular component biogenesis |
| GO:0051253 | 3.75% | negative regulation of RNA metabolic process |
| GO:2000113 | 3.75% | negative regulation of cellular macromolecule biosynthetic process |
| GO:0010558 | 3.75% | negative regulation of macromolecule biosynthetic process |
| GO:0090092 | 3.75% | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0048167 | 3.75% | regulation of synaptic plasticity |
| GO:0019318 | 3.75% | hexose metabolic process |
| GO:0005996 | 3.74% | monosaccharide metabolic process |
| GO:0006139 | 3.74% | nucleobase-containing compound metabolic process |
| GO:0012501 | 3.74% | programmed cell death |
| GO:0009636 | 3.74% | response to toxic substance |
| GO:0007389 | 3.74% | pattern specification process |
| GO:0007017 | 3.73% | microtubule-based process |
| GO:0071482 | 3.72% | cellular response to light stimulus |
| GO:0019722 | 3.72% | calcium-mediated signaling |
| GO:0110149 | 3.72% | regulation of biomineralization |
| GO:0031349 | 3.71% | positive regulation of defense response |
| GO:0010942 | 3.71% | positive regulation of cell death |
| GO:0065003 | 3.70% | protein-containing complex assembly |
| GO:1903831 | 3.70% | signal transduction involved in cellular response to ammonium ion |
| GO:0006644 | 3.70% | phospholipid metabolic process |
| GO:0043901 | 3.70% | negative regulation of multi-organism process |
| GO:0006875 | 3.70% | cellular metal ion homeostasis |
| GO:0099537 | 3.70% | trans-synaptic signaling |
| GO:0071241 | 3.68% | cellular response to inorganic substance |
| GO:0046889 | 3.68% | positive regulation of lipid biosynthetic process |
| GO:0044283 | 3.68% | small molecule biosynthetic process |
| GO:0007420 | 3.68% | brain development |
| GO:0034285 | 3.67% | response to disaccharide |
| GO:0010563 | 3.67% | negative regulation of phosphorus metabolic process |
| GO:0007623 | 3.67% | circadian rhythm |
| GO:0019098 | 3.66% | reproductive behavior |
| GO:0009611 | 3.66% | response to wounding |
| GO:0006457 | 3.65% | protein folding |
| GO:0006468 | 3.65% | protein phosphorylation |
| GO:0050954 | 3.64% | sensory perception of mechanical stimulus |
| GO:0099402 | 3.64% | plant organ development |
| GO:0007568 | 3.64% | aging |
| GO:0006979 | 3.64% | response to oxidative stress |
| GO:0002250 | 3.64% | adaptive immune response |
| GO:0045834 | 3.63% | positive regulation of lipid metabolic process |
| GO:0006972 | 3.62% | hyperosmotic response |
| GO:0010608 | 3.62% | posttranscriptional regulation of gene expression |
| GO:0008344 | 3.61% | adult locomotory behavior |
| GO:0045184 | 3.60% | establishment of protein localization |
| GO:0001894 | 3.60% | tissue homeostasis |
| GO:0048580 | 3.60% | regulation of post-embryonic development |
| GO:0006935 | 3.60% | chemotaxis |
| GO:0051345 | 3.60% | positive regulation of hydrolase activity |
| GO:0045859 | 3.60% | regulation of protein kinase activity |
| GO:0043934 | 3.59% | sporulation |
| GO:0009408 | 3.59% | response to heat |
| GO:0045937 | 3.58% | positive regulation of phosphate metabolic process |
| GO:0015698 | 3.58% | inorganic anion transport |
| GO:0009744 | 3.57% | response to sucrose |
| GO:0006820 | 3.57% | anion transport |
| GO:0046578 | 3.56% | regulation of Ras protein signal transduction |
| GO:0030258 | 3.56% | lipid modification |
| GO:0051348 | 3.56% | negative regulation of transferase activity |
| GO:0044248 | 3.56% | cellular catabolic process |
| GO:0010562 | 3.56% | positive regulation of phosphorus metabolic process |
| GO:0036293 | 3.55% | response to decreased oxygen levels |
| GO:0009894 | 3.55% | regulation of catabolic process |
| GO:0051056 | 3.55% | regulation of small GTPase mediated signal transduction |
| GO:0050909 | 3.55% | sensory perception of taste |
| GO:0001505 | 3.54% | regulation of neurotransmitter levels |
| GO:0043068 | 3.54% | positive regulation of programmed cell death |
| GO:0034248 | 3.54% | regulation of cellular amide metabolic process |
| GO:0072507 | 3.54% | divalent inorganic cation homeostasis |
| GO:0009581 | 3.53% | detection of external stimulus |
| GO:0060560 | 3.53% | developmental growth involved in morphogenesis |
| GO:0009583 | 3.53% | detection of light stimulus |
| GO:0009410 | 3.53% | response to xenobiotic stimulus |
| GO:0050807 | 3.53% | regulation of synapse organization |
| GO:0008643 | 3.53% | carbohydrate transport |
| GO:0035176 | 3.52% | social behavior |
| GO:0006959 | 3.52% | humoral immune response |
| GO:0048598 | 3.51% | embryonic morphogenesis |
| GO:0016192 | 3.50% | vesicle-mediated transport |
| GO:0042327 | 3.49% | positive regulation of phosphorylation |
| GO:0032881 | 3.49% | regulation of polysaccharide metabolic process |
| GO:0031329 | 3.49% | regulation of cellular catabolic process |
| GO:0010469 | 3.48% | regulation of signaling receptor activity |
| GO:0042330 | 3.48% | taxis |
| GO:0051346 | 3.47% | negative regulation of hydrolase activity |
| GO:0010959 | 3.46% | regulation of metal ion transport |
| GO:0001666 | 3.46% | response to hypoxia |
| GO:0043065 | 3.46% | positive regulation of apoptotic process |
| GO:0051726 | 3.45% | regulation of cell cycle |
| GO:0009582 | 3.45% | detection of abiotic stimulus |
| GO:0048831 | 3.45% | regulation of shoot system development |
| GO:0051604 | 3.45% | protein maturation |
| GO:0046488 | 3.44% | phosphatidylinositol metabolic process |
| GO:0061077 | 3.44% | chaperone-mediated protein folding |
| GO:0097435 | 3.44% | supramolecular fiber organization |
| GO:0000160 | 3.43% | phosphorelay signal transduction system |
| GO:0031668 | 3.43% | cellular response to extracellular stimulus |
| GO:0016052 | 3.42% | carbohydrate catabolic process |
| GO:0015833 | 3.42% | peptide transport |
| GO:0016053 | 3.42% | organic acid biosynthetic process |
| GO:0030855 | 3.42% | epithelial cell differentiation |
| GO:0042752 | 3.42% | regulation of circadian rhythm |
| GO:0050767 | 3.42% | regulation of neurogenesis |
| GO:0032880 | 3.41% | regulation of protein localization |
| GO:0042886 | 3.41% | amide transport |
| GO:0070167 | 3.41% | regulation of biomineral tissue development |
| GO:0006006 | 3.40% | glucose metabolic process |
| GO:0044419 | 3.39% | interspecies interaction between organisms |
| GO:0043410 | 3.39% | positive regulation of MAPK cascade |
| GO:1902532 | 3.39% | negative regulation of intracellular signal transduction |
| GO:0046903 | 3.39% | secretion |
| GO:0048588 | 3.39% | developmental cell growth |
| GO:0010628 | 3.38% | positive regulation of gene expression |
| GO:0035303 | 3.38% | regulation of dephosphorylation |
| GO:0055074 | 3.38% | calcium ion homeostasis |
| GO:0060249 | 3.38% | anatomical structure homeostasis |
| GO:0046854 | 3.38% | phosphatidylinositol phosphorylation |
| GO:0051046 | 3.38% | regulation of secretion |
| GO:0042594 | 3.37% | response to starvation |
| GO:0050795 | 3.37% | regulation of behavior |
| GO:0002831 | 3.36% | regulation of response to biotic stimulus |
| GO:0016049 | 3.36% | cell growth |
| GO:0008285 | 3.36% | negative regulation of cell population proliferation |
| GO:0032102 | 3.36% | negative regulation of response to external stimulus |
| GO:0003002 | 3.36% | regionalization |
| GO:0043467 | 3.36% | regulation of generation of precursor metabolites and energy |
| GO:0010243 | 3.35% | response to organonitrogen compound |
| GO:0022604 | 3.35% | regulation of cell morphogenesis |
| GO:0007204 | 3.34% | positive regulation of cytosolic calcium ion concentration |
| GO:0007617 | 3.34% | mating behavior |
| GO:0051302 | 3.34% | regulation of cell division |
| GO:0043122 | 3.33% | regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0048364 | 3.33% | root development |
| GO:0001819 | 3.32% | positive regulation of cytokine production |
| GO:0051493 | 3.32% | regulation of cytoskeleton organization |
| GO:0009415 | 3.32% | response to water |
| GO:0051480 | 3.32% | regulation of cytosolic calcium ion concentration |
| GO:0000910 | 3.31% | cytokinesis |
| GO:0090287 | 3.31% | regulation of cellular response to growth factor stimulus |
| GO:0006650 | 3.31% | glycerophospholipid metabolic process |
| GO:0009914 | 3.31% | hormone transport |
| GO:0071695 | 3.30% | anatomical structure maturation |
| GO:0071495 | 3.30% | cellular response to endogenous stimulus |
| GO:0019730 | 3.30% | antimicrobial humoral response |
| GO:1901654 | 3.30% | response to ketone |
| GO:0034762 | 3.29% | regulation of transmembrane transport |
| GO:0051247 | 3.29% | positive regulation of protein metabolic process |
| GO:0006508 | 3.29% | proteolysis |
| GO:0030336 | 3.29% | negative regulation of cell migration |
| GO:0032990 | 3.28% | cell part morphogenesis |
| GO:0097164 | 3.28% | ammonium ion metabolic process |
| GO:0015031 | 3.28% | protein transport |
| GO:0030155 | 3.26% | regulation of cell adhesion |
| GO:0022898 | 3.26% | regulation of transmembrane transporter activity |
| GO:0009642 | 3.25% | response to light intensity |
| GO:0032409 | 3.25% | regulation of transporter activity |
| GO:0009268 | 3.25% | response to pH |
| GO:0008286 | 3.25% | insulin receptor signaling pathway |
| GO:1901565 | 3.24% | organonitrogen compound catabolic process |
| GO:0009414 | 3.24% | response to water deprivation |
| GO:0006470 | 3.24% | protein dephosphorylation |
| GO:0030500 | 3.24% | regulation of bone mineralization |
| GO:0016042 | 3.24% | lipid catabolic process |
| GO:0033673 | 3.24% | negative regulation of kinase activity |
| GO:0050821 | 3.23% | protein stabilization |
| GO:0051606 | 3.23% | detection of stimulus |
| GO:0046394 | 3.23% | carboxylic acid biosynthetic process |
| GO:0045892 | 3.22% | negative regulation of transcription, DNA-templated |
| GO:0046834 | 3.22% | lipid phosphorylation |
| GO:0001933 | 3.22% | negative regulation of protein phosphorylation |
| GO:0043255 | 3.22% | regulation of carbohydrate biosynthetic process |
| GO:0042326 | 3.22% | negative regulation of phosphorylation |
| GO:0031669 | 3.22% | cellular response to nutrient levels |
| GO:0007635 | 3.21% | chemosensory behavior |
| GO:0098657 | 3.21% | import into cell |
| GO:0055114 | 3.20% | oxidation-reduction process |
| GO:0051259 | 3.20% | protein complex oligomerization |
| GO:1902679 | 3.20% | negative regulation of RNA biosynthetic process |
| GO:0051347 | 3.20% | positive regulation of transferase activity |
| GO:0034754 | 3.20% | cellular hormone metabolic process |
| GO:1900271 | 3.20% | regulation of long-term synaptic potentiation |
| GO:0071236 | 3.20% | cellular response to antibiotic |
| GO:0051353 | 3.19% | positive regulation of oxidoreductase activity |
| GO:0051705 | 3.19% | multi-organism behavior |
| GO:1903507 | 3.19% | negative regulation of nucleic acid-templated transcription |
| GO:0006937 | 3.19% | regulation of muscle contraction |
| GO:2000280 | 3.19% | regulation of root development |
| GO:0099120 | 3.19% | socially cooperative development |
| GO:0006915 | 3.18% | apoptotic process |
| GO:0006812 | 3.18% | cation transport |
| GO:0045598 | 3.18% | regulation of fat cell differentiation |
| GO:0043254 | 3.18% | regulation of protein complex assembly |
| GO:0009411 | 3.18% | response to UV |
| GO:0008202 | 3.17% | steroid metabolic process |
| GO:0019954 | 3.17% | asexual reproduction |
| GO:0090288 | 3.17% | negative regulation of cellular response to growth factor stimulus |
| GO:0008277 | 3.17% | regulation of G protein-coupled receptor signaling pathway |
| GO:0120039 | 3.17% | plasma membrane bounded cell projection morphogenesis |
| GO:0006417 | 3.17% | regulation of translation |
| GO:0048858 | 3.17% | cell projection morphogenesis |
| GO:0120161 | 3.16% | regulation of cold-induced thermogenesis |
| GO:0007632 | 3.16% | visual behavior |
| GO:0051339 | 3.16% | regulation of lyase activity |
| GO:0007602 | 3.15% | phototransduction |
| GO:0044070 | 3.15% | regulation of anion transport |
| GO:1903530 | 3.15% | regulation of secretion by cell |
| GO:0080154 | 3.14% | regulation of fertilization |
| GO:0050817 | 3.14% | coagulation |
| GO:0006874 | 3.14% | cellular calcium ion homeostasis |
| GO:0030001 | 3.14% | metal ion transport |
| GO:0006936 | 3.13% | muscle contraction |
| GO:0090304 | 3.13% | nucleic acid metabolic process |
| GO:0016477 | 3.13% | cell migration |
| GO:0040017 | 3.12% | positive regulation of locomotion |
| GO:0071453 | 3.11% | cellular response to oxygen levels |
| GO:0048729 | 3.11% | tissue morphogenesis |
| GO:0051051 | 3.10% | negative regulation of transport |
| GO:0048812 | 3.10% | neuron projection morphogenesis |
| GO:0072347 | 3.10% | response to anesthetic |
| GO:0062014 | 3.10% | negative regulation of small molecule metabolic process |
| GO:0030029 | 3.09% | actin filament-based process |
| GO:0051962 | 3.09% | positive regulation of nervous system development |
| GO:0070372 | 3.09% | regulation of ERK1 and ERK2 cascade |
| GO:0034599 | 3.09% | cellular response to oxidative stress |
| GO:0007612 | 3.09% | learning |
| GO:0006469 | 3.08% | negative regulation of protein kinase activity |
| GO:0008306 | 3.08% | associative learning |
| GO:0032412 | 3.08% | regulation of ion transmembrane transporter activity |
| GO:0050776 | 3.08% | regulation of immune response |
| GO:0001934 | 3.08% | positive regulation of protein phosphorylation |
| GO:0071456 | 3.07% | cellular response to hypoxia |
| GO:0071467 | 3.07% | cellular response to pH |
| GO:0019751 | 3.07% | polyol metabolic process |
| GO:0030308 | 3.07% | negative regulation of cell growth |
| GO:0006954 | 3.06% | inflammatory response |
| GO:0036294 | 3.06% | cellular response to decreased oxygen levels |
| GO:1905952 | 3.06% | regulation of lipid localization |
| GO:0009891 | 3.06% | positive regulation of biosynthetic process |
| GO:0022412 | 3.06% | cellular process involved in reproduction in multicellular organism |
| GO:0030278 | 3.05% | regulation of ossification |
| GO:0095500 | 3.05% | acetylcholine receptor signaling pathway |
| GO:1903426 | 3.04% | regulation of reactive oxygen species biosynthetic process |
| GO:0017144 | 3.04% | drug metabolic process |
| GO:0007599 | 3.04% | hemostasis |
| GO:0050806 | 3.03% | positive regulation of synaptic transmission |
| GO:0048468 | 3.03% | cell development |
| GO:2000377 | 3.03% | regulation of reactive oxygen species metabolic process |
| GO:0120036 | 3.03% | plasma membrane bounded cell projection organization |
| GO:0071229 | 3.03% | cellular response to acid chemical |
| GO:0006631 | 3.03% | fatty acid metabolic process |
| GO:0008340 | 3.02% | determination of adult lifespan |
| GO:0090066 | 3.02% | regulation of anatomical structure size |
| GO:0051272 | 3.01% | positive regulation of cellular component movement |
| GO:1903998 | 3.01% | regulation of eating behavior |
| GO:0098742 | 3.01% | cell-cell adhesion via plasma-membrane adhesion molecules |
| GO:0051592 | 3.00% | response to calcium ion |
| GO:0003013 | 3.00% | circulatory system process |
| GO:0031214 | 2.99% | biomineral tissue development |
| GO:0022600 | 2.99% | digestive system process |
| GO:0052547 | 2.98% | regulation of peptidase activity |
| GO:0009409 | 2.98% | response to cold |
| GO:0046486 | 2.97% | glycerolipid metabolic process |
| GO:0009401 | 2.96% | phosphoenolpyruvate-dependent sugar phosphotransferase system |
| GO:0045935 | 2.96% | positive regulation of nucleobase-containing compound metabolic process |
| GO:0042446 | 2.95% | hormone biosynthetic process |
| GO:0072503 | 2.95% | cellular divalent inorganic cation homeostasis |
| GO:0060390 | 2.95% | regulation of SMAD protein signal transduction |
| GO:0044703 | 2.95% | multi-organism reproductive process |
| GO:0032270 | 2.94% | positive regulation of cellular protein metabolic process |
| GO:0055085 | 2.94% | transmembrane transport |
| GO:0010286 | 2.94% | heat acclimation |
| GO:2000147 | 2.94% | positive regulation of cell motility |
| GO:0002684 | 2.93% | positive regulation of immune system process |
| GO:0048469 | 2.93% | cell maturation |
| GO:0070873 | 2.93% | regulation of glycogen metabolic process |
| GO:0090101 | 2.93% | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0045913 | 2.93% | positive regulation of carbohydrate metabolic process |
| GO:1903047 | 2.93% | mitotic cell cycle process |
| GO:0031279 | 2.92% | regulation of cyclase activity |
| GO:0019827 | 2.91% | stem cell population maintenance |
| GO:0002833 | 2.91% | positive regulation of response to biotic stimulus |
| GO:0097190 | 2.90% | apoptotic signaling pathway |
| GO:0098727 | 2.90% | maintenance of cell number |
| GO:0007266 | 2.90% | Rho protein signal transduction |
| GO:0006897 | 2.90% | endocytosis |
| GO:0031401 | 2.90% | positive regulation of protein modification process |
| GO:0043270 | 2.90% | positive regulation of ion transport |
| GO:0043588 | 2.90% | skin development |
| GO:0031099 | 2.90% | regeneration |
| GO:0007507 | 2.89% | heart development |
| GO:0016051 | 2.89% | carbohydrate biosynthetic process |
| GO:0045088 | 2.89% | regulation of innate immune response |
| GO:0007212 | 2.89% | dopamine receptor signaling pathway |
| GO:0042737 | 2.88% | drug catabolic process |
| GO:0050878 | 2.88% | regulation of body fluid levels |
| GO:0035690 | 2.88% | cellular response to drug |
| GO:0034765 | 2.88% | regulation of ion transmembrane transport |
| GO:1901616 | 2.88% | organic hydroxy compound catabolic process |
| GO:0022404 | 2.87% | molting cycle process |
| GO:0010447 | 2.87% | response to acidic pH |
| GO:0007584 | 2.87% | response to nutrient |
| GO:0035304 | 2.87% | regulation of protein dephosphorylation |
| GO:1901566 | 2.87% | organonitrogen compound biosynthetic process |
| GO:0009873 | 2.87% | ethylene-activated signaling pathway |
| GO:0030182 | 2.86% | neuron differentiation |
| GO:0000226 | 2.86% | microtubule cytoskeleton organization |
| GO:0015850 | 2.86% | organic hydroxy compound transport |
| GO:0090407 | 2.86% | organophosphate biosynthetic process |
| GO:0043603 | 2.86% | cellular amide metabolic process |
| GO:0044403 | 2.86% | symbiotic process |
| GO:0007264 | 2.85% | small GTPase mediated signal transduction |
| GO:0002009 | 2.85% | morphogenesis of an epithelium |
| GO:0015980 | 2.85% | energy derivation by oxidation of organic compounds |
| GO:0110148 | 2.85% | biomineralization |
| GO:0006909 | 2.85% | phagocytosis |
| GO:0035821 | 2.85% | modification of morphology or physiology of other organism |
| GO:2000242 | 2.84% | negative regulation of reproductive process |
| GO:0016101 | 2.84% | diterpenoid metabolic process |
| GO:0009740 | 2.83% | gibberellic acid mediated signaling pathway |
| GO:0048534 | 2.83% | hematopoietic or lymphoid organ development |
| GO:0070727 | 2.83% | cellular macromolecule localization |
| GO:0071248 | 2.83% | cellular response to metal ion |
| GO:0030097 | 2.83% | hemopoiesis |
| GO:0009734 | 2.83% | auxin-activated signaling pathway |
| GO:0051930 | 2.82% | regulation of sensory perception of pain |
| GO:0010921 | 2.82% | regulation of phosphatase activity |
| GO:0046034 | 2.82% | ATP metabolic process |
| GO:0060348 | 2.81% | bone development |
| GO:0003012 | 2.81% | muscle system process |
| GO:0009733 | 2.81% | response to auxin |
| GO:0140352 | 2.81% | export from cell |
| GO:0010721 | 2.80% | negative regulation of cell development |
| GO:0060341 | 2.80% | regulation of cellular localization |
| GO:0045777 | 2.80% | positive regulation of blood pressure |
| GO:0050905 | 2.79% | neuromuscular process |
| GO:0009743 | 2.79% | response to carbohydrate |
| GO:0010676 | 2.79% | positive regulation of cellular carbohydrate metabolic process |
| GO:0010639 | 2.79% | negative regulation of organelle organization |
| GO:0071468 | 2.79% | cellular response to acidic pH |
| GO:0006325 | 2.78% | chromatin organization |
| GO:0051961 | 2.78% | negative regulation of nervous system development |
| GO:0043401 | 2.78% | steroid hormone mediated signaling pathway |
| GO:0098926 | 2.78% | postsynaptic signal transduction |
| GO:0050854 | 2.78% | regulation of antigen receptor-mediated signaling pathway |
| GO:0051963 | 2.78% | regulation of synapse assembly |
| GO:0008544 | 2.78% | epidermis development |
| GO:0019221 | 2.78% | cytokine-mediated signaling pathway |
| GO:2000024 | 2.78% | regulation of leaf development |
| GO:1901699 | 2.77% | cellular response to nitrogen compound |
| GO:0002685 | 2.77% | regulation of leukocyte migration |
| GO:0008542 | 2.77% | visual learning |
| GO:0055086 | 2.77% | nucleobase-containing small molecule metabolic process |
| GO:0098743 | 2.77% | cell aggregation |
| GO:0072593 | 2.76% | reactive oxygen species metabolic process |
| GO:1901362 | 2.76% | organic cyclic compound biosynthetic process |
| GO:0045833 | 2.76% | negative regulation of lipid metabolic process |
| GO:0000122 | 2.76% | negative regulation of transcription by RNA polymerase II |
| GO:0034613 | 2.75% | cellular protein localization |
| GO:0060259 | 2.75% | regulation of feeding behavior |
| GO:0051931 | 2.75% | regulation of sensory perception |
| GO:0072330 | 2.75% | monocarboxylic acid biosynthetic process |
| GO:0046164 | 2.75% | alcohol catabolic process |
| GO:0007162 | 2.75% | negative regulation of cell adhesion |
| GO:0007265 | 2.75% | Ras protein signal transduction |
| GO:0070647 | 2.74% | protein modification by small protein conjugation or removal |
| GO:0043123 | 2.74% | positive regulation of I-kappaB kinase/NF-kappaB signaling |
| GO:0030198 | 2.73% | extracellular matrix organization |
| GO:0033238 | 2.73% | regulation of cellular amine metabolic process |
| GO:0071900 | 2.71% | regulation of protein serine/threonine kinase activity |
| GO:0055076 | 2.71% | transition metal ion homeostasis |
| GO:0045444 | 2.71% | fat cell differentiation |
| GO:0030335 | 2.71% | positive regulation of cell migration |
| GO:0032446 | 2.71% | protein modification by small protein conjugation |
| GO:0019236 | 2.71% | response to pheromone |
| GO:0032885 | 2.71% | regulation of polysaccharide biosynthetic process |
| GO:0007613 | 2.71% | memory |
| GO:1901214 | 2.70% | regulation of neuron death |
| GO:0031328 | 2.70% | positive regulation of cellular biosynthetic process |
| GO:0032940 | 2.70% | secretion by cell |
| GO:0006753 | 2.69% | nucleoside phosphate metabolic process |
| GO:0009117 | 2.69% | nucleotide metabolic process |
| GO:0008406 | 2.69% | gonad development |
| GO:0006898 | 2.68% | receptor-mediated endocytosis |
| GO:0030036 | 2.68% | actin cytoskeleton organization |
| GO:0007423 | 2.68% | sensory organ development |
| GO:0001649 | 2.68% | osteoblast differentiation |
| GO:0043455 | 2.68% | regulation of secondary metabolic process |
| GO:0032535 | 2.68% | regulation of cellular component size |
| GO:0000302 | 2.68% | response to reactive oxygen species |
| GO:0009312 | 2.68% | oligosaccharide biosynthetic process |
| GO:0007218 | 2.67% | neuropeptide signaling pathway |
| GO:0046907 | 2.67% | intracellular transport |
| GO:0010476 | 2.67% | gibberellin mediated signaling pathway |
| GO:0045761 | 2.67% | regulation of adenylate cyclase activity |
| GO:0033674 | 2.67% | positive regulation of kinase activity |
| GO:1903844 | 2.67% | regulation of cellular response to transforming growth factor beta stimulus |
| GO:0043266 | 2.66% | regulation of potassium ion transport |
| GO:0010564 | 2.66% | regulation of cell cycle process |
| GO:0009267 | 2.65% | cellular response to starvation |
| GO:0070374 | 2.65% | positive regulation of ERK1 and ERK2 cascade |
| GO:0061024 | 2.65% | membrane organization |
| GO:0034644 | 2.64% | cellular response to UV |
| GO:0050727 | 2.64% | regulation of inflammatory response |
| GO:0042447 | 2.64% | hormone catabolic process |
| GO:0071470 | 2.64% | cellular response to osmotic stress |
| GO:0019693 | 2.64% | ribose phosphate metabolic process |
| GO:0071396 | 2.64% | cellular response to lipid |
| GO:0043062 | 2.63% | extracellular structure organization |
| GO:0046999 | 2.63% | regulation of conjugation |
| GO:0043087 | 2.63% | regulation of GTPase activity |
| GO:0048520 | 2.63% | positive regulation of behavior |
| GO:0062013 | 2.63% | positive regulation of small molecule metabolic process |
| GO:0009612 | 2.62% | response to mechanical stimulus |
| GO:0001708 | 2.62% | cell fate specification |
| GO:0050921 | 2.62% | positive regulation of chemotaxis |
| GO:0044706 | 2.62% | multi-multicellular organism process |
| GO:0000281 | 2.62% | mitotic cytokinesis |
| GO:0002683 | 2.61% | negative regulation of immune system process |
| GO:1905954 | 2.61% | positive regulation of lipid localization |
| GO:0045785 | 2.61% | positive regulation of cell adhesion |
| GO:0031348 | 2.61% | negative regulation of defense response |
| GO:0048562 | 2.61% | embryonic organ morphogenesis |
| GO:0034109 | 2.60% | homotypic cell-cell adhesion |
| GO:0031175 | 2.60% | neuron projection development |
| GO:0043487 | 2.60% | regulation of RNA stability |
| GO:0045861 | 2.60% | negative regulation of proteolysis |
| GO:0009639 | 2.59% | response to red or far red light |
| GO:0051656 | 2.59% | establishment of organelle localization |
| GO:1903827 | 2.59% | regulation of cellular protein localization |
| GO:0016032 | 2.58% | viral process |
| GO:0048678 | 2.58% | response to axon injury |
| GO:0031344 | 2.58% | regulation of cell projection organization |
| GO:0007059 | 2.58% | chromosome segregation |
| GO:0009860 | 2.58% | pollen tube growth |
| GO:1903311 | 2.58% | regulation of mRNA metabolic process |
| GO:0009615 | 2.58% | response to virus |
| GO:0051091 | 2.58% | positive regulation of DNA-binding transcription factor activity |
| GO:0009826 | 2.58% | unidimensional cell growth |
| GO:2000649 | 2.58% | regulation of sodium ion transmembrane transporter activity |
| GO:0051640 | 2.57% | organelle localization |
| GO:0019748 | 2.57% | secondary metabolic process |
| GO:0023061 | 2.57% | signal release |
| GO:0048705 | 2.57% | skeletal system morphogenesis |
| GO:0007596 | 2.57% | blood coagulation |
| GO:0120162 | 2.56% | positive regulation of cold-induced thermogenesis |
| GO:0009566 | 2.56% | fertilization |
| GO:0016070 | 2.55% | RNA metabolic process |
| GO:0009308 | 2.55% | amine metabolic process |
| GO:0044271 | 2.55% | cellular nitrogen compound biosynthetic process |
| GO:0030216 | 2.55% | keratinocyte differentiation |
| GO:0051090 | 2.54% | regulation of DNA-binding transcription factor activity |
| GO:0043547 | 2.54% | positive regulation of GTPase activity |
| GO:0009737 | 2.54% | response to abscisic acid |
| GO:0032094 | 2.54% | response to food |
| GO:0001667 | 2.54% | ameboidal-type cell migration |
| GO:0017015 | 2.54% | regulation of transforming growth factor beta receptor signaling pathway |
| GO:0009793 | 2.54% | embryo development ending in seed dormancy |
| GO:0031554 | 2.54% | regulation of DNA-templated transcription, termination |
| GO:0034622 | 2.54% | cellular protein-containing complex assembly |
| GO:0061572 | 2.53% | actin filament bundle organization |
| GO:0009886 | 2.53% | post-embryonic animal morphogenesis |
| GO:0002252 | 2.53% | immune effector process |
| GO:0006633 | 2.53% | fatty acid biosynthetic process |
| GO:0042133 | 2.52% | neurotransmitter metabolic process |
| GO:0032355 | 2.52% | response to estradiol |
| GO:0061640 | 2.52% | cytoskeleton-dependent cytokinesis |
| GO:0045664 | 2.52% | regulation of neuron differentiation |
| GO:1902930 | 2.51% | regulation of alcohol biosynthetic process |
| GO:2000379 | 2.51% | positive regulation of reactive oxygen species metabolic process |
| GO:1902305 | 2.51% | regulation of sodium ion transmembrane transport |
| GO:0030324 | 2.51% | lung development |
| GO:0048545 | 2.51% | response to steroid hormone |
| GO:0060359 | 2.51% | response to ammonium ion |
| GO:0034220 | 2.50% | ion transmembrane transport |
| GO:0016054 | 2.50% | organic acid catabolic process |
| GO:0009649 | 2.50% | entrainment of circadian clock |
| GO:0046395 | 2.50% | carboxylic acid catabolic process |
| GO:0010087 | 2.50% | phloem or xylem histogenesis |
| GO:0050810 | 2.50% | regulation of steroid biosynthetic process |
| GO:0045454 | 2.50% | cell redox homeostasis |
| GO:0007631 | 2.49% | feeding behavior |
| GO:0032970 | 2.49% | regulation of actin filament-based process |
| GO:0008630 | 2.49% | intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:1902652 | 2.49% | secondary alcohol metabolic process |
| GO:0043112 | 2.49% | receptor metabolic process |
| GO:0031424 | 2.49% | keratinization |
| GO:1900076 | 2.49% | regulation of cellular response to insulin stimulus |
| GO:0018149 | 2.49% | peptide cross-linking |
| GO:0051321 | 2.49% | meiotic cell cycle |
| GO:0099175 | 2.48% | regulation of postsynapse organization |
| GO:0071407 | 2.48% | cellular response to organic cyclic compound |
| GO:0022411 | 2.48% | cellular component disassembly |
| GO:0042048 | 2.48% | olfactory behavior |
| GO:0032368 | 2.48% | regulation of lipid transport |
| GO:0009932 | 2.48% | cell tip growth |
| GO:0097193 | 2.48% | intrinsic apoptotic signaling pathway |
| GO:0007589 | 2.48% | body fluid secretion |
| GO:0110150 | 2.48% | negative regulation of biomineralization |
| GO:0030111 | 2.47% | regulation of Wnt signaling pathway |
| GO:0018958 | 2.47% | phenol-containing compound metabolic process |
| GO:0035023 | 2.47% | regulation of Rho protein signal transduction |
| GO:0022405 | 2.47% | hair cycle process |
| GO:0001523 | 2.47% | retinoid metabolic process |
| GO:2001020 | 2.47% | regulation of response to DNA damage stimulus |
| GO:0031137 | 2.47% | regulation of conjugation with cellular fusion |
| GO:0001775 | 2.47% | cell activation |
| GO:0031623 | 2.47% | receptor internalization |
| GO:1901652 | 2.46% | response to peptide |
| GO:1904062 | 2.46% | regulation of cation transmembrane transport |
| GO:0007409 | 2.46% | axonogenesis |
| GO:1901605 | 2.46% | alpha-amino acid metabolic process |
| GO:0051047 | 2.45% | positive regulation of secretion |
| GO:0010720 | 2.45% | positive regulation of cell development |
| GO:0034308 | 2.45% | primary alcohol metabolic process |
| GO:0009913 | 2.45% | epidermal cell differentiation |
| GO:1903427 | 2.45% | negative regulation of reactive oxygen species biosynthetic process |
| GO:0009644 | 2.45% | response to high light intensity |
| GO:0006520 | 2.45% | cellular amino acid metabolic process |
| GO:0010669 | 2.45% | epithelial structure maintenance |
| GO:0045165 | 2.44% | cell fate commitment |
| GO:0034614 | 2.44% | cellular response to reactive oxygen species |
| GO:0006643 | 2.44% | membrane lipid metabolic process |
| GO:0060627 | 2.44% | regulation of vesicle-mediated transport |
| GO:2001023 | 2.44% | regulation of response to drug |
| GO:0043271 | 2.43% | negative regulation of ion transport |
| GO:0071417 | 2.43% | cellular response to organonitrogen compound |
| GO:0051781 | 2.43% | positive regulation of cell division |
| GO:0009259 | 2.43% | ribonucleotide metabolic process |
| GO:0009648 | 2.43% | photoperiodism |
| GO:0050832 | 2.43% | defense response to fungus |
| GO:0045927 | 2.43% | positive regulation of growth |
| GO:0009311 | 2.43% | oligosaccharide metabolic process |
| GO:0045912 | 2.43% | negative regulation of carbohydrate metabolic process |
| GO:2000107 | 2.42% | negative regulation of leukocyte apoptotic process |
| GO:0051048 | 2.42% | negative regulation of secretion |
| GO:0050885 | 2.42% | neuromuscular process controlling balance |
| GO:1901361 | 2.42% | organic cyclic compound catabolic process |
| GO:0034764 | 2.42% | positive regulation of transmembrane transport |
| GO:0010638 | 2.42% | positive regulation of organelle organization |
| GO:0051098 | 2.41% | regulation of binding |
| GO:0007249 | 2.41% | I-kappaB kinase/NF-kappaB signaling |
| GO:0001906 | 2.41% | cell killing |
| GO:1901342 | 2.41% | regulation of vasculature development |
| GO:0009059 | 2.41% | macromolecule biosynthetic process |
| GO:0035264 | 2.40% | multicellular organism growth |
| GO:0045600 | 2.40% | positive regulation of fat cell differentiation |
| GO:0007417 | 2.40% | central nervous system development |
| GO:0051954 | 2.40% | positive regulation of amine transport |
| GO:0008360 | 2.40% | regulation of cell shape |
| GO:0046174 | 2.39% | polyol catabolic process |
| GO:0019217 | 2.39% | regulation of fatty acid metabolic process |
| GO:0002244 | 2.39% | hematopoietic progenitor cell differentiation |
| GO:0045765 | 2.39% | regulation of angiogenesis |
| GO:0097237 | 2.38% | cellular response to toxic substance |
| GO:0002688 | 2.38% | regulation of leukocyte chemotaxis |
| GO:0046365 | 2.38% | monosaccharide catabolic process |
| GO:0070507 | 2.38% | regulation of microtubule cytoskeleton organization |
| GO:0034645 | 2.38% | cellular macromolecule biosynthetic process |
| GO:0002274 | 2.38% | myeloid leukocyte activation |
| GO:0010043 | 2.38% | response to zinc ion |
| GO:0070542 | 2.38% | response to fatty acid |
| GO:1901606 | 2.37% | alpha-amino acid catabolic process |
| GO:0051952 | 2.37% | regulation of amine transport |
| GO:1903522 | 2.37% | regulation of blood circulation |
| GO:0050768 | 2.37% | negative regulation of neurogenesis |
| GO:1903725 | 2.37% | regulation of phospholipid metabolic process |
| GO:0040014 | 2.37% | regulation of multicellular organism growth |
| GO:0008584 | 2.37% | male gonad development |
| GO:0032465 | 2.37% | regulation of cytokinesis |
| GO:0009896 | 2.36% | positive regulation of catabolic process |
| GO:0007638 | 2.36% | mechanosensory behavior |
| GO:0045893 | 2.36% | positive regulation of transcription, DNA-templated |
| GO:0006939 | 2.36% | smooth muscle contraction |
| GO:0016567 | 2.36% | protein ubiquitination |
| GO:0050766 | 2.36% | positive regulation of phagocytosis |
| GO:0010962 | 2.35% | regulation of glucan biosynthetic process |
| GO:0046883 | 2.35% | regulation of hormone secretion |
| GO:0001818 | 2.35% | negative regulation of cytokine production |
| GO:0009620 | 2.35% | response to fungus |
| GO:0009895 | 2.35% | negative regulation of catabolic process |
| GO:0032104 | 2.35% | regulation of response to extracellular stimulus |
| GO:0043666 | 2.35% | regulation of phosphoprotein phosphatase activity |
| GO:0050679 | 2.35% | positive regulation of epithelial cell proliferation |
| GO:0001763 | 2.35% | morphogenesis of a branching structure |
| GO:0010042 | 2.35% | response to manganese ion |
| GO:0070527 | 2.34% | platelet aggregation |
| GO:1902680 | 2.34% | positive regulation of RNA biosynthetic process |
| GO:0045786 | 2.34% | negative regulation of cell cycle |
| GO:0051649 | 2.34% | establishment of localization in cell |
| GO:0032350 | 2.33% | regulation of hormone metabolic process |
| GO:0071472 | 2.33% | cellular response to salt stress |
| GO:0010557 | 2.33% | positive regulation of macromolecule biosynthetic process |
| GO:0035308 | 2.33% | negative regulation of protein dephosphorylation |
| GO:0051084 | 2.33% | 'de novo' posttranslational protein folding |
| GO:0072657 | 2.33% | protein localization to membrane |
| GO:0010810 | 2.32% | regulation of cell-substrate adhesion |
| GO:0043244 | 2.32% | regulation of protein complex disassembly |
| GO:0034605 | 2.32% | cellular response to heat |
| GO:0042476 | 2.32% | odontogenesis |
| GO:0008654 | 2.32% | phospholipid biosynthetic process |
| GO:1903508 | 2.32% | positive regulation of nucleic acid-templated transcription |
| GO:0009798 | 2.32% | axis specification |
| GO:0019320 | 2.32% | hexose catabolic process |
| GO:0031047 | 2.32% | gene silencing by RNA |
| GO:0051254 | 2.32% | positive regulation of RNA metabolic process |
| GO:1990778 | 2.32% | protein localization to cell periphery |
| GO:0034763 | 2.32% | negative regulation of transmembrane transport |
| GO:1903532 | 2.31% | positive regulation of secretion by cell |
| GO:0044060 | 2.31% | regulation of endocrine process |
| GO:0048581 | 2.31% | negative regulation of post-embryonic development |
| GO:0002686 | 2.31% | negative regulation of leukocyte migration |
| GO:0051591 | 2.31% | response to cAMP |
| GO:0007346 | 2.31% | regulation of mitotic cell cycle |
| GO:0061844 | 2.31% | antimicrobial humoral immune response mediated by antimicrobial peptide |
| GO:0048015 | 2.30% | phosphatidylinositol-mediated signaling |
| GO:0019218 | 2.30% | regulation of steroid metabolic process |
| GO:0052548 | 2.30% | regulation of endopeptidase activity |
| GO:0055072 | 2.30% | iron ion homeostasis |
| GO:0033273 | 2.29% | response to vitamin |
| GO:0001895 | 2.29% | retina homeostasis |
| GO:0006953 | 2.29% | acute-phase response |
| GO:0008652 | 2.29% | cellular amino acid biosynthetic process |
| GO:0045321 | 2.29% | leukocyte activation |
| GO:0048872 | 2.29% | homeostasis of number of cells |
| GO:0051055 | 2.28% | negative regulation of lipid biosynthetic process |
| GO:0010466 | 2.28% | negative regulation of peptidase activity |
| GO:0006396 | 2.28% | RNA processing |
| GO:0034695 | 2.28% | response to prostaglandin E |
| GO:0050829 | 2.28% | defense response to Gram-negative bacterium |
| GO:0009909 | 2.28% | regulation of flower development |
| GO:0030307 | 2.28% | positive regulation of cell growth |
| GO:0048582 | 2.28% | positive regulation of post-embryonic development |
| GO:0050678 | 2.27% | regulation of epithelial cell proliferation |
| GO:0019438 | 2.27% | aromatic compound biosynthetic process |
| GO:0007005 | 2.27% | mitochondrion organization |
| GO:0044364 | 2.27% | disruption of cells of other organism |
| GO:0001525 | 2.27% | angiogenesis |
| GO:0042180 | 2.27% | cellular ketone metabolic process |
| GO:0051817 | 2.27% | modification of morphology or physiology of other organism involved in symbiotic interaction |
| GO:0048145 | 2.27% | regulation of fibroblast proliferation |
| GO:0048017 | 2.26% | inositol lipid-mediated signaling |
| GO:0045667 | 2.26% | regulation of osteoblast differentiation |
| GO:0031929 | 2.26% | TOR signaling |
| GO:0098630 | 2.26% | aggregation of unicellular organisms |
| GO:0006338 | 2.26% | chromatin remodeling |
| GO:0035305 | 2.25% | negative regulation of dephosphorylation |
| GO:0051924 | 2.25% | regulation of calcium ion transport |
| GO:0031640 | 2.25% | killing of cells of other organism |
| GO:0046916 | 2.25% | cellular transition metal ion homeostasis |
| GO:0006112 | 2.25% | energy reserve metabolic process |
| GO:1901215 | 2.25% | negative regulation of neuron death |
| GO:0008037 | 2.25% | cell recognition |
| GO:1903793 | 2.25% | positive regulation of anion transport |
| GO:0010827 | 2.25% | regulation of glucose transmembrane transport |
| GO:0006099 | 2.24% | tricarboxylic acid cycle |
| GO:0031333 | 2.24% | negative regulation of protein complex assembly |
| GO:0009880 | 2.24% | embryonic pattern specification |
| GO:0046879 | 2.24% | hormone secretion |
| GO:1901617 | 2.24% | organic hydroxy compound biosynthetic process |
| GO:0050769 | 2.24% | positive regulation of neurogenesis |
| GO:0003014 | 2.23% | renal system process |
| GO:0001890 | 2.23% | placenta development |
| GO:1900273 | 2.23% | positive regulation of long-term synaptic potentiation |
| GO:0032870 | 2.23% | cellular response to hormone stimulus |
| GO:0072521 | 2.23% | purine-containing compound metabolic process |
| GO:0005976 | 2.23% | polysaccharide metabolic process |
| GO:0006721 | 2.23% | terpenoid metabolic process |
| GO:0070229 | 2.23% | negative regulation of lymphocyte apoptotic process |
| GO:0014074 | 2.23% | response to purine-containing compound |
| GO:0032107 | 2.22% | regulation of response to nutrient levels |
| GO:0051156 | 2.22% | glucose 6-phosphate metabolic process |
| GO:0050778 | 2.22% | positive regulation of immune response |
| GO:0070925 | 2.22% | organelle assembly |
| GO:0009723 | 2.22% | response to ethylene |
| GO:0002028 | 2.22% | regulation of sodium ion transport |
| GO:0018209 | 2.22% | peptidyl-serine modification |
| GO:0060537 | 2.22% | muscle tissue development |
| GO:0007009 | 2.22% | plasma membrane organization |
| GO:0090087 | 2.22% | regulation of peptide transport |
| GO:0030522 | 2.22% | intracellular receptor signaling pathway |
| GO:0018130 | 2.21% | heterocycle biosynthetic process |
| GO:0031032 | 2.21% | actomyosin structure organization |
| GO:0090596 | 2.20% | sensory organ morphogenesis |
| GO:0042060 | 2.20% | wound healing |
| GO:0022407 | 2.20% | regulation of cell-cell adhesion |
| GO:0019400 | 2.20% | alditol metabolic process |
| GO:0051968 | 2.20% | positive regulation of synaptic transmission, glutamatergic |
| GO:0010631 | 2.20% | epithelial cell migration |
| GO:0015711 | 2.20% | organic anion transport |
| GO:0048857 | 2.20% | neural nucleus development |
| GO:1903959 | 2.19% | regulation of anion transmembrane transport |
| GO:0031334 | 2.19% | positive regulation of protein complex assembly |
| GO:0051235 | 2.19% | maintenance of location |
| GO:0009057 | 2.19% | macromolecule catabolic process |
| GO:0055081 | 2.19% | anion homeostasis |
| GO:0051260 | 2.19% | protein homooligomerization |
| GO:1903046 | 2.19% | meiotic cell cycle process |
| GO:0098754 | 2.19% | detoxification |
| GO:0002573 | 2.19% | myeloid leukocyte differentiation |
| GO:0019731 | 2.19% | antibacterial humoral response |
| GO:0051100 | 2.18% | negative regulation of binding |
| GO:0019233 | 2.18% | sensory perception of pain |
| GO:0045637 | 2.18% | regulation of myeloid cell differentiation |
| GO:0051052 | 2.18% | regulation of DNA metabolic process |
| GO:0048871 | 2.18% | multicellular organismal homeostasis |
| GO:0042335 | 2.18% | cuticle development |
| GO:0071398 | 2.18% | cellular response to fatty acid |
| GO:0032890 | 2.18% | regulation of organic acid transport |
| GO:0030282 | 2.18% | bone mineralization |
| GO:0016485 | 2.18% | protein processing |
| GO:0060078 | 2.18% | regulation of postsynaptic membrane potential |
| GO:0043484 | 2.18% | regulation of RNA splicing |
| GO:0017157 | 2.18% | regulation of exocytosis |
| GO:0045089 | 2.17% | positive regulation of innate immune response |
| GO:0060918 | 2.17% | auxin transport |
| GO:0006518 | 2.17% | peptide metabolic process |
| GO:1904064 | 2.17% | positive regulation of cation transmembrane transport |
| GO:0010171 | 2.17% | body morphogenesis |
| GO:0051186 | 2.17% | cofactor metabolic process |
| GO:0050906 | 2.17% | detection of stimulus involved in sensory perception |
| GO:0010769 | 2.17% | regulation of cell morphogenesis involved in differentiation |
| GO:0051966 | 2.17% | regulation of synaptic transmission, glutamatergic |
| GO:0043462 | 2.17% | regulation of ATPase activity |
| GO:0010948 | 2.17% | negative regulation of cell cycle process |
| GO:1902074 | 2.17% | response to salt |
| GO:0007018 | 2.16% | microtubule-based movement |
| GO:0007160 | 2.16% | cell-matrix adhesion |
| GO:0045616 | 2.16% | regulation of keratinocyte differentiation |
| GO:0043279 | 2.16% | response to alkaloid |
| GO:0009150 | 2.16% | purine ribonucleotide metabolic process |
| GO:1902903 | 2.16% | regulation of supramolecular fiber organization |
| GO:0016458 | 2.15% | gene silencing |
| GO:0050773 | 2.15% | regulation of dendrite development |
| GO:0015918 | 2.15% | sterol transport |
| GO:0001508 | 2.15% | action potential |
| GO:0008361 | 2.15% | regulation of cell size |
| GO:0045860 | 2.15% | positive regulation of protein kinase activity |
| GO:0043627 | 2.15% | response to estrogen |
| GO:0030031 | 2.15% | cell projection assembly |
| GO:0009742 | 2.15% | brassinosteroid mediated signaling pathway |
| GO:0006458 | 2.15% | 'de novo' protein folding |
| GO:0017148 | 2.14% | negative regulation of translation |
| GO:0030279 | 2.14% | negative regulation of ossification |
| GO:0070201 | 2.14% | regulation of establishment of protein localization |
| GO:0002832 | 2.14% | negative regulation of response to biotic stimulus |
| GO:0050922 | 2.14% | negative regulation of chemotaxis |
| GO:0006694 | 2.14% | steroid biosynthetic process |
| GO:0006720 | 2.14% | isoprenoid metabolic process |
| GO:0051223 | 2.14% | regulation of protein transport |
| GO:0031670 | 2.14% | cellular response to nutrient |
| GO:0006259 | 2.14% | DNA metabolic process |
| GO:0032892 | 2.14% | positive regulation of organic acid transport |
| GO:0031960 | 2.14% | response to corticosteroid |
| GO:0043393 | 2.13% | regulation of protein binding |
| GO:0033363 | 2.13% | secretory granule organization |
| GO:0019953 | 2.13% | sexual reproduction |
| GO:0034637 | 2.13% | cellular carbohydrate biosynthetic process |
| GO:0006940 | 2.13% | regulation of smooth muscle contraction |
| GO:0034249 | 2.13% | negative regulation of cellular amide metabolic process |
| GO:0009629 | 2.13% | response to gravity |
| GO:0000278 | 2.13% | mitotic cell cycle |
| GO:0003018 | 2.13% | vascular process in circulatory system |
| GO:0034694 | 2.13% | response to prostaglandin |
| GO:0046885 | 2.13% | regulation of hormone biosynthetic process |
| GO:0032956 | 2.12% | regulation of actin cytoskeleton organization |
| GO:0032886 | 2.12% | regulation of microtubule-based process |
| GO:0120035 | 2.12% | regulation of plasma membrane bounded cell projection organization |
| GO:0010927 | 2.12% | cellular component assembly involved in morphogenesis |
| GO:0099601 | 2.12% | regulation of neurotransmitter receptor activity |
| GO:0048754 | 2.12% | branching morphogenesis of an epithelial tube |
| GO:0022408 | 2.12% | negative regulation of cell-cell adhesion |
| GO:0045471 | 2.12% | response to ethanol |
| GO:1901419 | 2.12% | regulation of response to alcohol |
| GO:0031098 | 2.12% | stress-activated protein kinase signaling cascade |
| GO:0030856 | 2.12% | regulation of epithelial cell differentiation |
| GO:0043523 | 2.12% | regulation of neuron apoptotic process |
| GO:0007595 | 2.12% | lactation |
| GO:0031646 | 2.11% | positive regulation of nervous system process |
| GO:0042542 | 2.11% | response to hydrogen peroxide |
| GO:1901657 | 2.11% | glycosyl compound metabolic process |
| GO:0019934 | 2.11% | cGMP-mediated signaling |
| GO:0043434 | 2.11% | response to peptide hormone |
| GO:0006766 | 2.11% | vitamin metabolic process |
| GO:0002700 | 2.11% | regulation of production of molecular mediator of immune response |
| GO:0009988 | 2.10% | cell-cell recognition |
| GO:0006281 | 2.10% | DNA repair |
| GO:0050764 | 2.10% | regulation of phagocytosis |
| GO:0048592 | 2.10% | eye morphogenesis |
| GO:1903829 | 2.10% | positive regulation of cellular protein localization |
| GO:0034767 | 2.10% | positive regulation of ion transmembrane transport |
| GO:0006040 | 2.10% | amino sugar metabolic process |
| GO:0060998 | 2.09% | regulation of dendritic spine development |
| GO:0046683 | 2.09% | response to organophosphorus |
| GO:0019439 | 2.09% | aromatic compound catabolic process |
| GO:0035107 | 2.09% | appendage morphogenesis |
| GO:0002521 | 2.09% | leukocyte differentiation |
| GO:1901264 | 2.09% | carbohydrate derivative transport |
| GO:0009751 | 2.09% | response to salicylic acid |
| GO:0051881 | 2.09% | regulation of mitochondrial membrane potential |
| GO:0042475 | 2.09% | odontogenesis of dentin-containing tooth |
| GO:0048367 | 2.08% | shoot system development |
| GO:0031100 | 2.08% | animal organ regeneration |
| GO:0051957 | 2.08% | positive regulation of amino acid transport |
| GO:0031330 | 2.08% | negative regulation of cellular catabolic process |
| GO:0051495 | 2.08% | positive regulation of cytoskeleton organization |
| GO:0009606 | 2.08% | tropism |
| GO:2001257 | 2.08% | regulation of cation channel activity |
| GO:0010224 | 2.08% | response to UV-B |
| GO:0010923 | 2.08% | negative regulation of phosphatase activity |
| GO:1903305 | 2.08% | regulation of regulated secretory pathway |
| GO:0006576 | 2.08% | cellular biogenic amine metabolic process |
| GO:0009738 | 2.08% | abscisic acid-activated signaling pathway |
| GO:0040029 | 2.08% | regulation of gene expression, epigenetic |
| GO:1903845 | 2.08% | negative regulation of cellular response to transforming growth factor beta stimulus |
| GO:0031346 | 2.07% | positive regulation of cell projection organization |
| GO:0030431 | 2.07% | sleep |
| GO:0016999 | 2.07% | antibiotic metabolic process |
| GO:0034097 | 2.07% | response to cytokine |
| GO:0051216 | 2.07% | cartilage development |
| GO:0043648 | 2.07% | dicarboxylic acid metabolic process |
| GO:0046928 | 2.07% | regulation of neurotransmitter secretion |
| GO:0002526 | 2.07% | acute inflammatory response |
| GO:0044275 | 2.07% | cellular carbohydrate catabolic process |
| GO:0010893 | 2.07% | positive regulation of steroid biosynthetic process |
| GO:0047484 | 2.07% | regulation of response to osmotic stress |
| GO:2001038 | 2.07% | regulation of cellular response to drug |
| GO:0015979 | 2.06% | photosynthesis |
| GO:0030512 | 2.06% | negative regulation of transforming growth factor beta receptor signaling pathway |
| GO:0009063 | 2.06% | cellular amino acid catabolic process |
| GO:0009584 | 2.06% | detection of visible light |
| GO:0098869 | 2.06% | cellular oxidant detoxification |
| GO:2001057 | 2.05% | reactive nitrogen species metabolic process |
| GO:0042254 | 2.05% | ribosome biogenesis |
| GO:0048284 | 2.05% | organelle fusion |
| GO:0048827 | 2.05% | phyllome development |
| GO:0045494 | 2.05% | photoreceptor cell maintenance |
| GO:0050433 | 2.05% | regulation of catecholamine secretion |
| GO:1901607 | 2.05% | alpha-amino acid biosynthetic process |
| GO:1900140 | 2.04% | regulation of seedling development |
| GO:1902932 | 2.04% | positive regulation of alcohol biosynthetic process |
| GO:0006446 | 2.04% | regulation of translational initiation |
| GO:0061138 | 2.04% | morphogenesis of a branching epithelium |
| GO:0045940 | 2.04% | positive regulation of steroid metabolic process |
| GO:0030099 | 2.04% | myeloid cell differentiation |
| GO:0042572 | 2.04% | retinol metabolic process |
| GO:0042135 | 2.04% | neurotransmitter catabolic process |
| GO:0046688 | 2.04% | response to copper ion |
| GO:0051702 | 2.04% | interaction with symbiont |
| GO:0044106 | 2.04% | cellular amine metabolic process |
| GO:0002237 | 2.04% | response to molecule of bacterial origin |
| GO:0045055 | 2.03% | regulated exocytosis |
| GO:2000027 | 2.03% | regulation of animal organ morphogenesis |
| GO:0010029 | 2.03% | regulation of seed germination |
| GO:0055088 | 2.03% | lipid homeostasis |
| GO:0097588 | 2.03% | archaeal or bacterial-type flagellum-dependent cell motility |
| GO:1905957 | 2.03% | regulation of cellular response to alcohol |
| GO:0008210 | 2.03% | estrogen metabolic process |
| GO:0031136 | 2.02% | positive regulation of conjugation |
| GO:0030048 | 2.02% | actin filament-based movement |
| GO:0002697 | 2.02% | regulation of immune effector process |
| GO:0006163 | 2.02% | purine nucleotide metabolic process |
| GO:0022900 | 2.02% | electron transport chain |
| GO:0006941 | 2.02% | striated muscle contraction |
| GO:0008016 | 2.02% | regulation of heart contraction |
| GO:0048732 | 2.02% | gland development |
| GO:0050777 | 2.02% | negative regulation of immune response |
| GO:0032963 | 2.02% | collagen metabolic process |
| GO:0008203 | 2.02% | cholesterol metabolic process |
| GO:0033555 | 2.02% | multicellular organismal response to stress |
| GO:0050729 | 2.02% | positive regulation of inflammatory response |
| GO:0032872 | 2.02% | regulation of stress-activated MAPK cascade |
| GO:0030587 | 2.01% | sorocarp development |
| GO:1905475 | 2.01% | regulation of protein localization to membrane |
| GO:0050684 | 2.01% | regulation of mRNA processing |
| GO:0051085 | 2.01% | chaperone cofactor-dependent protein refolding |
| GO:0043470 | 2.01% | regulation of carbohydrate catabolic process |
| GO:0090567 | 2.01% | reproductive shoot system development |
| GO:0009626 | 2.01% | plant-type hypersensitive response |
| GO:0008543 | 2.01% | fibroblast growth factor receptor signaling pathway |
| GO:0045685 | 2.01% | regulation of glial cell differentiation |
| GO:0043409 | 2.00% | negative regulation of MAPK cascade |
| GO:0001503 | 2.00% | ossification |
| GO:0070168 | 2.00% | negative regulation of biomineral tissue development |
| GO:1900424 | 2.00% | regulation of defense response to bacterium |
| GO:0032496 | 2.00% | response to lipopolysaccharide |
| GO:0031288 | 2.00% | sorocarp morphogenesis |
| GO:0034330 | 2.00% | cell junction organization |
| GO:0060326 | 2.00% | cell chemotaxis |
| GO:1903706 | 2.00% | regulation of hemopoiesis |
| GO:0051017 | 2.00% | actin filament bundle assembly |
| GO:0034284 | 1.99% | response to monosaccharide |
| GO:0042176 | 1.99% | regulation of protein catabolic process |
| GO:0007178 | 1.99% | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0042538 | 1.99% | hyperosmotic salinity response |
| GO:0045862 | 1.99% | positive regulation of proteolysis |
| GO:0090702 | 1.99% | non-reproductive fruiting body development |
| GO:0071941 | 1.99% | nitrogen cycle metabolic process |
| GO:0051851 | 1.99% | modification by host of symbiont morphology or physiology |
| GO:0006090 | 1.99% | pyruvate metabolic process |
| GO:0042537 | 1.99% | benzene-containing compound metabolic process |
| GO:0014706 | 1.99% | striated muscle tissue development |
| GO:0110053 | 1.99% | regulation of actin filament organization |
| GO:0061061 | 1.98% | muscle structure development |
| GO:0051955 | 1.98% | regulation of amino acid transport |
| GO:1905939 | 1.98% | regulation of gonad development |
| GO:0046324 | 1.98% | regulation of glucose import |
| GO:0060349 | 1.98% | bone morphogenesis |
| GO:0120163 | 1.98% | negative regulation of cold-induced thermogenesis |
| GO:0035150 | 1.98% | regulation of tube size |
| GO:0071277 | 1.98% | cellular response to calcium ion |
| GO:0035239 | 1.98% | tube morphogenesis |
| GO:0009952 | 1.98% | anterior/posterior pattern specification |
| GO:0010975 | 1.98% | regulation of neuron projection development |
| GO:0031331 | 1.98% | positive regulation of cellular catabolic process |
| GO:0120178 | 1.97% | steroid hormone biosynthetic process |
| GO:1900120 | 1.97% | regulation of receptor binding |
| GO:0034050 | 1.97% | host programmed cell death induced by symbiont |
| GO:0048286 | 1.97% | lung alveolus development |
| GO:0050805 | 1.97% | negative regulation of synaptic transmission |
| GO:0072350 | 1.97% | tricarboxylic acid metabolic process |
| GO:0000165 | 1.97% | MAPK cascade |
| GO:0010884 | 1.97% | positive regulation of lipid storage |
| GO:0046686 | 1.97% | response to cadmium ion |
| GO:0018105 | 1.97% | peptidyl-serine phosphorylation |
| GO:1901137 | 1.96% | carbohydrate derivative biosynthetic process |
| GO:0045746 | 1.96% | negative regulation of Notch signaling pathway |
| GO:0060966 | 1.96% | regulation of gene silencing by RNA |
| GO:0010907 | 1.96% | positive regulation of glucose metabolic process |
| GO:0032006 | 1.96% | regulation of TOR signaling |
| GO:0048168 | 1.96% | regulation of neuronal synaptic plasticity |
| GO:1905809 | 1.96% | negative regulation of synapse organization |
| GO:2001233 | 1.96% | regulation of apoptotic signaling pathway |
| GO:0010453 | 1.96% | regulation of cell fate commitment |
| GO:0048521 | 1.96% | negative regulation of behavior |
| GO:0001570 | 1.95% | vasculogenesis |
| GO:0031139 | 1.95% | positive regulation of conjugation with cellular fusion |
| GO:0043562 | 1.95% | cellular response to nitrogen levels |
| GO:0044042 | 1.95% | glucan metabolic process |
| GO:0015672 | 1.95% | monovalent inorganic cation transport |
| GO:0018193 | 1.95% | peptidyl-amino acid modification |
| GO:0006805 | 1.95% | xenobiotic metabolic process |
| GO:0050728 | 1.95% | negative regulation of inflammatory response |
| GO:0061013 | 1.95% | regulation of mRNA catabolic process |
| GO:0007157 | 1.95% | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0044264 | 1.95% | cellular polysaccharide metabolic process |
| GO:1902019 | 1.95% | regulation of cilium-dependent cell motility |
| GO:0043949 | 1.95% | regulation of cAMP-mediated signaling |
| GO:0045185 | 1.95% | maintenance of protein location |
| GO:0006073 | 1.95% | cellular glucan metabolic process |
| GO:0099174 | 1.95% | regulation of presynapse organization |
| GO:0033500 | 1.95% | carbohydrate homeostasis |
| GO:0009185 | 1.94% | ribonucleoside diphosphate metabolic process |
| GO:0009908 | 1.94% | flower development |
| GO:0097327 | 1.94% | response to antineoplastic agent |
| GO:2000106 | 1.94% | regulation of leukocyte apoptotic process |
| GO:0043200 | 1.94% | response to amino acid |
| GO:0050673 | 1.94% | epithelial cell proliferation |
| GO:0001942 | 1.94% | hair follicle development |
| GO:0009451 | 1.94% | RNA modification |
| GO:0032271 | 1.94% | regulation of protein polymerization |
| GO:0046942 | 1.94% | carboxylic acid transport |
| GO:0050808 | 1.94% | synapse organization |
| GO:0032526 | 1.94% | response to retinoic acid |
| GO:0070302 | 1.93% | regulation of stress-activated protein kinase signaling cascade |
| GO:1990748 | 1.93% | cellular detoxification |
| GO:0045944 | 1.93% | positive regulation of transcription by RNA polymerase II |
| GO:0048806 | 1.93% | genitalia development |
| GO:0042472 | 1.93% | inner ear morphogenesis |
| GO:0007163 | 1.93% | establishment or maintenance of cell polarity |
| GO:0009787 | 1.93% | regulation of abscisic acid-activated signaling pathway |
| GO:0035112 | 1.93% | genitalia morphogenesis |
| GO:0022413 | 1.93% | reproductive process in single-celled organism |
| GO:0006081 | 1.93% | cellular aldehyde metabolic process |
| GO:0014013 | 1.92% | regulation of gliogenesis |
| GO:0000041 | 1.92% | transition metal ion transport |
| GO:0055067 | 1.92% | monovalent inorganic cation homeostasis |
| GO:0050830 | 1.92% | defense response to Gram-positive bacterium |
| GO:0009753 | 1.92% | response to jasmonic acid |
| GO:0005984 | 1.92% | disaccharide metabolic process |
| GO:0019835 | 1.92% | cytolysis |
| GO:0032922 | 1.92% | circadian regulation of gene expression |
| GO:1901379 | 1.92% | regulation of potassium ion transmembrane transport |
| GO:0098900 | 1.92% | regulation of action potential |
| GO:0048660 | 1.92% | regulation of smooth muscle cell proliferation |
| GO:0097756 | 1.92% | negative regulation of blood vessel diameter |
| GO:0046165 | 1.92% | alcohol biosynthetic process |
| GO:0045604 | 1.91% | regulation of epidermal cell differentiation |
| GO:0010883 | 1.91% | regulation of lipid storage |
| GO:0007219 | 1.91% | Notch signaling pathway |
| GO:1905521 | 1.91% | regulation of macrophage migration |
| GO:0070232 | 1.91% | regulation of T cell apoptotic process |
| GO:0031641 | 1.91% | regulation of myelination |
| GO:0015849 | 1.91% | organic acid transport |
| GO:0043094 | 1.91% | cellular metabolic compound salvage |
| GO:0033135 | 1.91% | regulation of peptidyl-serine phosphorylation |
| GO:0042304 | 1.91% | regulation of fatty acid biosynthetic process |
| GO:0090100 | 1.91% | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0070373 | 1.91% | negative regulation of ERK1 and ERK2 cascade |
| GO:0023014 | 1.91% | signal transduction by protein phosphorylation |
| GO:0043488 | 1.90% | regulation of mRNA stability |
| GO:0070555 | 1.90% | response to interleukin-1 |
| GO:0042753 | 1.90% | positive regulation of circadian rhythm |
| GO:0044270 | 1.90% | cellular nitrogen compound catabolic process |
| GO:0002164 | 1.90% | larval development |
| GO:0006521 | 1.90% | regulation of cellular amino acid metabolic process |
| GO:0032413 | 1.90% | negative regulation of ion transmembrane transporter activity |
| GO:0032386 | 1.90% | regulation of intracellular transport |
| GO:0001889 | 1.90% | liver development |
| GO:0006662 | 1.90% | glycerol ether metabolic process |
| GO:0051896 | 1.89% | regulation of protein kinase B signaling |
| GO:0071345 | 1.89% | cellular response to cytokine stimulus |
| GO:0005979 | 1.89% | regulation of glycogen biosynthetic process |
| GO:0060179 | 1.89% | male mating behavior |
| GO:0009072 | 1.89% | aromatic amino acid family metabolic process |
| GO:0035265 | 1.89% | organ growth |
| GO:0042439 | 1.89% | ethanolamine-containing compound metabolic process |
| GO:0045668 | 1.89% | negative regulation of osteoblast differentiation |
| GO:0051384 | 1.89% | response to glucocorticoid |
| GO:1900078 | 1.89% | positive regulation of cellular response to insulin stimulus |
| GO:0051054 | 1.89% | positive regulation of DNA metabolic process |
| GO:0010212 | 1.89% | response to ionizing radiation |
| GO:0008593 | 1.89% | regulation of Notch signaling pathway |
| GO:0050730 | 1.89% | regulation of peptidyl-tyrosine phosphorylation |
| GO:0030832 | 1.89% | regulation of actin filament length |
| GO:0043542 | 1.88% | endothelial cell migration |
| GO:0007193 | 1.88% | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway |
| GO:0009746 | 1.88% | response to hexose |
| GO:0042402 | 1.88% | cellular biogenic amine catabolic process |
| GO:0006821 | 1.88% | chloride transport |
| GO:0030301 | 1.88% | cholesterol transport |
| GO:2001222 | 1.88% | regulation of neuron migration |
| GO:0009637 | 1.88% | response to blue light |
| GO:0018904 | 1.88% | ether metabolic process |
| GO:0006275 | 1.88% | regulation of DNA replication |
| GO:0042593 | 1.88% | glucose homeostasis |
| GO:0006413 | 1.87% | translational initiation |
| GO:0071260 | 1.87% | cellular response to mechanical stimulus |
| GO:0045428 | 1.87% | regulation of nitric oxide biosynthetic process |
| GO:0009699 | 1.87% | phenylpropanoid biosynthetic process |
| GO:0015718 | 1.87% | monocarboxylic acid transport |
| GO:0006879 | 1.87% | cellular iron ion homeostasis |
| GO:0051898 | 1.87% | negative regulation of protein kinase B signaling |
| GO:0006817 | 1.87% | phosphate ion transport |
| GO:0035036 | 1.86% | sperm-egg recognition |
| GO:0048568 | 1.86% | embryonic organ development |
| GO:0061515 | 1.86% | myeloid cell development |
| GO:0034329 | 1.86% | cell junction assembly |
| GO:2000179 | 1.86% | positive regulation of neural precursor cell proliferation |
| GO:0035296 | 1.86% | regulation of tube diameter |
| GO:0045666 | 1.86% | positive regulation of neuron differentiation |
| GO:0018298 | 1.86% | protein-chromophore linkage |
| GO:0030178 | 1.86% | negative regulation of Wnt signaling pathway |
| GO:0046887 | 1.85% | positive regulation of hormone secretion |
| GO:1904951 | 1.85% | positive regulation of establishment of protein localization |
| GO:0006740 | 1.85% | NADPH regeneration |
| GO:0061448 | 1.85% | connective tissue development |
| GO:0007281 | 1.85% | germ cell development |
| GO:0002366 | 1.85% | leukocyte activation involved in immune response |
| GO:0006575 | 1.85% | cellular modified amino acid metabolic process |
| GO:0030900 | 1.85% | forebrain development |
| GO:0006399 | 1.85% | tRNA metabolic process |
| GO:0071554 | 1.85% | cell wall organization or biogenesis |
| GO:0032984 | 1.85% | protein-containing complex disassembly |
| GO:0042044 | 1.85% | fluid transport |
| GO:0030316 | 1.85% | osteoclast differentiation |
| GO:0002263 | 1.84% | cell activation involved in immune response |
| GO:0006767 | 1.84% | water-soluble vitamin metabolic process |
| GO:0008156 | 1.84% | negative regulation of DNA replication |
| GO:0043524 | 1.84% | negative regulation of neuron apoptotic process |
| GO:0044265 | 1.84% | cellular macromolecule catabolic process |
| GO:0034612 | 1.84% | response to tumor necrosis factor |
| GO:0070098 | 1.84% | chemokine-mediated signaling pathway |
| GO:1901160 | 1.84% | primary amino compound metabolic process |
| GO:0032506 | 1.84% | cytokinetic process |
| GO:0017001 | 1.84% | antibiotic catabolic process |
| GO:0051222 | 1.83% | positive regulation of protein transport |
| GO:0042310 | 1.83% | vasoconstriction |
| GO:0003073 | 1.83% | regulation of systemic arterial blood pressure |
| GO:0006813 | 1.83% | potassium ion transport |
| GO:0097746 | 1.83% | regulation of blood vessel diameter |
| GO:0048713 | 1.83% | regulation of oligodendrocyte differentiation |
| GO:2001235 | 1.83% | positive regulation of apoptotic signaling pathway |
| GO:0071356 | 1.83% | cellular response to tumor necrosis factor |
| GO:0009749 | 1.83% | response to glucose |
| GO:0009310 | 1.83% | amine catabolic process |
| GO:0045229 | 1.83% | external encapsulating structure organization |
| GO:0051053 | 1.83% | negative regulation of DNA metabolic process |
| GO:0051092 | 1.83% | positive regulation of NF-kappaB transcription factor activity |
| GO:0006111 | 1.83% | regulation of gluconeogenesis |
| GO:0044085 | 1.83% | cellular component biogenesis |
| GO:0035295 | 1.82% | tube development |
| GO:0070228 | 1.82% | regulation of lymphocyte apoptotic process |
| GO:0016125 | 1.82% | sterol metabolic process |
| GO:0019321 | 1.82% | pentose metabolic process |
| GO:1902882 | 1.82% | regulation of response to oxidative stress |
| GO:0043392 | 1.82% | negative regulation of DNA binding |
| GO:0006887 | 1.82% | exocytosis |
| GO:0001822 | 1.82% | kidney development |
| GO:2001021 | 1.82% | negative regulation of response to DNA damage stimulus |
| GO:0009593 | 1.82% | detection of chemical stimulus |
| GO:0030947 | 1.82% | regulation of vascular endothelial growth factor receptor signaling pathway |
| GO:0048147 | 1.82% | negative regulation of fibroblast proliferation |
| GO:0032411 | 1.82% | positive regulation of transporter activity |
| GO:0006942 | 1.82% | regulation of striated muscle contraction |
| GO:0070633 | 1.82% | transepithelial transport |
| GO:0010811 | 1.82% | positive regulation of cell-substrate adhesion |
| GO:0040034 | 1.81% | regulation of development, heterochronic |
| GO:0050994 | 1.81% | regulation of lipid catabolic process |
| GO:0044550 | 1.81% | secondary metabolite biosynthetic process |
| GO:1901222 | 1.81% | regulation of NIK/NF-kappaB signaling |
| GO:0048024 | 1.81% | regulation of mRNA splicing, via spliceosome |
| GO:1903531 | 1.81% | negative regulation of secretion by cell |
| GO:0051057 | 1.81% | positive regulation of small GTPase mediated signal transduction |
| GO:2000378 | 1.80% | negative regulation of reactive oxygen species metabolic process |
| GO:0055083 | 1.80% | monovalent inorganic anion homeostasis |
| GO:0010001 | 1.80% | glial cell differentiation |
| GO:0046777 | 1.80% | protein autophosphorylation |
| GO:1900376 | 1.80% | regulation of secondary metabolite biosynthetic process |
| GO:0060828 | 1.80% | regulation of canonical Wnt signaling pathway |
| GO:0022602 | 1.80% | ovulation cycle process |
| GO:0007051 | 1.80% | spindle organization |
| GO:2001025 | 1.80% | positive regulation of response to drug |
| GO:0035108 | 1.80% | limb morphogenesis |
| GO:1905477 | 1.80% | positive regulation of protein localization to membrane |
| GO:0048662 | 1.79% | negative regulation of smooth muscle cell proliferation |
| GO:0051180 | 1.79% | vitamin transport |
| GO:0044242 | 1.79% | cellular lipid catabolic process |
| GO:0043457 | 1.79% | regulation of cellular respiration |
| GO:0035113 | 1.79% | embryonic appendage morphogenesis |
| GO:0034654 | 1.79% | nucleobase-containing compound biosynthetic process |
| GO:0033157 | 1.79% | regulation of intracellular protein transport |
| GO:0030865 | 1.79% | cortical cytoskeleton organization |
| GO:0006140 | 1.79% | regulation of nucleotide metabolic process |
| GO:1904396 | 1.79% | regulation of neuromuscular junction development |
| GO:0045930 | 1.79% | negative regulation of mitotic cell cycle |
| GO:0051783 | 1.79% | regulation of nuclear division |
| GO:0071555 | 1.79% | cell wall organization |
| GO:0051403 | 1.78% | stress-activated MAPK cascade |
| GO:0001707 | 1.78% | mesoderm formation |
| GO:0120031 | 1.78% | plasma membrane bounded cell projection assembly |
| GO:1901136 | 1.78% | carbohydrate derivative catabolic process |
| GO:0033574 | 1.78% | response to testosterone |
| GO:0044058 | 1.78% | regulation of digestive system process |
| GO:0032570 | 1.78% | response to progesterone |
| GO:0008582 | 1.78% | regulation of synaptic growth at neuromuscular junction |
| GO:0048366 | 1.78% | leaf development |
| GO:0048512 | 1.78% | circadian behavior |
| GO:0014065 | 1.78% | phosphatidylinositol 3-kinase signaling |
| GO:0045682 | 1.78% | regulation of epidermis development |
| GO:0008064 | 1.78% | regulation of actin polymerization or depolymerization |
| GO:0006775 | 1.78% | fat-soluble vitamin metabolic process |
| GO:0016050 | 1.78% | vesicle organization |
| GO:0043473 | 1.78% | pigmentation |
| GO:0006119 | 1.78% | oxidative phosphorylation |
| GO:0006661 | 1.78% | phosphatidylinositol biosynthetic process |
| GO:0031156 | 1.77% | regulation of sorocarp development |
| GO:0007622 | 1.77% | rhythmic behavior |
| GO:0002119 | 1.77% | nematode larval development |
| GO:0098660 | 1.77% | inorganic ion transmembrane transport |
| GO:0006739 | 1.77% | NADP metabolic process |
| GO:0046888 | 1.77% | negative regulation of hormone secretion |
| GO:0002791 | 1.77% | regulation of peptide secretion |
| GO:0045766 | 1.77% | positive regulation of angiogenesis |
| GO:0015931 | 1.77% | nucleobase-containing compound transport |
| GO:0008585 | 1.77% | female gonad development |
| GO:1900006 | 1.77% | positive regulation of dendrite development |
| GO:0032026 | 1.77% | response to magnesium ion |
| GO:0050858 | 1.77% | negative regulation of antigen receptor-mediated signaling pathway |
| GO:0001773 | 1.77% | myeloid dendritic cell activation |
| GO:0044782 | 1.77% | cilium organization |
| GO:0000578 | 1.76% | embryonic axis specification |
| GO:0045472 | 1.76% | response to ether |
| GO:1900426 | 1.76% | positive regulation of defense response to bacterium |
| GO:0042058 | 1.76% | regulation of epidermal growth factor receptor signaling pathway |
| GO:2000116 | 1.76% | regulation of cysteine-type endopeptidase activity |
| GO:0006732 | 1.76% | coenzyme metabolic process |
| GO:0070301 | 1.76% | cellular response to hydrogen peroxide |
| GO:0060999 | 1.76% | positive regulation of dendritic spine development |
| GO:0030705 | 1.76% | cytoskeleton-dependent intracellular transport |
| GO:0042743 | 1.76% | hydrogen peroxide metabolic process |
| GO:2000177 | 1.76% | regulation of neural precursor cell proliferation |
| GO:1900407 | 1.76% | regulation of cellular response to oxidative stress |
| GO:0051188 | 1.76% | cofactor biosynthetic process |
| GO:0046628 | 1.76% | positive regulation of insulin receptor signaling pathway |
| GO:1901184 | 1.75% | regulation of ERBB signaling pathway |
| GO:0009812 | 1.75% | flavonoid metabolic process |
| GO:0031345 | 1.75% | negative regulation of cell projection organization |
| GO:0050732 | 1.75% | negative regulation of peptidyl-tyrosine phosphorylation |
| GO:0031102 | 1.75% | neuron projection regeneration |
| GO:0046474 | 1.75% | glycerophospholipid biosynthetic process |
| GO:0045216 | 1.75% | cell-cell junction organization |
| GO:0051701 | 1.75% | interaction with host |
| GO:0090181 | 1.75% | regulation of cholesterol metabolic process |
| GO:0072659 | 1.75% | protein localization to plasma membrane |
| GO:0034310 | 1.75% | primary alcohol catabolic process |
| GO:0007254 | 1.74% | JNK cascade |
| GO:0002793 | 1.74% | positive regulation of peptide secretion |
| GO:0009630 | 1.74% | gravitropism |
| GO:0010632 | 1.74% | regulation of epithelial cell migration |
| GO:0120034 | 1.74% | positive regulation of plasma membrane bounded cell projection assembly |
| GO:0032370 | 1.74% | positive regulation of lipid transport |
| GO:0007088 | 1.74% | regulation of mitotic nuclear division |
| GO:0002790 | 1.74% | peptide secretion |
| GO:0034976 | 1.74% | response to endoplasmic reticulum stress |
| GO:0071902 | 1.74% | positive regulation of protein serine/threonine kinase activity |
| GO:0030326 | 1.74% | embryonic limb morphogenesis |
| GO:0048146 | 1.74% | positive regulation of fibroblast proliferation |
| GO:0008033 | 1.74% | tRNA processing |
| GO:0021675 | 1.74% | nerve development |
| GO:0022613 | 1.73% | ribonucleoprotein complex biogenesis |
| GO:0007566 | 1.73% | embryo implantation |
| GO:0051276 | 1.73% | chromosome organization |
| GO:0006605 | 1.73% | protein targeting |
| GO:0050708 | 1.73% | regulation of protein secretion |
| GO:0098586 | 1.73% | cellular response to virus |
| GO:0060147 | 1.73% | regulation of posttranscriptional gene silencing |
| GO:0002437 | 1.73% | inflammatory response to antigenic stimulus |
| GO:0033209 | 1.73% | tumor necrosis factor-mediated signaling pathway |
| GO:0051131 | 1.73% | chaperone-mediated protein complex assembly |
| GO:0051588 | 1.73% | regulation of neurotransmitter transport |
| GO:0042178 | 1.73% | xenobiotic catabolic process |
| GO:0006886 | 1.72% | intracellular protein transport |
| GO:0050865 | 1.72% | regulation of cell activation |
| GO:0032410 | 1.72% | negative regulation of transporter activity |
| GO:0043267 | 1.72% | negative regulation of potassium ion transport |
| GO:0071901 | 1.72% | negative regulation of protein serine/threonine kinase activity |
| GO:0034660 | 1.72% | ncRNA metabolic process |
| GO:0045995 | 1.72% | regulation of embryonic development |
| GO:0031152 | 1.72% | aggregation involved in sorocarp development |
| GO:0006995 | 1.72% | cellular response to nitrogen starvation |
| GO:0045665 | 1.72% | negative regulation of neuron differentiation |
| GO:0032515 | 1.72% | negative regulation of phosphoprotein phosphatase activity |
| GO:0010506 | 1.72% | regulation of autophagy |
| GO:0072329 | 1.72% | monocarboxylic acid catabolic process |
| GO:0042181 | 1.71% | ketone biosynthetic process |
| GO:0032868 | 1.71% | response to insulin |
| GO:2000272 | 1.71% | negative regulation of signaling receptor activity |
| GO:0030518 | 1.71% | intracellular steroid hormone receptor signaling pathway |
| GO:0030010 | 1.71% | establishment of cell polarity |
| GO:0061062 | 1.71% | regulation of nematode larval development |
| GO:1904018 | 1.70% | positive regulation of vasculature development |
| GO:0046717 | 1.70% | acid secretion |
| GO:0006826 | 1.70% | iron ion transport |
| GO:0046620 | 1.70% | regulation of organ growth |
| GO:0010594 | 1.70% | regulation of endothelial cell migration |
| GO:0042177 | 1.70% | negative regulation of protein catabolic process |
| GO:0030808 | 1.70% | regulation of nucleotide biosynthetic process |
| GO:0051148 | 1.70% | negative regulation of muscle cell differentiation |
| GO:0045824 | 1.70% | negative regulation of innate immune response |
| GO:0046621 | 1.70% | negative regulation of organ growth |
| GO:0048634 | 1.70% | regulation of muscle organ development |
| GO:0007179 | 1.70% | transforming growth factor beta receptor signaling pathway |
| GO:1900180 | 1.70% | regulation of protein localization to nucleus |
| GO:0034470 | 1.69% | ncRNA processing |
| GO:0000746 | 1.69% | conjugation |
| GO:0045732 | 1.69% | positive regulation of protein catabolic process |
| GO:0033280 | 1.69% | response to vitamin D |
| GO:0035335 | 1.69% | peptidyl-tyrosine dephosphorylation |
| GO:0014059 | 1.69% | regulation of dopamine secretion |
| GO:0009081 | 1.69% | branched-chain amino acid metabolic process |
| GO:0007229 | 1.69% | integrin-mediated signaling pathway |
| GO:0006790 | 1.69% | sulfur compound metabolic process |
| GO:0002687 | 1.68% | positive regulation of leukocyte migration |
| GO:1902369 | 1.68% | negative regulation of RNA catabolic process |
| GO:0048532 | 1.68% | anatomical structure arrangement |
| GO:0030168 | 1.68% | platelet activation |
| GO:1905114 | 1.68% | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0055070 | 1.68% | copper ion homeostasis |
| GO:0007339 | 1.68% | binding of sperm to zona pellucida |
| GO:0009867 | 1.68% | jasmonic acid mediated signaling pathway |
| GO:1903509 | 1.68% | liposaccharide metabolic process |
| GO:0046700 | 1.68% | heterocycle catabolic process |
| GO:0050927 | 1.67% | positive regulation of positive chemotaxis |
| GO:0060135 | 1.67% | maternal process involved in female pregnancy |
| GO:0061564 | 1.67% | axon development |
| GO:0060964 | 1.67% | regulation of gene silencing by miRNA |
| GO:1900077 | 1.67% | negative regulation of cellular response to insulin stimulus |
| GO:0033044 | 1.67% | regulation of chromosome organization |
| GO:0097009 | 1.67% | energy homeostasis |
| GO:0046209 | 1.67% | nitric oxide metabolic process |
| GO:0060491 | 1.67% | regulation of cell projection assembly |
| GO:0045333 | 1.67% | cellular respiration |
| GO:0097485 | 1.67% | neuron projection guidance |
| GO:0071824 | 1.67% | protein-DNA complex subunit organization |
| GO:0032414 | 1.67% | positive regulation of ion transmembrane transporter activity |
| GO:0010951 | 1.67% | negative regulation of endopeptidase activity |
| GO:1905606 | 1.67% | regulation of presynapse assembly |
| GO:0090102 | 1.67% | cochlea development |
| GO:0070848 | 1.67% | response to growth factor |
| GO:0035306 | 1.67% | positive regulation of dephosphorylation |
| GO:0002694 | 1.67% | regulation of leukocyte activation |
| GO:0007288 | 1.67% | sperm axoneme assembly |
| GO:1904705 | 1.66% | regulation of vascular smooth muscle cell proliferation |
| GO:0016441 | 1.66% | posttranscriptional gene silencing |
| GO:1905392 | 1.66% | plant organ morphogenesis |
| GO:0045933 | 1.66% | positive regulation of muscle contraction |
| GO:0140253 | 1.66% | cell-cell fusion |
| GO:0007569 | 1.66% | cell aging |
| GO:0030004 | 1.66% | cellular monovalent inorganic cation homeostasis |
| GO:0022618 | 1.66% | ribonucleoprotein complex assembly |
| GO:0042744 | 1.66% | hydrogen peroxide catabolic process |
| GO:0030574 | 1.66% | collagen catabolic process |
| GO:0071692 | 1.66% | protein localization to extracellular region |
| GO:0030437 | 1.66% | ascospore formation |
| GO:0030104 | 1.66% | water homeostasis |
| GO:0072089 | 1.66% | stem cell proliferation |
| GO:0048706 | 1.66% | embryonic skeletal system development |
| GO:0046467 | 1.66% | membrane lipid biosynthetic process |
| GO:0030163 | 1.66% | protein catabolic process |
| GO:0043604 | 1.66% | amide biosynthetic process |
| GO:0016071 | 1.66% | mRNA metabolic process |
| GO:0009110 | 1.66% | vitamin biosynthetic process |
| GO:0050796 | 1.65% | regulation of insulin secretion |
| GO:0051972 | 1.65% | regulation of telomerase activity |
| GO:0090276 | 1.65% | regulation of peptide hormone secretion |
| GO:0060193 | 1.65% | positive regulation of lipase activity |
| GO:0009073 | 1.65% | aromatic amino acid family biosynthetic process |
| GO:0032091 | 1.65% | negative regulation of protein binding |
| GO:0042596 | 1.65% | fear response |
| GO:0050907 | 1.65% | detection of chemical stimulus involved in sensory perception |
| GO:0010894 | 1.65% | negative regulation of steroid biosynthetic process |
| GO:0051193 | 1.65% | regulation of cofactor metabolic process |
| GO:0002209 | 1.64% | behavioral defense response |
| GO:0097529 | 1.64% | myeloid leukocyte migration |
| GO:0034219 | 1.64% | carbohydrate transmembrane transport |
| GO:0006665 | 1.64% | sphingolipid metabolic process |
| GO:0098655 | 1.64% | cation transmembrane transport |
| GO:0045639 | 1.64% | positive regulation of myeloid cell differentiation |
| GO:0032228 | 1.64% | regulation of synaptic transmission, GABAergic |
| GO:0046434 | 1.64% | organophosphate catabolic process |
| GO:0002253 | 1.64% | activation of immune response |
| GO:0034260 | 1.64% | negative regulation of GTPase activity |
| GO:0046173 | 1.64% | polyol biosynthetic process |
| GO:0045932 | 1.64% | negative regulation of muscle contraction |
| GO:0032954 | 1.64% | regulation of cytokinetic process |
| GO:0007411 | 1.64% | axon guidance |
| GO:0071826 | 1.64% | ribonucleoprotein complex subunit organization |
| GO:0007517 | 1.63% | muscle organ development |
| GO:0009698 | 1.63% | phenylpropanoid metabolic process |
| GO:0010677 | 1.63% | negative regulation of cellular carbohydrate metabolic process |
| GO:0006986 | 1.63% | response to unfolded protein |
| GO:0045787 | 1.63% | positive regulation of cell cycle |
| GO:0006400 | 1.63% | tRNA modification |
| GO:0042771 | 1.63% | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0031163 | 1.63% | metallo-sulfur cluster assembly |
| GO:0043903 | 1.63% | regulation of symbiosis, encompassing mutualism through parasitism |
| GO:0043268 | 1.63% | positive regulation of potassium ion transport |
| GO:0007565 | 1.63% | female pregnancy |
| GO:0010470 | 1.63% | regulation of gastrulation |
| GO:0001662 | 1.62% | behavioral fear response |
| GO:0046579 | 1.62% | positive regulation of Ras protein signal transduction |
| GO:0098693 | 1.62% | regulation of synaptic vesicle cycle |
| GO:0060968 | 1.62% | regulation of gene silencing |
| GO:1902105 | 1.62% | regulation of leukocyte differentiation |
| GO:1902905 | 1.62% | positive regulation of supramolecular fiber organization |
| GO:0044062 | 1.62% | regulation of excretion |
| GO:0007156 | 1.62% | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO:0051965 | 1.62% | positive regulation of synapse assembly |
| GO:0002761 | 1.62% | regulation of myeloid leukocyte differentiation |
| GO:0051101 | 1.62% | regulation of DNA binding |
| GO:0097028 | 1.62% | dendritic cell differentiation |
| GO:0090207 | 1.62% | regulation of triglyceride metabolic process |
| GO:0002702 | 1.62% | positive regulation of production of molecular mediator of immune response |
| GO:0051249 | 1.62% | regulation of lymphocyte activation |
| GO:0033365 | 1.62% | protein localization to organelle |
| GO:0035592 | 1.61% | establishment of protein localization to extracellular region |
| GO:0009404 | 1.61% | toxin metabolic process |
| GO:1904029 | 1.61% | regulation of cyclin-dependent protein kinase activity |
| GO:0051169 | 1.61% | nuclear transport |
| GO:1901568 | 1.61% | fatty acid derivative metabolic process |
| GO:0010039 | 1.61% | response to iron ion |
| GO:0009060 | 1.61% | aerobic respiration |
| GO:0032768 | 1.61% | regulation of monooxygenase activity |
| GO:0016055 | 1.61% | Wnt signaling pathway |
| GO:0046649 | 1.61% | lymphocyte activation |
| GO:0061687 | 1.61% | detoxification of inorganic compound |
| GO:0030833 | 1.61% | regulation of actin filament polymerization |
| GO:0048639 | 1.60% | positive regulation of developmental growth |
| GO:0006913 | 1.60% | nucleocytoplasmic transport |
| GO:0048704 | 1.60% | embryonic skeletal system morphogenesis |
| GO:0009850 | 1.60% | auxin metabolic process |
| GO:0001568 | 1.60% | blood vessel development |
| GO:0032677 | 1.60% | regulation of interleukin-8 production |
| GO:0042749 | 1.60% | regulation of circadian sleep/wake cycle |
| GO:0033108 | 1.60% | mitochondrial respiratory chain complex assembly |
| GO:0032781 | 1.60% | positive regulation of ATPase activity |
| GO:0098656 | 1.60% | anion transmembrane transport |
| GO:1990138 | 1.60% | neuron projection extension |
| GO:0050900 | 1.60% | leukocyte migration |
| GO:0035148 | 1.60% | tube formation |
| GO:0006007 | 1.60% | glucose catabolic process |
| GO:0007338 | 1.60% | single fertilization |
| GO:0001938 | 1.60% | positive regulation of endothelial cell proliferation |
| GO:0006664 | 1.60% | glycolipid metabolic process |
| GO:0097191 | 1.60% | extrinsic apoptotic signaling pathway |
| GO:1903010 | 1.60% | regulation of bone development |
| GO:0090311 | 1.60% | regulation of protein deacetylation |
| GO:1901655 | 1.60% | cellular response to ketone |
| GO:0043433 | 1.60% | negative regulation of DNA-binding transcription factor activity |
| GO:0071216 | 1.60% | cellular response to biotic stimulus |
| GO:0044030 | 1.60% | regulation of DNA methylation |
| GO:0016226 | 1.60% | iron-sulfur cluster assembly |
| GO:0009108 | 1.59% | coenzyme biosynthetic process |
| GO:1903670 | 1.59% | regulation of sprouting angiogenesis |
| GO:0032365 | 1.59% | intracellular lipid transport |
| GO:0010228 | 1.59% | vegetative to reproductive phase transition of meristem |
| GO:0050714 | 1.59% | positive regulation of protein secretion |
| GO:0043647 | 1.59% | inositol phosphate metabolic process |
| GO:0030968 | 1.59% | endoplasmic reticulum unfolded protein response |
| GO:0010634 | 1.59% | positive regulation of epithelial cell migration |
| GO:0051883 | 1.59% | killing of cells in other organism involved in symbiotic interaction |
| GO:0050912 | 1.59% | detection of chemical stimulus involved in sensory perception of taste |
| GO:0051818 | 1.59% | disruption of cells of other organism involved in symbiotic interaction |
| GO:0008380 | 1.59% | RNA splicing |
| GO:0009082 | 1.59% | branched-chain amino acid biosynthetic process |
| GO:0010226 | 1.59% | response to lithium ion |
| GO:0016339 | 1.59% | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO:0090277 | 1.58% | positive regulation of peptide hormone secretion |
| GO:0043405 | 1.58% | regulation of MAP kinase activity |
| GO:0046627 | 1.58% | negative regulation of insulin receptor signaling pathway |
| GO:0072332 | 1.58% | intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0032652 | 1.58% | regulation of interleukin-1 production |
| GO:0042246 | 1.58% | tissue regeneration |
| GO:0046328 | 1.58% | regulation of JNK cascade |
| GO:0045987 | 1.58% | positive regulation of smooth muscle contraction |
| GO:0010712 | 1.58% | regulation of collagen metabolic process |
| GO:0033138 | 1.58% | positive regulation of peptidyl-serine phosphorylation |
| GO:1903320 | 1.58% | regulation of protein modification by small protein conjugation or removal |
| GO:0071867 | 1.58% | response to monoamine |
| GO:0051928 | 1.58% | positive regulation of calcium ion transport |
| GO:0034655 | 1.58% | nucleobase-containing compound catabolic process |
| GO:0006012 | 1.58% | galactose metabolic process |
| GO:0000272 | 1.58% | polysaccharide catabolic process |
| GO:0007286 | 1.57% | spermatid development |
| GO:0060191 | 1.57% | regulation of lipase activity |
| GO:0042303 | 1.57% | molting cycle |
| GO:0040018 | 1.57% | positive regulation of multicellular organism growth |
| GO:1904375 | 1.57% | regulation of protein localization to cell periphery |
| GO:0060271 | 1.57% | cilium assembly |
| GO:0042659 | 1.57% | regulation of cell fate specification |
| GO:0009306 | 1.57% | protein secretion |
| GO:0007616 | 1.57% | long-term memory |
| GO:0046850 | 1.57% | regulation of bone remodeling |
| GO:1902850 | 1.57% | microtubule cytoskeleton organization involved in mitosis |
| GO:0110151 | 1.57% | positive regulation of biomineralization |
| GO:0001654 | 1.57% | eye development |
| GO:0050866 | 1.57% | negative regulation of cell activation |
| GO:0051852 | 1.57% | disruption by host of symbiont cells |
| GO:0046626 | 1.57% | regulation of insulin receptor signaling pathway |
| GO:0061351 | 1.57% | neural precursor cell proliferation |
| GO:0035194 | 1.56% | posttranscriptional gene silencing by RNA |
| GO:0051099 | 1.56% | positive regulation of binding |
| GO:0009112 | 1.56% | nucleobase metabolic process |
| GO:1903321 | 1.56% | negative regulation of protein modification by small protein conjugation or removal |
| GO:0009712 | 1.56% | catechol-containing compound metabolic process |
| GO:0030091 | 1.56% | protein repair |
| GO:0007530 | 1.56% | sex determination |
| GO:0090693 | 1.56% | plant organ senescence |
| GO:0043153 | 1.56% | entrainment of circadian clock by photoperiod |
| GO:0002718 | 1.56% | regulation of cytokine production involved in immune response |
| GO:0045017 | 1.56% | glycerolipid biosynthetic process |
| GO:0009135 | 1.56% | purine nucleoside diphosphate metabolic process |
| GO:0032273 | 1.56% | positive regulation of protein polymerization |
| GO:1903035 | 1.56% | negative regulation of response to wounding |
| GO:0046470 | 1.56% | phosphatidylcholine metabolic process |
| GO:0010922 | 1.56% | positive regulation of phosphatase activity |
| GO:1903708 | 1.56% | positive regulation of hemopoiesis |
| GO:1902883 | 1.56% | negative regulation of response to oxidative stress |
| GO:0048285 | 1.55% | organelle fission |
| GO:0030595 | 1.55% | leukocyte chemotaxis |
| GO:0051897 | 1.55% | positive regulation of protein kinase B signaling |
| GO:0045939 | 1.55% | negative regulation of steroid metabolic process |
| GO:0009066 | 1.55% | aspartate family amino acid metabolic process |
| GO:0051147 | 1.55% | regulation of muscle cell differentiation |
| GO:0007043 | 1.55% | cell-cell junction assembly |
| GO:2000249 | 1.55% | regulation of actin cytoskeleton reorganization |
| GO:0050849 | 1.55% | negative regulation of calcium-mediated signaling |
| GO:1901570 | 1.55% | fatty acid derivative biosynthetic process |
| GO:0051225 | 1.55% | spindle assembly |
| GO:0050863 | 1.55% | regulation of T cell activation |
| GO:0010812 | 1.55% | negative regulation of cell-substrate adhesion |
| GO:0032098 | 1.55% | regulation of appetite |
| GO:0019757 | 1.55% | glycosinolate metabolic process |
| GO:0002690 | 1.55% | positive regulation of leukocyte chemotaxis |
| GO:0010150 | 1.55% | leaf senescence |
| GO:0060148 | 1.55% | positive regulation of posttranscriptional gene silencing |
| GO:0050856 | 1.54% | regulation of T cell receptor signaling pathway |
| GO:0042755 | 1.54% | eating behavior |
| GO:0006814 | 1.54% | sodium ion transport |
| GO:0048666 | 1.54% | neuron development |
| GO:1903428 | 1.54% | positive regulation of reactive oxygen species biosynthetic process |
| GO:0042551 | 1.54% | neuron maturation |
| GO:1901016 | 1.54% | regulation of potassium ion transmembrane transporter activity |
| GO:0070838 | 1.54% | divalent metal ion transport |
| GO:0010467 | 1.54% | gene expression |
| GO:0043935 | 1.54% | sexual sporulation resulting in formation of a cellular spore |
| GO:0045839 | 1.54% | negative regulation of mitotic nuclear division |
| GO:0019430 | 1.54% | removal of superoxide radicals |
| GO:0061035 | 1.54% | regulation of cartilage development |
| GO:0022904 | 1.54% | respiratory electron transport chain |
| GO:0007519 | 1.54% | skeletal muscle tissue development |
| GO:0046189 | 1.54% | phenol-containing compound biosynthetic process |
| GO:1903169 | 1.54% | regulation of calcium ion transmembrane transport |
| GO:0018205 | 1.54% | peptidyl-lysine modification |
| GO:0071870 | 1.54% | cellular response to catecholamine stimulus |
| GO:0046822 | 1.54% | regulation of nucleocytoplasmic transport |
| GO:2000278 | 1.54% | regulation of DNA biosynthetic process |
| GO:0044770 | 1.53% | cell cycle phase transition |
| GO:0045776 | 1.53% | negative regulation of blood pressure |
| GO:0042306 | 1.53% | regulation of protein import into nucleus |
| GO:0002229 | 1.53% | defense response to oomycetes |
| GO:0002065 | 1.53% | columnar/cuboidal epithelial cell differentiation |
| GO:0051784 | 1.53% | negative regulation of nuclear division |
| GO:0019760 | 1.53% | glucosinolate metabolic process |
| GO:2000637 | 1.53% | positive regulation of gene silencing by miRNA |
| GO:0032388 | 1.53% | positive regulation of intracellular transport |
| GO:0051603 | 1.53% | proteolysis involved in cellular protein catabolic process |
| GO:0045745 | 1.53% | positive regulation of G protein-coupled receptor signaling pathway |
| GO:0071684 | 1.53% | organism emergence from protective structure |
| GO:2000300 | 1.53% | regulation of synaptic vesicle exocytosis |
| GO:0031103 | 1.53% | axon regeneration |
| GO:0008299 | 1.52% | isoprenoid biosynthetic process |
| GO:0009068 | 1.52% | aspartate family amino acid catabolic process |
| GO:2000401 | 1.52% | regulation of lymphocyte migration |
| GO:0050926 | 1.52% | regulation of positive chemotaxis |
| GO:1901653 | 1.52% | cellular response to peptide |
| GO:0001764 | 1.52% | neuron migration |
| GO:0071559 | 1.52% | response to transforming growth factor beta |
| GO:0048026 | 1.52% | positive regulation of mRNA splicing, via spliceosome |
| GO:0006641 | 1.52% | triglyceride metabolic process |
| GO:0098662 | 1.52% | inorganic cation transmembrane transport |
| GO:1900542 | 1.52% | regulation of purine nucleotide metabolic process |
| GO:0046320 | 1.52% | regulation of fatty acid oxidation |
| GO:0019915 | 1.51% | lipid storage |
| GO:0008637 | 1.51% | apoptotic mitochondrial changes |
| GO:0034766 | 1.51% | negative regulation of ion transmembrane transport |
| GO:0034728 | 1.51% | nucleosome organization |
| GO:0042545 | 1.51% | cell wall modification |
| GO:0050657 | 1.51% | nucleic acid transport |
| GO:0071869 | 1.51% | response to catecholamine |
| GO:0043043 | 1.51% | peptide biosynthetic process |
| GO:0051926 | 1.51% | negative regulation of calcium ion transport |
| GO:0021953 | 1.51% | central nervous system neuron differentiation |
| GO:0090322 | 1.51% | regulation of superoxide metabolic process |
| GO:0009179 | 1.51% | purine ribonucleoside diphosphate metabolic process |
| GO:0032418 | 1.51% | lysosome localization |
| GO:0030838 | 1.50% | positive regulation of actin filament polymerization |
| GO:0072331 | 1.50% | signal transduction by p53 class mediator |
| GO:0007098 | 1.50% | centrosome cycle |
| GO:0001580 | 1.50% | detection of chemical stimulus involved in sensory perception of bitter taste |
| GO:0009071 | 1.50% | serine family amino acid catabolic process |
| GO:0060612 | 1.50% | adipose tissue development |
| GO:1902742 | 1.50% | apoptotic process involved in development |
| GO:0099003 | 1.50% | vesicle-mediated transport in synapse |
| GO:0032874 | 1.50% | positive regulation of stress-activated MAPK cascade |
| GO:0043327 | 1.50% | chemotaxis to cAMP |
| GO:0006690 | 1.50% | icosanoid metabolic process |
| GO:0051453 | 1.50% | regulation of intracellular pH |
| GO:0015908 | 1.50% | fatty acid transport |
| GO:0051873 | 1.50% | killing by host of symbiont cells |
| GO:0001959 | 1.50% | regulation of cytokine-mediated signaling pathway |
| GO:0034293 | 1.50% | sexual sporulation |
| GO:0043278 | 1.50% | response to morphine |
| GO:0000387 | 1.50% | spliceosomal snRNP assembly |
| GO:0007052 | 1.50% | mitotic spindle organization |
| GO:2001242 | 1.50% | regulation of intrinsic apoptotic signaling pathway |
| GO:1904063 | 1.50% | negative regulation of cation transmembrane transport |
| GO:1903034 | 1.50% | regulation of response to wounding |
| GO:0070169 | 1.50% | positive regulation of biomineral tissue development |
| GO:0043242 | 1.49% | negative regulation of protein complex disassembly |
| GO:0048813 | 1.49% | dendrite morphogenesis |
| GO:0015749 | 1.49% | monosaccharide transmembrane transport |
| GO:0045793 | 1.49% | positive regulation of cell size |
| GO:0048736 | 1.49% | appendage development |
| GO:0021955 | 1.49% | central nervous system neuron axonogenesis |
| GO:0072175 | 1.49% | epithelial tube formation |
| GO:0002239 | 1.49% | response to oomycetes |
| GO:0031023 | 1.49% | microtubule organizing center organization |
| GO:0016114 | 1.49% | terpenoid biosynthetic process |
| GO:0071347 | 1.49% | cellular response to interleukin-1 |
| GO:0051607 | 1.49% | defense response to virus |
| GO:1902904 | 1.49% | negative regulation of supramolecular fiber organization |
| GO:0030100 | 1.49% | regulation of endocytosis |
| GO:0048565 | 1.48% | digestive tract development |
| GO:1905393 | 1.48% | plant organ formation |
| GO:0042430 | 1.48% | indole-containing compound metabolic process |
| GO:0072511 | 1.48% | divalent inorganic cation transport |
| GO:1903338 | 1.48% | regulation of cell wall organization or biogenesis |
| GO:0006582 | 1.48% | melanin metabolic process |
| GO:1903578 | 1.48% | regulation of ATP metabolic process |
| GO:0046855 | 1.48% | inositol phosphate dephosphorylation |
| GO:0099111 | 1.48% | microtubule-based transport |
| GO:0006302 | 1.48% | double-strand break repair |
| GO:0060485 | 1.48% | mesenchyme development |
| GO:0070252 | 1.48% | actin-mediated cell contraction |
| GO:0071634 | 1.48% | regulation of transforming growth factor beta production |
| GO:0045187 | 1.48% | regulation of circadian sleep/wake cycle, sleep |
| GO:0010976 | 1.48% | positive regulation of neuron projection development |
| GO:0009624 | 1.48% | response to nematode |
| GO:0106070 | 1.48% | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO:0006801 | 1.48% | superoxide metabolic process |
| GO:0061097 | 1.48% | regulation of protein tyrosine kinase activity |
| GO:1901216 | 1.48% | positive regulation of neuron death |
| GO:0006584 | 1.48% | catecholamine metabolic process |
| GO:2001251 | 1.47% | negative regulation of chromosome organization |
| GO:0090068 | 1.47% | positive regulation of cell cycle process |
| GO:0030002 | 1.47% | cellular anion homeostasis |
| GO:0045670 | 1.47% | regulation of osteoclast differentiation |
| GO:0090150 | 1.47% | establishment of protein localization to membrane |
| GO:0045744 | 1.47% | negative regulation of G protein-coupled receptor signaling pathway |
| GO:0009132 | 1.47% | nucleoside diphosphate metabolic process |
| GO:0071219 | 1.47% | cellular response to molecule of bacterial origin |
| GO:0002064 | 1.47% | epithelial cell development |
| GO:0046326 | 1.47% | positive regulation of glucose import |
| GO:0031648 | 1.47% | protein destabilization |
| GO:0071868 | 1.47% | cellular response to monoamine stimulus |
| GO:0010828 | 1.47% | positive regulation of glucose transmembrane transport |
| GO:0015893 | 1.47% | drug transport |
| GO:1901381 | 1.47% | positive regulation of potassium ion transmembrane transport |
| GO:0016241 | 1.47% | regulation of macroautophagy |
| GO:0016143 | 1.47% | S-glycoside metabolic process |
| GO:0018108 | 1.47% | peptidyl-tyrosine phosphorylation |
| GO:0033120 | 1.47% | positive regulation of RNA splicing |
| GO:0009116 | 1.47% | nucleoside metabolic process |
| GO:0000917 | 1.47% | division septum assembly |
| GO:0044772 | 1.47% | mitotic cell cycle phase transition |
| GO:1903317 | 1.46% | regulation of protein maturation |
| GO:0016202 | 1.46% | regulation of striated muscle tissue development |
| GO:0030641 | 1.46% | regulation of cellular pH |
| GO:0021545 | 1.46% | cranial nerve development |
| GO:0022612 | 1.46% | gland morphogenesis |
| GO:0035966 | 1.46% | response to topologically incorrect protein |
| GO:0018107 | 1.46% | peptidyl-threonine phosphorylation |
| GO:0046031 | 1.46% | ADP metabolic process |
| GO:0006706 | 1.46% | steroid catabolic process |
| GO:0050848 | 1.46% | regulation of calcium-mediated signaling |
| GO:0060759 | 1.46% | regulation of response to cytokine stimulus |
| GO:0048229 | 1.46% | gametophyte development |
| GO:0008209 | 1.46% | androgen metabolic process |
| GO:0090279 | 1.46% | regulation of calcium ion import |
| GO:0040036 | 1.46% | regulation of fibroblast growth factor receptor signaling pathway |
| GO:0006165 | 1.45% | nucleoside diphosphate phosphorylation |
| GO:0045980 | 1.45% | negative regulation of nucleotide metabolic process |
| GO:0009064 | 1.45% | glutamine family amino acid metabolic process |
| GO:0042692 | 1.45% | muscle cell differentiation |
| GO:0090316 | 1.45% | positive regulation of intracellular protein transport |
| GO:0051236 | 1.45% | establishment of RNA localization |
| GO:0016570 | 1.45% | histone modification |
| GO:0001835 | 1.45% | blastocyst hatching |
| GO:0032965 | 1.45% | regulation of collagen biosynthetic process |
| GO:0007422 | 1.45% | peripheral nervous system development |
| GO:0002699 | 1.45% | positive regulation of immune effector process |
| GO:0008625 | 1.45% | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0048569 | 1.45% | post-embryonic animal organ development |
| GO:1902275 | 1.45% | regulation of chromatin organization |
| GO:2001259 | 1.45% | positive regulation of cation channel activity |
| GO:0001704 | 1.44% | formation of primary germ layer |
| GO:0043248 | 1.44% | proteasome assembly |
| GO:0006885 | 1.44% | regulation of pH |
| GO:0007349 | 1.44% | cellularization |
| GO:0000271 | 1.44% | polysaccharide biosynthetic process |
| GO:1901293 | 1.44% | nucleoside phosphate biosynthetic process |
| GO:0006692 | 1.44% | prostanoid metabolic process |
| GO:0010970 | 1.44% | transport along microtubule |
| GO:1901623 | 1.44% | regulation of lymphocyte chemotaxis |
| GO:0000280 | 1.44% | nuclear division |
| GO:1990266 | 1.44% | neutrophil migration |
| GO:0002218 | 1.44% | activation of innate immune response |
| GO:0006323 | 1.44% | DNA packaging |
| GO:0006816 | 1.44% | calcium ion transport |
| GO:0043113 | 1.44% | receptor clustering |
| GO:1903828 | 1.44% | negative regulation of cellular protein localization |
| GO:0055008 | 1.44% | cardiac muscle tissue morphogenesis |
| GO:0032147 | 1.44% | activation of protein kinase activity |
| GO:0050658 | 1.44% | RNA transport |
| GO:0071222 | 1.44% | cellular response to lipopolysaccharide |
| GO:0010803 | 1.44% | regulation of tumor necrosis factor-mediated signaling pathway |
| GO:0003254 | 1.44% | regulation of membrane depolarization |
| GO:0071709 | 1.44% | membrane assembly |
| GO:0090529 | 1.43% | cell septum assembly |
| GO:0045214 | 1.43% | sarcomere organization |
| GO:0010393 | 1.43% | galacturonan metabolic process |
| GO:0060021 | 1.43% | roof of mouth development |
| GO:1901343 | 1.43% | negative regulation of vasculature development |
| GO:0006071 | 1.43% | glycerol metabolic process |
| GO:0043281 | 1.43% | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0043951 | 1.43% | negative regulation of cAMP-mediated signaling |
| GO:0070304 | 1.43% | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0009069 | 1.43% | serine family amino acid metabolic process |
| GO:1990928 | 1.43% | response to amino acid starvation |
| GO:0036296 | 1.43% | response to increased oxygen levels |
| GO:0051494 | 1.43% | negative regulation of cytoskeleton organization |
| GO:1900371 | 1.43% | regulation of purine nucleotide biosynthetic process |
| GO:0006878 | 1.43% | cellular copper ion homeostasis |
| GO:0042440 | 1.43% | pigment metabolic process |
| GO:0006730 | 1.43% | one-carbon metabolic process |
| GO:0000038 | 1.42% | very long-chain fatty acid metabolic process |
| GO:1903201 | 1.42% | regulation of oxidative stress-induced cell death |
| GO:0060761 | 1.42% | negative regulation of response to cytokine stimulus |
| GO:0003009 | 1.42% | skeletal muscle contraction |
| GO:0006693 | 1.42% | prostaglandin metabolic process |
| GO:0048839 | 1.42% | inner ear development |
| GO:0033143 | 1.42% | regulation of intracellular steroid hormone receptor signaling pathway |
| GO:0015721 | 1.42% | bile acid and bile salt transport |
| GO:0046390 | 1.42% | ribose phosphate biosynthetic process |
| GO:1904893 | 1.42% | negative regulation of receptor signaling pathway via STAT |
| GO:1904377 | 1.42% | positive regulation of protein localization to cell periphery |
| GO:0045669 | 1.42% | positive regulation of osteoblast differentiation |
| GO:0051282 | 1.42% | regulation of sequestering of calcium ion |
| GO:0051187 | 1.42% | cofactor catabolic process |
| GO:0048008 | 1.42% | platelet-derived growth factor receptor signaling pathway |
| GO:1903798 | 1.42% | regulation of production of miRNAs involved in gene silencing by miRNA |
| GO:0048814 | 1.42% | regulation of dendrite morphogenesis |
| GO:1901071 | 1.42% | glucosamine-containing compound metabolic process |
| GO:0007549 | 1.42% | dosage compensation |
| GO:0009845 | 1.42% | seed germination |
| GO:0042573 | 1.42% | retinoic acid metabolic process |
| GO:0002695 | 1.42% | negative regulation of leukocyte activation |
| GO:0045778 | 1.42% | positive regulation of ossification |
| GO:0051782 | 1.42% | negative regulation of cell division |
| GO:0033875 | 1.42% | ribonucleoside bisphosphate metabolic process |
| GO:1901019 | 1.42% | regulation of calcium ion transmembrane transporter activity |
| GO:0014910 | 1.42% | regulation of smooth muscle cell migration |
| GO:0042435 | 1.42% | indole-containing compound biosynthetic process |
| GO:0050891 | 1.42% | multicellular organismal water homeostasis |
| GO:0060048 | 1.41% | cardiac muscle contraction |
| GO:0009187 | 1.41% | cyclic nucleotide metabolic process |
| GO:0051973 | 1.41% | positive regulation of telomerase activity |
| GO:0097366 | 1.41% | response to bronchodilator |
| GO:0042069 | 1.41% | regulation of catecholamine metabolic process |
| GO:0014072 | 1.41% | response to isoquinoline alkaloid |
| GO:0061045 | 1.41% | negative regulation of wound healing |
| GO:0006397 | 1.41% | mRNA processing |
| GO:0001709 | 1.41% | cell fate determination |
| GO:0032660 | 1.41% | regulation of interleukin-17 production |
| GO:1903524 | 1.41% | positive regulation of blood circulation |
| GO:0048563 | 1.41% | post-embryonic animal organ morphogenesis |
| GO:0022409 | 1.41% | positive regulation of cell-cell adhesion |
| GO:0010119 | 1.41% | regulation of stomatal movement |
| GO:0001960 | 1.41% | negative regulation of cytokine-mediated signaling pathway |
| GO:0048873 | 1.41% | homeostasis of number of cells within a tissue |
| GO:0016925 | 1.41% | protein sumoylation |
| GO:0010524 | 1.41% | positive regulation of calcium ion transport into cytosol |
| GO:1900744 | 1.41% | regulation of p38MAPK cascade |
| GO:0042026 | 1.40% | protein refolding |
| GO:0032352 | 1.40% | positive regulation of hormone metabolic process |
| GO:0032008 | 1.40% | positive regulation of TOR signaling |
| GO:0030510 | 1.40% | regulation of BMP signaling pathway |
| GO:0070417 | 1.40% | cellular response to cold |
| GO:0090090 | 1.40% | negative regulation of canonical Wnt signaling pathway |
| GO:0043954 | 1.40% | cellular component maintenance |
| GO:0043551 | 1.40% | regulation of phosphatidylinositol 3-kinase activity |
| GO:1900181 | 1.40% | negative regulation of protein localization to nucleus |
| GO:0060840 | 1.40% | artery development |
| GO:2001258 | 1.40% | negative regulation of cation channel activity |
| GO:0006004 | 1.40% | fucose metabolic process |
| GO:0016569 | 1.40% | covalent chromatin modification |
| GO:0033559 | 1.40% | unsaturated fatty acid metabolic process |
| GO:0038179 | 1.40% | neurotrophin signaling pathway |
| GO:0030072 | 1.40% | peptide hormone secretion |
| GO:1905897 | 1.40% | regulation of response to endoplasmic reticulum stress |
| GO:0014911 | 1.40% | positive regulation of smooth muscle cell migration |
| GO:0060688 | 1.40% | regulation of morphogenesis of a branching structure |
| GO:0072524 | 1.39% | pyridine-containing compound metabolic process |
| GO:1903409 | 1.39% | reactive oxygen species biosynthetic process |
| GO:0006865 | 1.39% | amino acid transport |
| GO:0045488 | 1.39% | pectin metabolic process |
| GO:0032651 | 1.39% | regulation of interleukin-1 beta production |
| GO:0061919 | 1.39% | process utilizing autophagic mechanism |
| GO:0098815 | 1.39% | modulation of excitatory postsynaptic potential |
| GO:0000079 | 1.39% | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0071715 | 1.39% | icosanoid transport |
| GO:0048641 | 1.39% | regulation of skeletal muscle tissue development |
| GO:0002027 | 1.39% | regulation of heart rate |
| GO:0001676 | 1.39% | long-chain fatty acid metabolic process |
| GO:2000181 | 1.39% | negative regulation of blood vessel morphogenesis |
| GO:0046838 | 1.39% | phosphorylated carbohydrate dephosphorylation |
| GO:1901658 | 1.39% | glycosyl compound catabolic process |
| GO:0050819 | 1.39% | negative regulation of coagulation |
| GO:0001944 | 1.39% | vasculature development |
| GO:0050996 | 1.39% | positive regulation of lipid catabolic process |
| GO:1903078 | 1.39% | positive regulation of protein localization to plasma membrane |
| GO:0009657 | 1.39% | plastid organization |
| GO:0010522 | 1.39% | regulation of calcium ion transport into cytosol |
| GO:0019405 | 1.38% | alditol catabolic process |
| GO:0021537 | 1.38% | telencephalon development |
| GO:0071320 | 1.38% | cellular response to cAMP |
| GO:0046685 | 1.38% | response to arsenic-containing substance |
| GO:0007528 | 1.38% | neuromuscular junction development |
| GO:1904589 | 1.38% | regulation of protein import |
| GO:2000403 | 1.38% | positive regulation of lymphocyte migration |
| GO:0033865 | 1.38% | nucleoside bisphosphate metabolic process |
| GO:0042126 | 1.38% | nitrate metabolic process |
| GO:0014048 | 1.38% | regulation of glutamate secretion |
| GO:0009950 | 1.38% | dorsal/ventral axis specification |
| GO:2000008 | 1.38% | regulation of protein localization to cell surface |
| GO:0002088 | 1.38% | lens development in camera-type eye |
| GO:0071675 | 1.38% | regulation of mononuclear cell migration |
| GO:0090025 | 1.38% | regulation of monocyte chemotaxis |
| GO:0035188 | 1.38% | hatching |
| GO:0061037 | 1.38% | negative regulation of cartilage development |
| GO:1901739 | 1.38% | regulation of myoblast fusion |
| GO:0010518 | 1.38% | positive regulation of phospholipase activity |
| GO:0009165 | 1.38% | nucleotide biosynthetic process |
| GO:1901031 | 1.37% | regulation of response to reactive oxygen species |
| GO:0006566 | 1.37% | threonine metabolic process |
| GO:0046839 | 1.37% | phospholipid dephosphorylation |
| GO:0060415 | 1.37% | muscle tissue morphogenesis |
| GO:0060142 | 1.37% | regulation of syncytium formation by plasma membrane fusion |
| GO:0071363 | 1.37% | cellular response to growth factor stimulus |
| GO:0007292 | 1.37% | female gamete generation |
| GO:0060456 | 1.37% | positive regulation of digestive system process |
| GO:1901987 | 1.37% | regulation of cell cycle phase transition |
| GO:0050931 | 1.37% | pigment cell differentiation |
| GO:0003279 | 1.37% | cardiac septum development |
| GO:0070663 | 1.37% | regulation of leukocyte proliferation |
| GO:0010288 | 1.37% | response to lead ion |
| GO:0018212 | 1.37% | peptidyl-tyrosine modification |
| GO:0005977 | 1.37% | glycogen metabolic process |
| GO:0006914 | 1.36% | autophagy |
| GO:0090598 | 1.36% | male anatomical structure morphogenesis |
| GO:2001024 | 1.36% | negative regulation of response to drug |
| GO:0030177 | 1.36% | positive regulation of Wnt signaling pathway |
| GO:0051491 | 1.36% | positive regulation of filopodium assembly |
| GO:0050918 | 1.36% | positive chemotaxis |
| GO:0051261 | 1.36% | protein depolymerization |
| GO:0046939 | 1.36% | nucleotide phosphorylation |
| GO:0071669 | 1.36% | plant-type cell wall organization or biogenesis |
| GO:1903036 | 1.36% | positive regulation of response to wounding |
| GO:0010758 | 1.36% | regulation of macrophage chemotaxis |
| GO:0034103 | 1.36% | regulation of tissue remodeling |
| GO:0007585 | 1.36% | respiratory gaseous exchange by respiratory system |
| GO:0043010 | 1.36% | camera-type eye development |
| GO:0032928 | 1.36% | regulation of superoxide anion generation |
| GO:0003382 | 1.36% | epithelial cell morphogenesis |
| GO:0050995 | 1.36% | negative regulation of lipid catabolic process |
| GO:0061025 | 1.36% | membrane fusion |
| GO:0042481 | 1.36% | regulation of odontogenesis |
| GO:0090342 | 1.36% | regulation of cell aging |
| GO:0032680 | 1.36% | regulation of tumor necrosis factor production |
| GO:0006103 | 1.36% | 2-oxoglutarate metabolic process |
| GO:0051650 | 1.36% | establishment of vesicle localization |
| GO:0030858 | 1.36% | positive regulation of epithelial cell differentiation |
| GO:0071466 | 1.36% | cellular response to xenobiotic stimulus |
| GO:0070050 | 1.36% | neuron cellular homeostasis |
| GO:0042761 | 1.36% | very long-chain fatty acid biosynthetic process |
| GO:0045921 | 1.36% | positive regulation of exocytosis |
| GO:1902667 | 1.36% | regulation of axon guidance |
| GO:1903202 | 1.36% | negative regulation of oxidative stress-induced cell death |
| GO:0097428 | 1.35% | protein maturation by iron-sulfur cluster transfer |
| GO:0071805 | 1.35% | potassium ion transmembrane transport |
| GO:0045599 | 1.35% | negative regulation of fat cell differentiation |
| GO:0070830 | 1.35% | bicellular tight junction assembly |
| GO:0042113 | 1.35% | B cell activation |
| GO:0030261 | 1.35% | chromosome condensation |
| GO:0042136 | 1.35% | neurotransmitter biosynthetic process |
| GO:0071548 | 1.35% | response to dexamethasone |
| GO:0035307 | 1.35% | positive regulation of protein dephosphorylation |
| GO:0010977 | 1.35% | negative regulation of neuron projection development |
| GO:0034311 | 1.35% | diol metabolic process |
| GO:0042698 | 1.35% | ovulation cycle |
| GO:0034032 | 1.35% | purine nucleoside bisphosphate metabolic process |
| GO:1903432 | 1.35% | regulation of TORC1 signaling |
| GO:0032720 | 1.35% | negative regulation of tumor necrosis factor production |
| GO:1900449 | 1.35% | regulation of glutamate receptor signaling pathway |
| GO:0090329 | 1.35% | regulation of DNA-dependent DNA replication |
| GO:0055093 | 1.35% | response to hyperoxia |
| GO:1902692 | 1.35% | regulation of neuroblast proliferation |
| GO:0006089 | 1.35% | lactate metabolic process |
| GO:1903580 | 1.35% | positive regulation of ATP metabolic process |
| GO:0002698 | 1.35% | negative regulation of immune effector process |
| GO:1903312 | 1.35% | negative regulation of mRNA metabolic process |
| GO:1901571 | 1.35% | fatty acid derivative transport |
| GO:0060079 | 1.35% | excitatory postsynaptic potential |
| GO:0001936 | 1.35% | regulation of endothelial cell proliferation |
| GO:0060122 | 1.35% | inner ear receptor cell stereocilium organization |
| GO:0046697 | 1.34% | decidualization |
| GO:0099173 | 1.34% | postsynapse organization |
| GO:0035082 | 1.34% | axoneme assembly |
| GO:1902749 | 1.34% | regulation of cell cycle G2/M phase transition |
| GO:0060306 | 1.34% | regulation of membrane repolarization |
| GO:0034446 | 1.34% | substrate adhesion-dependent cell spreading |
| GO:0072091 | 1.34% | regulation of stem cell proliferation |
| GO:0002285 | 1.34% | lymphocyte activation involved in immune response |
| GO:0045843 | 1.34% | negative regulation of striated muscle tissue development |
| GO:0033627 | 1.34% | cell adhesion mediated by integrin |
| GO:2000826 | 1.34% | regulation of heart morphogenesis |
| GO:0031342 | 1.34% | negative regulation of cell killing |
| GO:2001234 | 1.34% | negative regulation of apoptotic signaling pathway |
| GO:0048477 | 1.34% | oogenesis |
| GO:0003281 | 1.34% | ventricular septum development |
| GO:0030866 | 1.34% | cortical actin cytoskeleton organization |
| GO:1901861 | 1.33% | regulation of muscle tissue development |
| GO:0016048 | 1.33% | detection of temperature stimulus |
| GO:0006096 | 1.33% | glycolytic process |
| GO:0002385 | 1.33% | mucosal immune response |
| GO:0061245 | 1.33% | establishment or maintenance of bipolar cell polarity |
| GO:0042364 | 1.33% | water-soluble vitamin biosynthetic process |
| GO:0050000 | 1.33% | chromosome localization |
| GO:0070920 | 1.33% | regulation of production of small RNA involved in gene silencing by RNA |
| GO:2000114 | 1.33% | regulation of establishment of cell polarity |
| GO:0042128 | 1.33% | nitrate assimilation |
| GO:0002062 | 1.33% | chondrocyte differentiation |
| GO:0045742 | 1.33% | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:1902117 | 1.33% | positive regulation of organelle assembly |
| GO:0006260 | 1.33% | DNA replication |
| GO:0045124 | 1.33% | regulation of bone resorption |
| GO:0031341 | 1.33% | regulation of cell killing |
| GO:2000573 | 1.33% | positive regulation of DNA biosynthetic process |
| GO:0045475 | 1.32% | locomotor rhythm |
| GO:0007274 | 1.32% | neuromuscular synaptic transmission |
| GO:0006839 | 1.32% | mitochondrial transport |
| GO:0045920 | 1.32% | negative regulation of exocytosis |
| GO:0002026 | 1.32% | regulation of the force of heart contraction |
| GO:0045638 | 1.32% | negative regulation of myeloid cell differentiation |
| GO:0001837 | 1.32% | epithelial to mesenchymal transition |
| GO:0002275 | 1.32% | myeloid cell activation involved in immune response |
| GO:0016525 | 1.32% | negative regulation of angiogenesis |
| GO:0032007 | 1.32% | negative regulation of TOR signaling |
| GO:0062149 | 1.32% | detection of stimulus involved in sensory perception of pain |
| GO:0007034 | 1.32% | vacuolar transport |
| GO:1903076 | 1.32% | regulation of protein localization to plasma membrane |
| GO:1900745 | 1.32% | positive regulation of p38MAPK cascade |
| GO:0002703 | 1.32% | regulation of leukocyte mediated immunity |
| GO:0007548 | 1.32% | sex differentiation |
| GO:0035902 | 1.32% | response to immobilization stress |
| GO:0006144 | 1.32% | purine nucleobase metabolic process |
| GO:0016358 | 1.32% | dendrite development |
| GO:0072594 | 1.32% | establishment of protein localization to organelle |
| GO:0032024 | 1.32% | positive regulation of insulin secretion |
| GO:0090659 | 1.32% | walking behavior |
| GO:0033692 | 1.31% | cellular polysaccharide biosynthetic process |
| GO:0019941 | 1.31% | modification-dependent protein catabolic process |
| GO:0030511 | 1.31% | positive regulation of transforming growth factor beta receptor signaling pathway |
| GO:0007044 | 1.31% | cell-substrate junction assembly |
| GO:0002262 | 1.31% | myeloid cell homeostasis |
| GO:0031645 | 1.31% | negative regulation of nervous system process |
| GO:0032770 | 1.31% | positive regulation of monooxygenase activity |
| GO:1900408 | 1.31% | negative regulation of cellular response to oxidative stress |
| GO:0048863 | 1.31% | stem cell differentiation |
| GO:0043489 | 1.31% | RNA stabilization |
| GO:0046456 | 1.31% | icosanoid biosynthetic process |
| GO:0033189 | 1.31% | response to vitamin A |
| GO:0051647 | 1.31% | nucleus localization |
| GO:0010830 | 1.31% | regulation of myotube differentiation |
| GO:0009251 | 1.31% | glucan catabolic process |
| GO:0002251 | 1.31% | organ or tissue specific immune response |
| GO:0032732 | 1.31% | positive regulation of interleukin-1 production |
| GO:0070613 | 1.31% | regulation of protein processing |
| GO:0035282 | 1.31% | segmentation |
| GO:0110020 | 1.31% | regulation of actomyosin structure organization |
| GO:0043550 | 1.31% | regulation of lipid kinase activity |
| GO:1901862 | 1.31% | negative regulation of muscle tissue development |
| GO:0040028 | 1.30% | regulation of vulval development |
| GO:0044247 | 1.30% | cellular polysaccharide catabolic process |
| GO:0002443 | 1.30% | leukocyte mediated immunity |
| GO:2000406 | 1.30% | positive regulation of T cell migration |
| GO:0050731 | 1.30% | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0006757 | 1.30% | ATP generation from ADP |
| GO:0071545 | 1.30% | inositol phosphate catabolic process |
| GO:0010517 | 1.30% | regulation of phospholipase activity |
| GO:0007619 | 1.30% | courtship behavior |
| GO:0043632 | 1.30% | modification-dependent macromolecule catabolic process |
| GO:0048738 | 1.30% | cardiac muscle tissue development |
| GO:0006833 | 1.30% | water transport |
| GO:1903362 | 1.30% | regulation of cellular protein catabolic process |
| GO:0010771 | 1.30% | negative regulation of cell morphogenesis involved in differentiation |
| GO:0032330 | 1.30% | regulation of chondrocyte differentiation |
| GO:0033005 | 1.30% | positive regulation of mast cell activation |
| GO:0043406 | 1.30% | positive regulation of MAP kinase activity |
| GO:0051262 | 1.30% | protein tetramerization |
| GO:0014823 | 1.30% | response to activity |
| GO:0050792 | 1.29% | regulation of viral process |
| GO:0048240 | 1.29% | sperm capacitation |
| GO:0090208 | 1.29% | positive regulation of triglyceride metabolic process |
| GO:0008038 | 1.29% | neuron recognition |
| GO:0010155 | 1.29% | regulation of proton transport |
| GO:1901990 | 1.29% | regulation of mitotic cell cycle phase transition |
| GO:0009555 | 1.29% | pollen development |
| GO:1903792 | 1.29% | negative regulation of anion transport |
| GO:0009799 | 1.29% | specification of symmetry |
| GO:0009260 | 1.29% | ribonucleotide biosynthetic process |
| GO:1903555 | 1.29% | regulation of tumor necrosis factor superfamily cytokine production |
| GO:0006777 | 1.29% | Mo-molybdopterin cofactor biosynthetic process |
| GO:0042403 | 1.29% | thyroid hormone metabolic process |
| GO:0010717 | 1.29% | regulation of epithelial to mesenchymal transition |
| GO:1903846 | 1.29% | positive regulation of cellular response to transforming growth factor beta stimulus |
| GO:1902229 | 1.29% | regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0043277 | 1.29% | apoptotic cell clearance |
| GO:1903556 | 1.29% | negative regulation of tumor necrosis factor superfamily cytokine production |
| GO:0007045 | 1.29% | cell-substrate adherens junction assembly |
| GO:1901186 | 1.29% | positive regulation of ERBB signaling pathway |
| GO:0043545 | 1.29% | molybdopterin cofactor metabolic process |
| GO:0015748 | 1.28% | organophosphate ester transport |
| GO:0046651 | 1.28% | lymphocyte proliferation |
| GO:0001935 | 1.28% | endothelial cell proliferation |
| GO:0072527 | 1.28% | pyrimidine-containing compound metabolic process |
| GO:0050999 | 1.28% | regulation of nitric-oxide synthase activity |
| GO:0034204 | 1.28% | lipid translocation |
| GO:0032088 | 1.28% | negative regulation of NF-kappaB transcription factor activity |
| GO:0071276 | 1.28% | cellular response to cadmium ion |
| GO:0010633 | 1.28% | negative regulation of epithelial cell migration |
| GO:0014075 | 1.28% | response to amine |
| GO:0032878 | 1.28% | regulation of establishment or maintenance of cell polarity |
| GO:0097530 | 1.28% | granulocyte migration |
| GO:0051189 | 1.28% | prosthetic group metabolic process |
| GO:0048041 | 1.28% | focal adhesion assembly |
| GO:0010596 | 1.28% | negative regulation of endothelial cell migration |
| GO:0032259 | 1.28% | methylation |
| GO:0006586 | 1.28% | indolalkylamine metabolic process |
| GO:0061041 | 1.28% | regulation of wound healing |
| GO:0002758 | 1.28% | innate immune response-activating signal transduction |
| GO:1903900 | 1.27% | regulation of viral life cycle |
| GO:0048635 | 1.27% | negative regulation of muscle organ development |
| GO:1903523 | 1.27% | negative regulation of blood circulation |
| GO:0032653 | 1.27% | regulation of interleukin-10 production |
| GO:0042462 | 1.27% | eye photoreceptor cell development |
| GO:1902230 | 1.27% | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage |
| GO:0042908 | 1.27% | xenobiotic transport |
| GO:0055001 | 1.27% | muscle cell development |
| GO:0050685 | 1.27% | positive regulation of mRNA processing |
| GO:0006402 | 1.27% | mRNA catabolic process |
| GO:0007214 | 1.27% | gamma-aminobutyric acid signaling pathway |
| GO:0010595 | 1.27% | positive regulation of endothelial cell migration |
| GO:0006412 | 1.27% | translation |
| GO:0048679 | 1.27% | regulation of axon regeneration |
| GO:0031503 | 1.27% | protein-containing complex localization |
| GO:0031056 | 1.26% | regulation of histone modification |
| GO:0001659 | 1.26% | temperature homeostasis |
| GO:0046605 | 1.26% | regulation of centrosome cycle |
| GO:0050873 | 1.26% | brown fat cell differentiation |
| GO:0070085 | 1.26% | glycosylation |
| GO:0045922 | 1.26% | negative regulation of fatty acid metabolic process |
| GO:0002920 | 1.26% | regulation of humoral immune response |
| GO:0014015 | 1.26% | positive regulation of gliogenesis |
| GO:1904706 | 1.26% | negative regulation of vascular smooth muscle cell proliferation |
| GO:0051489 | 1.26% | regulation of filopodium assembly |
| GO:0043114 | 1.26% | regulation of vascular permeability |
| GO:0042461 | 1.26% | photoreceptor cell development |
| GO:0046113 | 1.26% | nucleobase catabolic process |
| GO:0043543 | 1.26% | protein acylation |
| GO:0007006 | 1.26% | mitochondrial membrane organization |
| GO:0071103 | 1.26% | DNA conformation change |
| GO:0032757 | 1.26% | positive regulation of interleukin-8 production |
| GO:0017156 | 1.26% | calcium-ion regulated exocytosis |
| GO:0043502 | 1.26% | regulation of muscle adaptation |
| GO:0051291 | 1.26% | protein heterooligomerization |
| GO:0035904 | 1.26% | aorta development |
| GO:0033146 | 1.26% | regulation of intracellular estrogen receptor signaling pathway |
| GO:0019720 | 1.26% | Mo-molybdopterin cofactor metabolic process |
| GO:0016239 | 1.26% | positive regulation of macroautophagy |
| GO:0006637 | 1.26% | acyl-CoA metabolic process |
| GO:0001578 | 1.26% | microtubule bundle formation |
| GO:0043161 | 1.26% | proteasome-mediated ubiquitin-dependent protein catabolic process |
| GO:0071621 | 1.26% | granulocyte chemotaxis |
| GO:0002040 | 1.25% | sprouting angiogenesis |
| GO:0071071 | 1.25% | regulation of phospholipid biosynthetic process |
| GO:0042220 | 1.25% | response to cocaine |
| GO:0006304 | 1.25% | DNA modification |
| GO:0060325 | 1.25% | face morphogenesis |
| GO:0061512 | 1.25% | protein localization to cilium |
| GO:0006577 | 1.25% | amino-acid betaine metabolic process |
| GO:1902107 | 1.25% | positive regulation of leukocyte differentiation |
| GO:0010714 | 1.25% | positive regulation of collagen metabolic process |
| GO:0007031 | 1.25% | peroxisome organization |
| GO:0035383 | 1.25% | thioester metabolic process |
| GO:0007614 | 1.25% | short-term memory |
| GO:2000648 | 1.25% | positive regulation of stem cell proliferation |
| GO:0032981 | 1.25% | mitochondrial respiratory chain complex I assembly |
| GO:0060429 | 1.25% | epithelium development |
| GO:0007498 | 1.25% | mesoderm development |
| GO:0055075 | 1.25% | potassium ion homeostasis |
| GO:0010738 | 1.25% | regulation of protein kinase A signaling |
| GO:0060041 | 1.25% | retina development in camera-type eye |
| GO:0002312 | 1.25% | B cell activation involved in immune response |
| GO:0045687 | 1.25% | positive regulation of glial cell differentiation |
| GO:0071230 | 1.25% | cellular response to amino acid stimulus |
| GO:2000191 | 1.25% | regulation of fatty acid transport |
| GO:0010259 | 1.25% | multicellular organism aging |
| GO:0002764 | 1.25% | immune response-regulating signaling pathway |
| GO:0045851 | 1.24% | pH reduction |
| GO:0098813 | 1.24% | nuclear chromosome segregation |
| GO:0042773 | 1.24% | ATP synthesis coupled electron transport |
| GO:0010257 | 1.24% | NADH dehydrogenase complex assembly |
| GO:0048762 | 1.24% | mesenchymal cell differentiation |
| GO:0042129 | 1.24% | regulation of T cell proliferation |
| GO:0035088 | 1.24% | establishment or maintenance of apical/basal cell polarity |
| GO:0009067 | 1.24% | aspartate family amino acid biosynthetic process |
| GO:0031057 | 1.24% | negative regulation of histone modification |
| GO:0090630 | 1.24% | activation of GTPase activity |
| GO:0070661 | 1.24% | leukocyte proliferation |
| GO:0090049 | 1.24% | regulation of cell migration involved in sprouting angiogenesis |
| GO:1904892 | 1.24% | regulation of receptor signaling pathway via STAT |
| GO:0002757 | 1.24% | immune response-activating signal transduction |
| GO:1990830 | 1.24% | cellular response to leukemia inhibitory factor |
| GO:0051170 | 1.24% | import into nucleus |
| GO:0008356 | 1.24% | asymmetric cell division |
| GO:0140013 | 1.24% | meiotic nuclear division |
| GO:1901385 | 1.23% | regulation of voltage-gated calcium channel activity |
| GO:0030593 | 1.23% | neutrophil chemotaxis |
| GO:0009309 | 1.23% | amine biosynthetic process |
| GO:0001953 | 1.23% | negative regulation of cell-matrix adhesion |
| GO:0006612 | 1.23% | protein targeting to membrane |
| GO:0051155 | 1.23% | positive regulation of striated muscle cell differentiation |
| GO:1900274 | 1.23% | regulation of phospholipase C activity |
| GO:0045807 | 1.23% | positive regulation of endocytosis |
| GO:0018345 | 1.23% | protein palmitoylation |
| GO:0030098 | 1.23% | lymphocyte differentiation |
| GO:0051560 | 1.23% | mitochondrial calcium ion homeostasis |
| GO:1903707 | 1.23% | negative regulation of hemopoiesis |
| GO:1990823 | 1.23% | response to leukemia inhibitory factor |
| GO:0001541 | 1.23% | ovarian follicle development |
| GO:0008608 | 1.23% | attachment of spindle microtubules to kinetochore |
| GO:0010623 | 1.23% | programmed cell death involved in cell development |
| GO:2001022 | 1.23% | positive regulation of response to DNA damage stimulus |
| GO:0021766 | 1.23% | hippocampus development |
| GO:0051153 | 1.23% | regulation of striated muscle cell differentiation |
| GO:0008645 | 1.23% | hexose transmembrane transport |
| GO:1903306 | 1.23% | negative regulation of regulated secretory pathway |
| GO:0050670 | 1.23% | regulation of lymphocyte proliferation |
| GO:0007628 | 1.23% | adult walking behavior |
| GO:0032689 | 1.23% | negative regulation of interferon-gamma production |
| GO:0006568 | 1.23% | tryptophan metabolic process |
| GO:0060760 | 1.23% | positive regulation of response to cytokine stimulus |
| GO:0048489 | 1.22% | synaptic vesicle transport |
| GO:0001778 | 1.22% | plasma membrane repair |
| GO:0002227 | 1.22% | innate immune response in mucosa |
| GO:0022617 | 1.22% | extracellular matrix disassembly |
| GO:0032943 | 1.22% | mononuclear cell proliferation |
| GO:1900047 | 1.22% | negative regulation of hemostasis |
| GO:0014066 | 1.22% | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0042417 | 1.22% | dopamine metabolic process |
| GO:0030728 | 1.22% | ovulation |
| GO:0046847 | 1.22% | filopodium assembly |
| GO:0006825 | 1.22% | copper ion transport |
| GO:0050919 | 1.22% | negative chemotaxis |
| GO:0050867 | 1.22% | positive regulation of cell activation |
| GO:0098801 | 1.22% | regulation of renal system process |
| GO:0014743 | 1.22% | regulation of muscle hypertrophy |
| GO:0010389 | 1.22% | regulation of G2/M transition of mitotic cell cycle |
| GO:2001236 | 1.22% | regulation of extrinsic apoptotic signaling pathway |
| GO:0001952 | 1.22% | regulation of cell-matrix adhesion |
| GO:0033617 | 1.22% | mitochondrial respiratory chain complex IV assembly |
| GO:0009855 | 1.22% | determination of bilateral symmetry |
| GO:0002066 | 1.22% | columnar/cuboidal epithelial cell development |
| GO:0048169 | 1.22% | regulation of long-term neuronal synaptic plasticity |
| GO:0002931 | 1.21% | response to ischemia |
| GO:0016331 | 1.21% | morphogenesis of embryonic epithelium |
| GO:0048048 | 1.21% | embryonic eye morphogenesis |
| GO:0006639 | 1.21% | acylglycerol metabolic process |
| GO:0050892 | 1.21% | intestinal absorption |
| GO:1901018 | 1.21% | positive regulation of potassium ion transmembrane transporter activity |
| GO:0071560 | 1.21% | cellular response to transforming growth factor beta stimulus |
| GO:0043950 | 1.21% | positive regulation of cAMP-mediated signaling |
| GO:0045332 | 1.21% | phospholipid translocation |
| GO:0051250 | 1.21% | negative regulation of lymphocyte activation |
| GO:0030513 | 1.21% | positive regulation of BMP signaling pathway |
| GO:0001975 | 1.21% | response to amphetamine |
| GO:0032944 | 1.21% | regulation of mononuclear cell proliferation |
| GO:0046622 | 1.21% | positive regulation of organ growth |
| GO:0070997 | 1.21% | neuron death |
| GO:1903363 | 1.21% | negative regulation of cellular protein catabolic process |
| GO:0055006 | 1.21% | cardiac cell development |
| GO:0035640 | 1.21% | exploration behavior |
| GO:0009437 | 1.21% | carnitine metabolic process |
| GO:0017004 | 1.21% | cytochrome complex assembly |
| GO:0071852 | 1.21% | fungal-type cell wall organization or biogenesis |
| GO:0050770 | 1.20% | regulation of axonogenesis |
| GO:0009658 | 1.20% | chloroplast organization |
| GO:0071300 | 1.20% | cellular response to retinoic acid |
| GO:0030199 | 1.20% | collagen fibril organization |
| GO:0031110 | 1.20% | regulation of microtubule polymerization or depolymerization |
| GO:2000765 | 1.20% | regulation of cytoplasmic translation |
| GO:0051651 | 1.20% | maintenance of location in cell |
| GO:0006448 | 1.20% | regulation of translational elongation |
| GO:0032873 | 1.20% | negative regulation of stress-activated MAPK cascade |
| GO:1905268 | 1.20% | negative regulation of chromatin organization |
| GO:0048544 | 1.20% | recognition of pollen |
| GO:0043299 | 1.20% | leukocyte degranulation |
| GO:0019369 | 1.20% | arachidonic acid metabolic process |
| GO:1903313 | 1.20% | positive regulation of mRNA metabolic process |
| GO:0007588 | 1.20% | excretion |
| GO:0070646 | 1.20% | protein modification by small protein removal |
| GO:0002052 | 1.20% | positive regulation of neuroblast proliferation |
| GO:0009247 | 1.20% | glycolipid biosynthetic process |
| GO:1903429 | 1.20% | regulation of cell maturation |
| GO:0006333 | 1.20% | chromatin assembly or disassembly |
| GO:0045923 | 1.20% | positive regulation of fatty acid metabolic process |
| GO:1901796 | 1.20% | regulation of signal transduction by p53 class mediator |
| GO:0002696 | 1.20% | positive regulation of leukocyte activation |
| GO:0070206 | 1.20% | protein trimerization |
| GO:0045646 | 1.20% | regulation of erythrocyte differentiation |
| GO:1903557 | 1.20% | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:0008535 | 1.20% | respiratory chain complex IV assembly |
| GO:1901661 | 1.20% | quinone metabolic process |
| GO:0030183 | 1.20% | B cell differentiation |
| GO:0048193 | 1.19% | Golgi vesicle transport |
| GO:0046330 | 1.19% | positive regulation of JNK cascade |
| GO:0033344 | 1.19% | cholesterol efflux |
| GO:0034504 | 1.19% | protein localization to nucleus |
| GO:0055010 | 1.19% | ventricular cardiac muscle tissue morphogenesis |
| GO:0002335 | 1.19% | mature B cell differentiation |
| GO:0051181 | 1.19% | cofactor transport |
| GO:0007097 | 1.19% | nuclear migration |
| GO:0006511 | 1.19% | ubiquitin-dependent protein catabolic process |
| GO:0071674 | 1.19% | mononuclear cell migration |
| GO:0002260 | 1.19% | lymphocyte homeostasis |
| GO:0045721 | 1.19% | negative regulation of gluconeogenesis |
| GO:0001658 | 1.19% | branching involved in ureteric bud morphogenesis |
| GO:0120193 | 1.19% | tight junction organization |
| GO:1904262 | 1.19% | negative regulation of TORC1 signaling |
| GO:0051445 | 1.19% | regulation of meiotic cell cycle |
| GO:1902115 | 1.19% | regulation of organelle assembly |
| GO:0001756 | 1.19% | somitogenesis |
| GO:0032675 | 1.19% | regulation of interleukin-6 production |
| GO:0042182 | 1.19% | ketone catabolic process |
| GO:0051385 | 1.19% | response to mineralocorticoid |
| GO:0051668 | 1.19% | localization within membrane |
| GO:0051865 | 1.19% | protein autoubiquitination |
| GO:0040019 | 1.19% | positive regulation of embryonic development |
| GO:0010611 | 1.19% | regulation of cardiac muscle hypertrophy |
| GO:0051648 | 1.19% | vesicle localization |
| GO:0035094 | 1.19% | response to nicotine |
| GO:0002715 | 1.19% | regulation of natural killer cell mediated immunity |
| GO:0051452 | 1.19% | intracellular pH reduction |
| GO:0006401 | 1.19% | RNA catabolic process |
| GO:0070570 | 1.19% | regulation of neuron projection regeneration |
| GO:0000018 | 1.18% | regulation of DNA recombination |
| GO:0097061 | 1.18% | dendritic spine organization |
| GO:0042762 | 1.18% | regulation of sulfur metabolic process |
| GO:0120032 | 1.18% | regulation of plasma membrane bounded cell projection assembly |
| GO:0046640 | 1.18% | regulation of alpha-beta T cell proliferation |
| GO:0055002 | 1.18% | striated muscle cell development |
| GO:0034250 | 1.18% | positive regulation of cellular amide metabolic process |
| GO:0071731 | 1.18% | response to nitric oxide |
| GO:1901678 | 1.18% | iron coordination entity transport |
| GO:0010498 | 1.18% | proteasomal protein catabolic process |
| GO:0030195 | 1.18% | negative regulation of blood coagulation |
| GO:0098661 | 1.18% | inorganic anion transmembrane transport |
| GO:0052803 | 1.18% | imidazole-containing compound metabolic process |
| GO:1904356 | 1.18% | regulation of telomere maintenance via telomere lengthening |
| GO:0001678 | 1.18% | cellular glucose homeostasis |
| GO:2000463 | 1.18% | positive regulation of excitatory postsynaptic potential |
| GO:0072525 | 1.18% | pyridine-containing compound biosynthetic process |
| GO:0034105 | 1.18% | positive regulation of tissue remodeling |
| GO:0035418 | 1.18% | protein localization to synapse |
| GO:0007190 | 1.18% | activation of adenylate cyclase activity |
| GO:0090698 | 1.18% | post-embryonic plant morphogenesis |
| GO:0036075 | 1.18% | replacement ossification |
| GO:0042401 | 1.18% | cellular biogenic amine biosynthetic process |
| GO:0010165 | 1.18% | response to X-ray |
| GO:2000404 | 1.18% | regulation of T cell migration |
| GO:0002768 | 1.18% | immune response-regulating cell surface receptor signaling pathway |
| GO:0071677 | 1.18% | positive regulation of mononuclear cell migration |
| GO:0048771 | 1.18% | tissue remodeling |
| GO:1903037 | 1.18% | regulation of leukocyte cell-cell adhesion |
| GO:0043624 | 1.17% | cellular protein complex disassembly |
| GO:0006573 | 1.17% | valine metabolic process |
| GO:0098751 | 1.17% | bone cell development |
| GO:0034333 | 1.17% | adherens junction assembly |
| GO:0042733 | 1.17% | embryonic digit morphogenesis |
| GO:0032204 | 1.17% | regulation of telomere maintenance |
| GO:0001958 | 1.17% | endochondral ossification |
| GO:0002429 | 1.17% | immune response-activating cell surface receptor signaling pathway |
| GO:0042269 | 1.17% | regulation of natural killer cell mediated cytotoxicity |
| GO:2001238 | 1.17% | positive regulation of extrinsic apoptotic signaling pathway |
| GO:0046824 | 1.17% | positive regulation of nucleocytoplasmic transport |
| GO:0021987 | 1.17% | cerebral cortex development |
| GO:0045686 | 1.17% | negative regulation of glial cell differentiation |
| GO:0140029 | 1.17% | exocytic process |
| GO:0060976 | 1.17% | coronary vasculature development |
| GO:0002067 | 1.17% | glandular epithelial cell differentiation |
| GO:0046349 | 1.17% | amino sugar biosynthetic process |
| GO:0072523 | 1.17% | purine-containing compound catabolic process |
| GO:0007368 | 1.17% | determination of left/right symmetry |
| GO:0046058 | 1.17% | cAMP metabolic process |
| GO:0031505 | 1.17% | fungal-type cell wall organization |
| GO:0048013 | 1.17% | ephrin receptor signaling pathway |
| GO:0045490 | 1.17% | pectin catabolic process |
| GO:0051303 | 1.17% | establishment of chromosome localization |
| GO:0051446 | 1.17% | positive regulation of meiotic cell cycle |
| GO:0050688 | 1.17% | regulation of defense response to virus |
| GO:0016102 | 1.17% | diterpenoid biosynthetic process |
| GO:0051496 | 1.16% | positive regulation of stress fiber assembly |
| GO:2000142 | 1.16% | regulation of DNA-templated transcription, initiation |
| GO:0051150 | 1.16% | regulation of smooth muscle cell differentiation |
| GO:0010824 | 1.16% | regulation of centrosome duplication |
| GO:0010950 | 1.16% | positive regulation of endopeptidase activity |
| GO:0032722 | 1.16% | positive regulation of chemokine production |
| GO:0070303 | 1.16% | negative regulation of stress-activated protein kinase signaling cascade |
| GO:0043300 | 1.16% | regulation of leukocyte degranulation |
| GO:0010831 | 1.16% | positive regulation of myotube differentiation |
| GO:0006949 | 1.16% | syncytium formation |
| GO:1901224 | 1.16% | positive regulation of NIK/NF-kappaB signaling |
| GO:0016072 | 1.16% | rRNA metabolic process |
| GO:0099024 | 1.16% | plasma membrane invagination |
| GO:2000171 | 1.16% | negative regulation of dendrite development |
| GO:0006020 | 1.16% | inositol metabolic process |
| GO:0007297 | 1.16% | ovarian follicle cell migration |
| GO:0071806 | 1.16% | protein transmembrane transport |
| GO:0045197 | 1.16% | establishment or maintenance of epithelial cell apical/basal polarity |
| GO:0010952 | 1.16% | positive regulation of peptidase activity |
| GO:0006638 | 1.16% | neutral lipid metabolic process |
| GO:1901983 | 1.16% | regulation of protein acetylation |
| GO:0052126 | 1.16% | movement in host environment |
| GO:0031343 | 1.16% | positive regulation of cell killing |
| GO:0072522 | 1.15% | purine-containing compound biosynthetic process |
| GO:0090559 | 1.15% | regulation of membrane permeability |
| GO:0002097 | 1.15% | tRNA wobble base modification |
| GO:2001243 | 1.15% | negative regulation of intrinsic apoptotic signaling pathway |
| GO:0048821 | 1.15% | erythrocyte development |
| GO:0016079 | 1.15% | synaptic vesicle exocytosis |
| GO:0051281 | 1.15% | positive regulation of release of sequestered calcium ion into cytosol |
| GO:0007416 | 1.15% | synapse assembly |
| GO:0051149 | 1.15% | positive regulation of muscle cell differentiation |
| GO:0031069 | 1.15% | hair follicle morphogenesis |
| GO:2000772 | 1.15% | regulation of cellular senescence |
| GO:0019228 | 1.15% | neuronal action potential |
| GO:0030514 | 1.15% | negative regulation of BMP signaling pathway |
| GO:0035435 | 1.15% | phosphate ion transmembrane transport |
| GO:0120192 | 1.15% | tight junction assembly |
| GO:0010765 | 1.15% | positive regulation of sodium ion transport |
| GO:0071479 | 1.15% | cellular response to ionizing radiation |
| GO:1903672 | 1.15% | positive regulation of sprouting angiogenesis |
| GO:0006549 | 1.15% | isoleucine metabolic process |
| GO:0002183 | 1.15% | cytoplasmic translational initiation |
| GO:0006206 | 1.14% | pyrimidine nucleobase metabolic process |
| GO:0007041 | 1.14% | lysosomal transport |
| GO:0072676 | 1.14% | lymphocyte migration |
| GO:2001252 | 1.14% | positive regulation of chromosome organization |
| GO:0090263 | 1.14% | positive regulation of canonical Wnt signaling pathway |
| GO:0050482 | 1.14% | arachidonic acid secretion |
| GO:0060706 | 1.14% | cell differentiation involved in embryonic placenta development |
| GO:0090305 | 1.14% | nucleic acid phosphodiester bond hydrolysis |
| GO:0009954 | 1.14% | proximal/distal pattern formation |
| GO:0001556 | 1.14% | oocyte maturation |
| GO:0030952 | 1.14% | establishment or maintenance of cytoskeleton polarity |
| GO:0035116 | 1.14% | embryonic hindlimb morphogenesis |
| GO:0042398 | 1.14% | cellular modified amino acid biosynthetic process |
| GO:1904037 | 1.14% | positive regulation of epithelial cell apoptotic process |
| GO:1902373 | 1.14% | negative regulation of mRNA catabolic process |
| GO:0002098 | 1.14% | tRNA wobble uridine modification |
| GO:0044257 | 1.14% | cellular protein catabolic process |
| GO:0000082 | 1.14% | G1/S transition of mitotic cell cycle |
| GO:0050886 | 1.14% | endocrine process |
| GO:0006120 | 1.14% | mitochondrial electron transport, NADH to ubiquinone |
| GO:0046425 | 1.14% | regulation of receptor signaling pathway via JAK-STAT |
| GO:0099643 | 1.14% | signal release from synapse |
| GO:0001961 | 1.14% | positive regulation of cytokine-mediated signaling pathway |
| GO:0032760 | 1.14% | positive regulation of tumor necrosis factor production |
| GO:0006884 | 1.14% | cell volume homeostasis |
| GO:0140056 | 1.14% | organelle localization by membrane tethering |
| GO:0009100 | 1.13% | glycoprotein metabolic process |
| GO:0010866 | 1.13% | regulation of triglyceride biosynthetic process |
| GO:0140115 | 1.13% | export across plasma membrane |
| GO:0032309 | 1.13% | icosanoid secretion |
| GO:1905330 | 1.13% | regulation of morphogenesis of an epithelium |
| GO:0010660 | 1.13% | regulation of muscle cell apoptotic process |
| GO:0042255 | 1.13% | ribosome assembly |
| GO:0070192 | 1.13% | chromosome organization involved in meiotic cell cycle |
| GO:0045684 | 1.13% | positive regulation of epidermis development |
| GO:0010863 | 1.13% | positive regulation of phospholipase C activity |
| GO:0003156 | 1.13% | regulation of animal organ formation |
| GO:0090174 | 1.13% | organelle membrane fusion |
| GO:0001782 | 1.13% | B cell homeostasis |
| GO:0002548 | 1.13% | monocyte chemotaxis |
| GO:0071312 | 1.13% | cellular response to alkaloid |
| GO:0030516 | 1.13% | regulation of axon extension |
| GO:0072665 | 1.13% | protein localization to vacuole |
| GO:0070584 | 1.13% | mitochondrion morphogenesis |
| GO:0065004 | 1.13% | protein-DNA complex assembly |
| GO:0009250 | 1.13% | glucan biosynthetic process |
| GO:0006606 | 1.13% | protein import into nucleus |
| GO:1903307 | 1.13% | positive regulation of regulated secretory pathway |
| GO:0051354 | 1.13% | negative regulation of oxidoreductase activity |
| GO:0035162 | 1.13% | embryonic hemopoiesis |
| GO:0032692 | 1.13% | negative regulation of interleukin-1 production |
| GO:0010837 | 1.13% | regulation of keratinocyte proliferation |
| GO:0034332 | 1.13% | adherens junction organization |
| GO:0006047 | 1.13% | UDP-N-acetylglucosamine metabolic process |
| GO:0061458 | 1.13% | reproductive system development |
| GO:1903008 | 1.12% | organelle disassembly |
| GO:0110110 | 1.12% | positive regulation of animal organ morphogenesis |
| GO:0098534 | 1.12% | centriole assembly |
| GO:0032967 | 1.12% | positive regulation of collagen biosynthetic process |
| GO:0051315 | 1.12% | attachment of mitotic spindle microtubules to kinetochore |
| GO:2000058 | 1.12% | regulation of ubiquitin-dependent protein catabolic process |
| GO:2000311 | 1.12% | regulation of AMPA receptor activity |
| GO:0046068 | 1.12% | cGMP metabolic process |
| GO:0044843 | 1.12% | cell cycle G1/S phase transition |
| GO:0055092 | 1.12% | sterol homeostasis |
| GO:0046185 | 1.12% | aldehyde catabolic process |
| GO:0044273 | 1.12% | sulfur compound catabolic process |
| GO:0036314 | 1.12% | response to sterol |
| GO:0009664 | 1.12% | plant-type cell wall organization |
| GO:2001039 | 1.12% | negative regulation of cellular response to drug |
| GO:0051251 | 1.12% | positive regulation of lymphocyte activation |
| GO:1903053 | 1.12% | regulation of extracellular matrix organization |
| GO:0021533 | 1.12% | cell differentiation in hindbrain |
| GO:0000723 | 1.12% | telomere maintenance |
| GO:0009084 | 1.12% | glutamine family amino acid biosynthetic process |
| GO:0050680 | 1.12% | negative regulation of epithelial cell proliferation |
| GO:0019882 | 1.12% | antigen processing and presentation |
| GO:0048002 | 1.12% | antigen processing and presentation of peptide antigen |
| GO:1902600 | 1.11% | proton transmembrane transport |
| GO:0034198 | 1.11% | cellular response to amino acid starvation |
| GO:0032649 | 1.11% | regulation of interferon-gamma production |
| GO:0046148 | 1.11% | pigment biosynthetic process |
| GO:0016579 | 1.11% | protein deubiquitination |
| GO:0065005 | 1.11% | protein-lipid complex assembly |
| GO:0071322 | 1.11% | cellular response to carbohydrate stimulus |
| GO:0042110 | 1.11% | T cell activation |
| GO:1903038 | 1.11% | negative regulation of leukocyte cell-cell adhesion |
| GO:0033688 | 1.11% | regulation of osteoblast proliferation |
| GO:0018210 | 1.11% | peptidyl-threonine modification |
| GO:1900544 | 1.11% | positive regulation of purine nucleotide metabolic process |
| GO:0000075 | 1.11% | cell cycle checkpoint |
| GO:0034698 | 1.11% | response to gonadotropin |
| GO:0009262 | 1.11% | deoxyribonucleotide metabolic process |
| GO:0042558 | 1.11% | pteridine-containing compound metabolic process |
| GO:0018200 | 1.11% | peptidyl-glutamic acid modification |
| GO:0007492 | 1.11% | endoderm development |
| GO:0043506 | 1.11% | regulation of JUN kinase activity |
| GO:0000096 | 1.11% | sulfur amino acid metabolic process |
| GO:0006473 | 1.11% | protein acetylation |
| GO:2000279 | 1.11% | negative regulation of DNA biosynthetic process |
| GO:0001910 | 1.10% | regulation of leukocyte mediated cytotoxicity |
| GO:0008333 | 1.10% | endosome to lysosome transport |
| GO:0051146 | 1.10% | striated muscle cell differentiation |
| GO:0055013 | 1.10% | cardiac muscle cell development |
| GO:0090278 | 1.10% | negative regulation of peptide hormone secretion |
| GO:0032755 | 1.10% | positive regulation of interleukin-6 production |
| GO:1902884 | 1.10% | positive regulation of response to oxidative stress |
| GO:0006910 | 1.10% | phagocytosis, recognition |
| GO:0007007 | 1.10% | inner mitochondrial membrane organization |
| GO:0006282 | 1.10% | regulation of DNA repair |
| GO:0032774 | 1.10% | RNA biosynthetic process |
| GO:0006534 | 1.10% | cysteine metabolic process |
| GO:1903963 | 1.10% | arachidonate transport |
| GO:0032869 | 1.10% | cellular response to insulin stimulus |
| GO:0030218 | 1.10% | erythrocyte differentiation |
| GO:1901988 | 1.10% | negative regulation of cell cycle phase transition |
| GO:0006547 | 1.10% | histidine metabolic process |
| GO:0045671 | 1.10% | negative regulation of osteoclast differentiation |
| GO:0009948 | 1.10% | anterior/posterior axis specification |
| GO:0043650 | 1.10% | dicarboxylic acid biosynthetic process |
| GO:0061982 | 1.10% | meiosis I cell cycle process |
| GO:0007159 | 1.10% | leukocyte cell-cell adhesion |
| GO:0006094 | 1.10% | gluconeogenesis |
| GO:0002495 | 1.10% | antigen processing and presentation of peptide antigen via MHC class II |
| GO:0071375 | 1.09% | cellular response to peptide hormone stimulus |
| GO:0007143 | 1.09% | female meiotic nuclear division |
| GO:0006733 | 1.09% | oxidoreduction coenzyme metabolic process |
| GO:0045648 | 1.09% | positive regulation of erythrocyte differentiation |
| GO:0046364 | 1.09% | monosaccharide biosynthetic process |
| GO:1902750 | 1.09% | negative regulation of cell cycle G2/M phase transition |
| GO:0031122 | 1.09% | cytoplasmic microtubule organization |
| GO:0006305 | 1.09% | DNA alkylation |
| GO:0061387 | 1.09% | regulation of extent of cell growth |
| GO:0051279 | 1.09% | regulation of release of sequestered calcium ion into cytosol |
| GO:0016073 | 1.09% | snRNA metabolic process |
| GO:1904427 | 1.09% | positive regulation of calcium ion transmembrane transport |
| GO:0072384 | 1.09% | organelle transport along microtubule |
| GO:0000725 | 1.09% | recombinational repair |
| GO:0150104 | 1.09% | transport across blood-brain barrier |
| GO:0042632 | 1.09% | cholesterol homeostasis |
| GO:0009953 | 1.09% | dorsal/ventral pattern formation |
| GO:0070723 | 1.09% | response to cholesterol |
| GO:0031396 | 1.09% | regulation of protein ubiquitination |
| GO:0031529 | 1.09% | ruffle organization |
| GO:0015909 | 1.09% | long-chain fatty acid transport |
| GO:2000677 | 1.09% | regulation of transcription regulatory region DNA binding |
| GO:0032210 | 1.08% | regulation of telomere maintenance via telomerase |
| GO:0032200 | 1.08% | telomere organization |
| GO:0006636 | 1.08% | unsaturated fatty acid biosynthetic process |
| GO:0032272 | 1.08% | negative regulation of protein polymerization |
| GO:0046823 | 1.08% | negative regulation of nucleocytoplasmic transport |
| GO:0007272 | 1.08% | ensheathment of neurons |
| GO:0090313 | 1.08% | regulation of protein targeting to membrane |
| GO:0002090 | 1.08% | regulation of receptor internalization |
| GO:1990961 | 1.08% | xenobiotic detoxification by transmembrane export across the plasma membrane |
| GO:0043414 | 1.08% | macromolecule methylation |
| GO:0090501 | 1.08% | RNA phosphodiester bond hydrolysis |
| GO:0009152 | 1.08% | purine ribonucleotide biosynthetic process |
| GO:0010842 | 1.08% | retina layer formation |
| GO:1903319 | 1.08% | positive regulation of protein maturation |
| GO:0090303 | 1.08% | positive regulation of wound healing |
| GO:0042552 | 1.08% | myelination |
| GO:0051224 | 1.08% | negative regulation of protein transport |
| GO:0006306 | 1.08% | DNA methylation |
| GO:2000045 | 1.08% | regulation of G1/S transition of mitotic cell cycle |
| GO:0032231 | 1.08% | regulation of actin filament bundle assembly |
| GO:0052192 | 1.08% | movement in environment of other organism involved in symbiotic interaction |
| GO:0016556 | 1.08% | mRNA modification |
| GO:0010955 | 1.08% | negative regulation of protein processing |
| GO:0030878 | 1.08% | thyroid gland development |
| GO:0006553 | 1.08% | lysine metabolic process |
| GO:0008366 | 1.07% | axon ensheathment |
| GO:0048536 | 1.07% | spleen development |
| GO:1903203 | 1.07% | regulation of oxidative stress-induced neuron death |
| GO:0008207 | 1.07% | C21-steroid hormone metabolic process |
| GO:0033198 | 1.07% | response to ATP |
| GO:0001776 | 1.07% | leukocyte homeostasis |
| GO:0042059 | 1.07% | negative regulation of epidermal growth factor receptor signaling pathway |
| GO:0008088 | 1.07% | axo-dendritic transport |
| GO:0030517 | 1.07% | negative regulation of axon extension |
| GO:0016236 | 1.07% | macroautophagy |
| GO:0006403 | 1.07% | RNA localization |
| GO:0006551 | 1.07% | leucine metabolic process |
| GO:0019319 | 1.07% | hexose biosynthetic process |
| GO:0007369 | 1.07% | gastrulation |
| GO:0044728 | 1.07% | DNA methylation or demethylation |
| GO:0022008 | 1.07% | neurogenesis |
| GO:0006956 | 1.07% | complement activation |
| GO:0015914 | 1.07% | phospholipid transport |
| GO:0042130 | 1.07% | negative regulation of T cell proliferation |
| GO:1902106 | 1.07% | negative regulation of leukocyte differentiation |
| GO:2000059 | 1.07% | negative regulation of ubiquitin-dependent protein catabolic process |
| GO:0031507 | 1.07% | heterochromatin assembly |
| GO:0010324 | 1.07% | membrane invagination |
| GO:0008589 | 1.07% | regulation of smoothened signaling pathway |
| GO:0002705 | 1.07% | positive regulation of leukocyte mediated immunity |
| GO:0032197 | 1.07% | transposition, RNA-mediated |
| GO:0006364 | 1.07% | rRNA processing |
| GO:0002504 | 1.07% | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II |
| GO:1904950 | 1.07% | negative regulation of establishment of protein localization |
| GO:0046825 | 1.06% | regulation of protein export from nucleus |
| GO:0006310 | 1.06% | DNA recombination |
| GO:0010821 | 1.06% | regulation of mitochondrion organization |
| GO:0051646 | 1.06% | mitochondrion localization |
| GO:0070828 | 1.06% | heterochromatin organization |
| GO:1900101 | 1.06% | regulation of endoplasmic reticulum unfolded protein response |
| GO:0009101 | 1.06% | glycoprotein biosynthetic process |
| GO:0051492 | 1.06% | regulation of stress fiber assembly |
| GO:0043407 | 1.06% | negative regulation of MAP kinase activity |
| GO:0000724 | 1.06% | double-strand break repair via homologous recombination |
| GO:2000736 | 1.06% | regulation of stem cell differentiation |
| GO:0045954 | 1.06% | positive regulation of natural killer cell mediated cytotoxicity |
| GO:0050771 | 1.06% | negative regulation of axonogenesis |
| GO:1904659 | 1.06% | glucose transmembrane transport |
| GO:0032642 | 1.06% | regulation of chemokine production |
| GO:0035914 | 1.06% | skeletal muscle cell differentiation |
| GO:0050982 | 1.06% | detection of mechanical stimulus |
| GO:2001239 | 1.06% | regulation of extrinsic apoptotic signaling pathway in absence of ligand |
| GO:0060291 | 1.06% | long-term synaptic potentiation |
| GO:1900182 | 1.05% | positive regulation of protein localization to nucleus |
| GO:0000266 | 1.05% | mitochondrial fission |
| GO:0043044 | 1.05% | ATP-dependent chromatin remodeling |
| GO:0072583 | 1.05% | clathrin-dependent endocytosis |
| GO:1903050 | 1.05% | regulation of proteolysis involved in cellular protein catabolic process |
| GO:0032731 | 1.05% | positive regulation of interleukin-1 beta production |
| GO:0042157 | 1.05% | lipoprotein metabolic process |
| GO:0002720 | 1.05% | positive regulation of cytokine production involved in immune response |
| GO:0002460 | 1.05% | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0032092 | 1.05% | positive regulation of protein binding |
| GO:0046676 | 1.05% | negative regulation of insulin secretion |
| GO:0002888 | 1.05% | positive regulation of myeloid leukocyte mediated immunity |
| GO:0060143 | 1.05% | positive regulation of syncytium formation by plasma membrane fusion |
| GO:0042098 | 1.05% | T cell proliferation |
| GO:0045103 | 1.05% | intermediate filament-based process |
| GO:1900015 | 1.05% | regulation of cytokine production involved in inflammatory response |
| GO:1903727 | 1.05% | positive regulation of phospholipid metabolic process |
| GO:0021510 | 1.05% | spinal cord development |
| GO:0007035 | 1.05% | vacuolar acidification |
| GO:0022406 | 1.05% | membrane docking |
| GO:0016036 | 1.05% | cellular response to phosphate starvation |
| GO:2000117 | 1.05% | negative regulation of cysteine-type endopeptidase activity |
| GO:1902170 | 1.05% | cellular response to reactive nitrogen species |
| GO:0006164 | 1.04% | purine nucleotide biosynthetic process |
| GO:0070328 | 1.04% | triglyceride homeostasis |
| GO:0051125 | 1.04% | regulation of actin nucleation |
| GO:1904376 | 1.04% | negative regulation of protein localization to cell periphery |
| GO:0021549 | 1.04% | cerebellum development |
| GO:0055090 | 1.04% | acylglycerol homeostasis |
| GO:0097479 | 1.04% | synaptic vesicle localization |
| GO:0009395 | 1.04% | phospholipid catabolic process |
| GO:0046427 | 1.04% | positive regulation of receptor signaling pathway via JAK-STAT |
| GO:0140238 | 1.04% | presynaptic endocytosis |
| GO:2000756 | 1.04% | regulation of peptidyl-lysine acetylation |
| GO:0006858 | 1.04% | extracellular transport |
| GO:1901185 | 1.04% | negative regulation of ERBB signaling pathway |
| GO:0045010 | 1.04% | actin nucleation |
| GO:0010614 | 1.04% | negative regulation of cardiac muscle hypertrophy |
| GO:0031063 | 1.04% | regulation of histone deacetylation |
| GO:0043302 | 1.04% | positive regulation of leukocyte degranulation |
| GO:0060260 | 1.04% | regulation of transcription initiation from RNA polymerase II promoter |
| GO:0007020 | 1.04% | microtubule nucleation |
| GO:1901797 | 1.04% | negative regulation of signal transduction by p53 class mediator |
| GO:0031365 | 1.04% | N-terminal protein amino acid modification |
| GO:0097035 | 1.04% | regulation of membrane lipid distribution |
| GO:0032467 | 1.04% | positive regulation of cytokinesis |
| GO:0035114 | 1.04% | imaginal disc-derived appendage morphogenesis |
| GO:0055117 | 1.04% | regulation of cardiac muscle contraction |
| GO:0035809 | 1.04% | regulation of urine volume |
| GO:0045132 | 1.04% | meiotic chromosome segregation |
| GO:1905879 | 1.04% | regulation of oogenesis |
| GO:0031638 | 1.04% | zymogen activation |
| GO:0046856 | 1.04% | phosphatidylinositol dephosphorylation |
| GO:0045453 | 1.04% | bone resorption |
| GO:1902042 | 1.04% | negative regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0045069 | 1.04% | regulation of viral genome replication |
| GO:0061005 | 1.04% | cell differentiation involved in kidney development |
| GO:0034620 | 1.04% | cellular response to unfolded protein |
| GO:0048103 | 1.03% | somatic stem cell division |
| GO:0045724 | 1.03% | positive regulation of cilium assembly |
| GO:1990090 | 1.03% | cellular response to nerve growth factor stimulus |
| GO:0006351 | 1.03% | transcription, DNA-templated |
| GO:0071825 | 1.03% | protein-lipid complex subunit organization |
| GO:0010719 | 1.03% | negative regulation of epithelial to mesenchymal transition |
| GO:0097659 | 1.03% | nucleic acid-templated transcription |
| GO:0006110 | 1.03% | regulation of glycolytic process |
| GO:0006997 | 1.03% | nucleus organization |
| GO:0050974 | 1.03% | detection of mechanical stimulus involved in sensory perception |
| GO:0045981 | 1.03% | positive regulation of nucleotide metabolic process |
| GO:0002286 | 1.03% | T cell activation involved in immune response |
| GO:0098581 | 1.03% | detection of external biotic stimulus |
| GO:0000377 | 1.03% | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile |
| GO:0002717 | 1.03% | positive regulation of natural killer cell mediated immunity |
| GO:0044272 | 1.03% | sulfur compound biosynthetic process |
| GO:0051402 | 1.03% | neuron apoptotic process |
| GO:0050850 | 1.03% | positive regulation of calcium-mediated signaling |
| GO:0034656 | 1.03% | nucleobase-containing small molecule catabolic process |
| GO:0003007 | 1.03% | heart morphogenesis |
| GO:0070988 | 1.03% | demethylation |
| GO:1905953 | 1.03% | negative regulation of lipid localization |
| GO:0003015 | 1.03% | heart process |
| GO:0006022 | 1.03% | aminoglycan metabolic process |
| GO:0050868 | 1.03% | negative regulation of T cell activation |
| GO:0045576 | 1.03% | mast cell activation |
| GO:0016197 | 1.03% | endosomal transport |
| GO:1902806 | 1.03% | regulation of cell cycle G1/S phase transition |
| GO:0048255 | 1.03% | mRNA stabilization |
| GO:0003085 | 1.03% | negative regulation of systemic arterial blood pressure |
| GO:1904894 | 1.03% | positive regulation of receptor signaling pathway via STAT |
| GO:0002082 | 1.03% | regulation of oxidative phosphorylation |
| GO:0033003 | 1.03% | regulation of mast cell activation |
| GO:0002759 | 1.03% | regulation of antimicrobial humoral response |
| GO:0071242 | 1.03% | cellular response to ammonium ion |
| GO:0034341 | 1.02% | response to interferon-gamma |
| GO:0051590 | 1.02% | positive regulation of neurotransmitter transport |
| GO:0060322 | 1.02% | head development |
| GO:0032434 | 1.02% | regulation of proteasomal ubiquitin-dependent protein catabolic process |
| GO:0048488 | 1.02% | synaptic vesicle endocytosis |
| GO:0010954 | 1.02% | positive regulation of protein processing |
| GO:0032387 | 1.02% | negative regulation of intracellular transport |
| GO:0002762 | 1.02% | negative regulation of myeloid leukocyte differentiation |
| GO:0030243 | 1.02% | cellulose metabolic process |
| GO:0032479 | 1.02% | regulation of type I interferon production |
| GO:0042116 | 1.02% | macrophage activation |
| GO:0043388 | 1.02% | positive regulation of DNA binding |
| GO:0090183 | 1.02% | regulation of kidney development |
| GO:0010529 | 1.02% | negative regulation of transposition |
| GO:0002886 | 1.02% | regulation of myeloid leukocyte mediated immunity |
| GO:1903318 | 1.02% | negative regulation of protein maturation |
| GO:0043486 | 1.02% | histone exchange |
| GO:0000086 | 1.02% | G2/M transition of mitotic cell cycle |
| GO:1901020 | 1.02% | negative regulation of calcium ion transmembrane transporter activity |
| GO:0006525 | 1.02% | arginine metabolic process |
| GO:0090069 | 1.02% | regulation of ribosome biogenesis |
| GO:0051310 | 1.02% | metaphase plate congression |
| GO:0006656 | 1.02% | phosphatidylcholine biosynthetic process |
| GO:0006906 | 1.02% | vesicle fusion |
| GO:0002269 | 1.02% | leukocyte activation involved in inflammatory response |
| GO:0046329 | 1.02% | negative regulation of JNK cascade |
| GO:0035813 | 1.01% | regulation of renal sodium excretion |
| GO:0032691 | 1.01% | negative regulation of interleukin-1 beta production |
| GO:0019646 | 1.01% | aerobic electron transport chain |
| GO:0043280 | 1.01% | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0006544 | 1.01% | glycine metabolic process |
| GO:0008154 | 1.01% | actin polymerization or depolymerization |
| GO:0006984 | 1.01% | ER-nucleus signaling pathway |
| GO:1903205 | 1.01% | regulation of hydrogen peroxide-induced cell death |
| GO:1904030 | 1.01% | negative regulation of cyclin-dependent protein kinase activity |
| GO:0032733 | 1.01% | positive regulation of interleukin-10 production |
| GO:0000398 | 1.01% | mRNA splicing, via spliceosome |
| GO:0032507 | 1.01% | maintenance of protein location in cell |
| GO:0045910 | 1.01% | negative regulation of DNA recombination |
| GO:0031497 | 1.01% | chromatin assembly |
| GO:2001244 | 1.01% | positive regulation of intrinsic apoptotic signaling pathway |
| GO:0050779 | 1.01% | RNA destabilization |
| GO:0008045 | 1.01% | motor neuron axon guidance |
| GO:1903115 | 1.01% | regulation of actin filament-based movement |
| GO:1903779 | 1.01% | regulation of cardiac conduction |
| GO:0072528 | 1.01% | pyrimidine-containing compound biosynthetic process |
| GO:1905476 | 1.01% | negative regulation of protein localization to membrane |
| GO:2001056 | 1.01% | positive regulation of cysteine-type endopeptidase activity |
| GO:0001774 | 1.00% | microglial cell activation |
| GO:2000104 | 1.00% | negative regulation of DNA-dependent DNA replication |
| GO:0044319 | 1.00% | wound healing, spreading of cells |
| GO:0035120 | 1.00% | post-embryonic appendage morphogenesis |
| GO:0014014 | 1.00% | negative regulation of gliogenesis |
| GO:0006958 | 1.00% | complement activation, classical pathway |
| GO:0045823 | 1.00% | positive regulation of heart contraction |
| GO:0042278 | 1.00% | purine nucleoside metabolic process |
| GO:0030203 | 1.00% | glycosaminoglycan metabolic process |
| GO:0031397 | 1.00% | negative regulation of protein ubiquitination |
| GO:0001562 | 1.00% | response to protozoan |
| GO:0031000 | 1.00% | response to caffeine |
| GO:0018195 | 1.00% | peptidyl-arginine modification |
| GO:0097755 | 1.00% | positive regulation of blood vessel diameter |
| GO:0007030 | 1.00% | Golgi organization |
| GO:0007099 | 1.00% | centriole replication |
| GO:0033137 | 1.00% | negative regulation of peptidyl-serine phosphorylation |
| GO:0006122 | 1.00% | mitochondrial electron transport, ubiquinol to cytochrome c |
| GO:0001909 | 1.00% | leukocyte mediated cytotoxicity |
| GO:0030318 | 1.00% | melanocyte differentiation |
| GO:0009713 | 1.00% | catechol-containing compound biosynthetic process |